[
{
    "Title": "Abacavir",
    "Text1": "Abacavir sulfate is a nucleoside analogue and reverse transcriptase inhibitor which is used in combination with other agents in the therapy of the human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Abacavir is a rare cause of clinically apparent drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548225/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617015.html"
},
{
    "Title": "Abatacept",
    "Text1": "Abatacept is a recombinant fusion protein of the cell surface marker CTLA-4 and immunoglobulin that acts by interfering with T cell activation and is used to treat rheumatoid arthritis. Abatacept has been linked to a low rate of serum enzyme elevations during therapy, but has not been linked to cases of idiosyncratic, clinically apparent liver injury with jaundice. Because abatacept is a potent inhibitor of lymphocyte function, it may cause reactivation of chronic hepatitis B in susceptible patients.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548442/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a606016.html"
},
{
    "Title": "Abemaciclib",
    "Text1": "Abemaciclib is a unique cyclin-dependent kinase inhibitor that is used in combination with an antiestrogen in the treatment of postmenopausal women with metastatic breast cancer. Abemaciclib is associated with a moderate rate of serum aminotransferase elevations during therapy and is suspected to be a rare cause of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548807/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617049.html"
},
{
    "Title": "Abiraterone",
    "Text1": "Abiraterone is an antiandrogen used to treat metastatic, castration-resistant prostate cancer. Abiraterone is associated with a not uncommon rate of serum enzyme elevation during therapy, but has not been clearly linked to cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548136/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611046.html"
},
{
    "Title": "Acalabrutinib",
    "Text1": "Acalabrutinib is an oral inhibitor of Bruton’s tyrosine kinase that is used in the therapy of B cell malignancies including refractory mantle cell lymphoma and chronic lymphocytic leukemia. Acalabrutinib has been associated with mild-to-moderate serum enzyme elevations during therapy but has not been linked to instances of idiosyncratic acute liver injury, although it has been associated with cases of reactivation of hepatitis B which can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548486/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618004.html"
},
{
    "Title": "Acamprosate",
    "Text1": "Acamprosate is a synthetic amino acid and a neurotransmitter analogue that is used as an alcohol deterrent in management of alcohol dependence and abuse. Acamprosate has not been linked to serum enzyme elevations during therapy and has not been linked to cases of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548677/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604028.html"
},
{
    "Title": "Acarbose",
    "Text1": "Acarbose is an alpha glucosidase inhibitor which decreases intestinal absorption of carbohydrates and is used as an adjunctive therapy in the management of type 2 diabetes. Acarbose has been linked to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548181/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a696015.html"
},
{
    "Title": "Acebutolol",
    "Text1": "Acebutolol is a cardioselective beta-blocker used in the treatment of hypertension, angina pectoris and cardiac arrhythmias. Acebutolol has been linked to several instances of clinically apparent drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548853/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a687003.html"
},
{
    "Title": "Acetaminophen",
    "Text1": "Acetaminophen is a widely used nonprescription analgesic and antipyretic medication for mild-to-moderate pain and fever. Harmless at low doses, acetaminophen has direct hepatotoxic potential when taken as an overdose and can cause acute liver injury and death from acute liver failure. Even in therapeutic doses, acetaminophen can cause transient serum aminotransferase elevations.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548162/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601009.html"
},
{
    "Title": "Acetylcysteine",
    "Text1": "Acetylcysteine, also known as N-acetylcysteine (NAC), is a modified amino acid that is used as an antidote for acetaminophen overdose to prevent hepatic injury. Acetylcysteine is a hepatoprotective agent and has not been linked to significant serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548401/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615021.html"
},
{
    "Title": "Acitretin",
    "Text1": "Acitretin is a retinoid and vitamin A derivative currently used in the treatment of psoriasis. Acitretin, like many retinoids, can lead to increase in serum aminotransferase levels and has been implicated in cases of acute liver injury which can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548784/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601010.html"
},
{
    "Title": "Aclidinium",
    "Text1": "Aclidinium is a synthetic anticholinergic agent that is used as an inhalant for treatment of acute bronchospasm due to chronic bronchitis or emphysema. Aclidinium has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548832/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613001.html"
},
{
    "Title": "Acyclovir",
    "Text1": "Acyclovir is a nucleoside analogue and antiviral agent used in therapy of herpes and varicella-zoster virus infections. Acyclovir has not been associated with clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548548/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a606001.html"
},
{
    "Title": "Adalimumab",
    "Text1": "Adalimumab is a monoclonal antibody to human tumor necrosis factor (TNF) alpha which has potent antiinflammatory activity and is used in the therapy of severe rheumatoid arthritis and inflammatory bowel disease. Adalimumab has been linked to rare instances of idiosyncratic acute liver injury and is a potential cause of reactivation of hepatitis B.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548542/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a603010.html"
},
{
    "Title": "Adefovir",
    "Text1": "Adefovir dipivoxil is an acyclic nucleotide analogue of adenosine used either alone or in combination with other agents as therapy of chronic hepatitis B. Adefovir does not appear to be a significant cause of drug induced liver injury, but initiation of therapy and sudden withdrawal of therapy can induce a transient exacerbation of the underlying hepatitis B.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548633/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605024.html"
},
{
    "Title": "Afatinib",
    "Text1": "Afatinib is a tyrosine kinase receptor inhibitor that is used in the therapy of selected forms of metastatic non-small cell lung cancer. Afatinib is associated with transient elevations in serum aminotransferase levels during therapy and has been reported to cause clinically apparent acute liver injury and rare instances of death.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548772/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613044.html"
},
{
    "Title": "Albendazole",
    "Text1": "Albendazole is an anthelmintic agent used predominantly in treatment of echinococcosis, a parasitic worm that causes cysts in liver and lung. Albendazole therapy is commonly associated with mild and transient serum enzyme elevations and rarely can lead to clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548360/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a610019.html"
},
{
    "Title": "Albiglutide",
    "Text1": "Albiglutide is a recombinant DNA produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents. There have been no published reports of hepatotoxicity attributed to albiglutide therapy.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548054/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614031.html"
},
{
    "Title": "Aldesleukin",
    "Text1": "Aldesleukin is a recombinant form of human interleukin-2, a cytokine that stimulates the proliferation and maturation of T cells, which is used in immune therapy of renal cell cancer and malignant melanoma. When given in high doses, interleukin-2 regularly causes mild-to-moderate elevations in serum enzymes and bilirubin, but it rarely results in clinically significant acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548091/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a692009.html"
},
{
    "Title": "Alemtuzumab",
    "Text1": "Alemtuzumab is a recombinant human monoclonal antibody to human CD52 which is used in the therapy of chronic lymphocytic leukemia, in induction regimens for solid organ transplantation and for resistant forms of relapsing multiple sclerosis. Alemtuzumab has not been linked to serum aminotransferase elevations during therapy but has been implicated in rare cases of clinically apparent liver injury as well as reactivation of chronic hepatitis B and exacerbations of chronic hepatitis C that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548212/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608053.html"
},
{
    "Title": "Alfuzosin",
    "Text1": "Alfuzosin is a nonselective alpha-1 adrenergic antagonist used in the therapy of benign prostatic hypertrophy. Alfuzosin is associated with a low rate of transient serum aminotransferase elevations and with rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548748/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604002.html"
},
{
    "Title": "Alirocumab",
    "Text1": "Alirocumab is a human monoclonal antibody to PCSK9 (proprotein convertase subtilisin/kexin type 9), a circulating protein that modulates the activity of the LDL cholesterol receptor in the liver. The monoclonal antibody lowers serum LDL cholesterol and is used to treat severe hypercholesterolemia. Alirocumab therapy has been associated with a low rate of serum aminotransferase elevations and has yet to be linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548190/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615035.html"
},
{
    "Title": "Aliskiren",
    "Text1": "Aliskiren is a unique antihypertensive agent that acts by direct inhibition of renin and has only recently been introduced into clinical practice. Aliskiren has been linked to rare instances of serum aminotransferase elevations during therapy and rare cases of idiosyncratic, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548884/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607039.html"
},
{
    "Title": "Allopurinol",
    "Text1": "Allopurinol is a xanthine oxidase inhibitor and a widely used medication for gout. Allopurinol is a rare but well known cause of acute liver injury that has features of a hypersensitivity reaction and can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548098/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682673.html"
},
{
    "Title": "Alogliptin",
    "Text1": "Alogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other oral hypoglycemic agents. Alogliptin has been reported to cause liver injury, but the characteristics and details of the injury have not been defined in the published literature.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548275/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613026.html"
},
{
    "Title": "Alprazolam",
    "Text1": "Alprazolam is an orally available benzodiazepine used predominantly for therapy of anxiety. As with most benzodiazepines, alprazolam therapy has not been associated with serum aminotransferase or alkaline phosphatase elevations, and clinically apparent liver injury from alprazolam has been reported, but is very rare.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548178/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684001.html"
},
{
    "Title": "Altretamine",
    "Text1": "Altretamine is an orally administered alkylating agent, formerly known as hexamethylmelamine, which is currently used as a secondary therapy for advanced ovarian carcinoma. Altretamine therapy has been associated with low rates of serum enzyme elevations during therapy and with rare instances of acute, clinically apparent injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548524/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601200.html"
},
{
    "Title": "Amantadine",
    "Text1": "Amantadine is a primary amine that has both antiviral and dopaminergic activity and is used in the therapy of influenza A and management of Parkinson disease. Amantadine has not been associated with clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547954/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682064.html"
},
{
    "Title": "Ambrisentan",
    "Text1": "Ambrisentan is an endothelin receptor antagonist used in the therapy of pulmonary arterial hypertension (PAH). Ambrisentan has been associated with a low rate of serum enzyme elevations during therapy, but has yet to be implicated in cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548675/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612023.html"
},
{
    "Title": "Amikacin",
    "Text1": "Amikacin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for severe gram negative infections. Despite widespread use, amikacin has not been associated with instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548695/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682661.html"
},
{
    "Title": "Amiloride",
    "Text1": "Amiloride is a potassium-sparing diuretic used in the therapy of edema often in combination with thiazide diuretics. Amiloride has been linked to rare cases of clinically apparent drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547934/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615029.html"
},
{
    "Title": "Amiodarone",
    "Text1": "Amiodarone is a potent arrhythmia suppressing agent that has been clearly linked to several distinct forms of drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548109/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a687009.html"
},
{
    "Title": "Amitriptyline",
    "Text1": "Amitriptyline is a tricyclic antidepressant that is widely used in the therapy of depression. Amitriptyline can cause mild and transient serum enzyme elevations and is rare cause of clinically apparent acute cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548410/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682388.html"
},
{
    "Title": "Amlodipine",
    "Text1": "Amlodipine besylate is a second generation calcium channel blocker that is used in the therapy of hypertension and angina pectoris. Amlodipine has been linked to a low rate of serum enzyme elevations during therapy and to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548585/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601018.html"
},
{
    "Title": "Amoxapine",
    "Text1": "Amoxapine is a tetracyclic antidepressant used for relief of symptoms of depression caused by either reactive or psychotic depression. Amoxapine has been associated with a low rate of minor serum aminotransferase elevations during treatment and to very rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548520/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682202.html"
},
{
    "Title": "Amphotericin B",
    "Text1": "Amphotericin B is an antifungal agent with a broad spectrum of activity against many fungal species. Amphotericin B commonly causes mild to moderate serum aminotransferase elevations and can cause hyperbilirubinemia, but acute, clinically apparent drug induced liver injury from amphotericin B therapy is exceedingly rare.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548141/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616018.html"
},
{
    "Title": "Anagrelide",
    "Text1": "Anagrelide is an antithrombotic and platelet reducing agent that is used to treat the thrombocythemia associated with myeloproliferative diseases. Anagrelide has had limited clinical use, but has not been linked to significant serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548467/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601020.html"
},
{
    "Title": "Anakinra",
    "Text1": "Anakinra is a recombinant interleukin-1 (IL-1) receptor antagonist that has antiinflammatory and immunomodulatory actions and is used in the therapy of rheumatoid arthritis and other inflammatory arthritides. Anakinra is associated with a low rate of serum enzyme elevations during therapy and with rare instances of clinically apparent, acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548615/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a602001.html"
},
{
    "Title": "Anastrozole",
    "Text1": "Anastrozole is a nonsteroidal inhibitor of aromatase which effectively blocks estrogen synthesis in postmenopausal women and is used as therapy of estrogen receptor positive breast cancer. Anastrozole has been associated with a low rate of serum enzyme elevations during therapy and rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548189/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a696018.html"
},
{
    "Title": "Apalutamide",
    "Text1": "Apalutamide is a nonsteroidal antiandrogen used to treat nonmetastatic castration-resistant prostate cancer. Apalutamide is associated with a low rate of serum enzyme elevation during therapy, but has not been linked to cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547950/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618018.html"
},
{
    "Title": "Apixaban",
    "Text1": "Apixaban is an oral anticoagulant and direct inhibitor of factor Xa which is used to decrease the risk of venous thromboses, systemic embolization and stroke in patients with atrial fibrillation, and lower the risk of deep vein thrombosis and pulmonary embolus after knee or hip replacement surgery. Apixaban has been linked to a low rate of serum aminotransferase elevations during therapy and to rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548281/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613032.html"
},
{
    "Title": "Apomorphine",
    "Text1": "Apomorphine is a subcutaneously administered dopamine receptor agonist used predominantly in the therapy of hypomobility of advanced Parkinson disease. The use of apomorphine has been limited, but it has not been associated with serum enzyme elevations during treatment nor has it been implicated in cases of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548143/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604020.html"
},
{
    "Title": "Apremilast",
    "Text1": "Apremilast is an orally available, small molecule inhibitor of phosphodiesterase-4 (PDE-4) and an immunomodulating agent that is used for treatment of refractory psoriatic arthritis. Apremilast has been linked to a low rate of serum enzyme elevations during therapy, but has not been implicated in cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547974/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614022.html"
},
{
    "Title": "Aprepitant",
    "Text1": "Aprepitant is an orally available antiemetic agent that is used to prevent postoperative or cancer chemotherapy related nausea and vomiting. Aprepitant is associated with a low rate of serum enzyme elevations during therapy, but has not been clearly linked to cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548897/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604003.html"
},
{
    "Title": "Aripiprazole",
    "Text1": "Aripiprazole is an atypical antipsychotic used in the treatment of schizophrenia and bipolar illness. Aripiprazole therapy has not been associated consistently with serum aminotransferase elevations and has yet to be linked to cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547858/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a603012.html"
},
{
    "Title": "Arsenic",
    "Text1": "Arsenic is a nonessential trace element that is widely distributed in nature. Arsenic was used in medicinal agents in the 19th and early 20th centuries, but has been replaced by safer and more effective agents and has not been in use for over 50 years. Nevertheless, arsenic is found widely in nature and accidental or intentional acute or chronic exposures to moderate or high levels of arsenic can cause liver injury, sometimes presenting long after the exposure.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548692/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608017.html"
},
{
    "Title": "Asenapine",
    "Text1": "Asenapine is a second generation (atypical) antipsychotic agent that is taken sublingually and used in the treatment of schizophrenia and manic or mixed episodes associated with bipolar 1 disorder. Asenapine is associated with a low rate of transient and mild serum aminotransferase elevations during therapy, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548092/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a610015.html"
},
{
    "Title": "Asparaginase",
    "Text1": "Asparaginase is a bacterial enzyme that is used as an antineoplastic agent, largely in the therapy of acute lymphocytic leukemia. L-asparaginase has many side effects, one of which is hepatic injury that is characterized by inhibition of hepatic protein synthesis and steatosis, which can be severe and lead to death from hepatic failure.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548488/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612034.html"
},
{
    "Title": "Aspirin",
    "Text1": "Aspirin or acetylsalicylic acid is perhaps the most commonly used analgesic and antipyretic medication worldwide, having been in clinical use for over 100 years. Aspirin can cause several forms of liver injury: in high doses, aspirin can cause moderate to marked serum aminotransferase elevations occasionally with jaundice or signs of liver dysfunction, and in lower doses in susceptible children with a febrile illness aspirin can lead to Reye syndrome.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548900/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682878.html"
},
{
    "Title": "Atazanavir",
    "Text1": "Atazanavir is an antiretroviral protease inhibitor that is used in the therapy and prevention of human immunodeficiency virus (HIV-1) infection and the acquired immunodeficiency syndrome (AIDS). Atazanavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels, mild elevations in indirect bilirubin concentration and, rarely, clinically apparent, acute liver injury. In HBV or HCV coinfected patients, highly active antiretroviral therapy with atazanavir may result of an exacerbation of the underlying chronic hepatitis B or C.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547918/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a603019.html"
},
{
    "Title": "Atenolol",
    "Text1": "Atenolol is a cardioselective beta-blocker that is widely used in the treatment of hypertension and angina pectoris. Atenolol has been linked to rare cases of drug induced liver injury, some of which have been fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548379/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684031.html"
},
{
    "Title": "Atezolizumab",
    "Text1": "Atezolizumab is a humanized monoclonal antibody to programmed death-ligand 1 (PD-L1) that increases immune reactivity to tumor neoantigens and is used as immunotherapy of selected cancers of the bladder and lung. Atezolizumab has been associated with a low rate of serum enzyme elevations during therapy and with uncommon instances of clinically apparent, immune-mediated liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548858/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616035.html"
},
{
    "Title": "Atomoxetine",
    "Text1": "Atomoxetine is a selective norepinephrine reuptake inhibitor used primarily for therapy of attention deficit hyperactivity disorder. Atomoxetine has been linked to a low rate of serum aminotransferase elevations and to rare cases of acute, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548671/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a603013.html"
},
{
    "Title": "Atorvastatin",
    "Text1": "Atorvastatin is a commonly used cholesterol lowering agent (statin) that is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy and rarely with clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548236/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a600045.html"
},
{
    "Title": "Atovaquone",
    "Text1": "Atovaquone is a naphthoquinone used for the prevention and treatment of Pneumocystis jevorici (formerly carinii) pneumonia and, in combination with proguanil, prevention and treatment of P. falciparum malaria. Atovaquone therapy is associated with low rates of serum enzyme elevations and has been linked to only rare cases of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548592/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a693003.html"
},
{
    "Title": "Atropine",
    "Text1": "Atropine is a natural alkaloid anticholinergic agent that has potent antimuscarinic effects and is used by injection to treat symptomatic bradycardia, severe bronchospasm and to reduce vagal stimulation. Atropine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548915/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682487.html"
},
{
    "Title": "Avanafil",
    "Text1": "Avanafil is a selective inhibitor of phosphodiesterase type 5 (PDE5) and is used as therapy of erectile dysfunction. Avanafil is a relatively new medication and has yet to be linked to instances of serum enzyme elevations or with clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548149/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614010.html"
},
{
    "Title": "Avelumab",
    "Text1": "Avelumab is a human monoclonal antibody to programmed cell death receptor ligand 1 (PD-L1), which modulates T cell immune reactivity and is used in the immunotherapy of cancer. Avelumab has major side effects and particularly immune related conditions, including acute liver injury which can be serious and even life threatening.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548530/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617006.html"
},
{
    "Title": "Axitinib",
    "Text1": "Axitinib is an oral tyrosine kinase inhibitor selective for vascular endothelial growth factor (VEGF) receptors -1, -2 and -3 that is used in the therapy of advanced renal cell carcinoma. Axitinib therapy is commonly associated with transient elevations in serum aminotransferase that are generally mild and asymptomatic. Axitinib has yet to be linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548139/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612017.html"
},
{
    "Title": "Azacitidine",
    "Text1": "Azacitidine is a cytosine analogue and antineoplastic agent used in the therapy of myelodysplastic syndromes. Azacitidine is associated with a low rate of transient serum enzyme elevations during therapy and has only rarely been implicated in cases of clinically apparent acute liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548363/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a620060.html"
},
{
    "Title": "Azathioprine",
    "Text1": "Azathioprine is a purine analogue and prodrug of mercaptopurine that is used as an immunosuppressive agent in organ transplantation to prevent rejection and in autoimmune diseases as a corticosteroid sparing agent. Azathioprine is associated with minor, usually transient and asymptomatic elevations in serum aminotransferase levels during therapy and with rare instances of acute, cholestatic liver injury and, with long term use, noncirrhotic portal hypertension as a result of nodular regenerative hyperplasia or sinusoidal obstruction syndrome.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548332/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682167.html"
},
{
    "Title": "Azilsartan",
    "Text1": "Azilsartan is an angiotensin II receptor blocker (ARB) used in the therapy of hypertension. It is associated with a low rate of transient serum aminotransferase elevations, but has yet to be linked to instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548036/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611028.html"
},
{
    "Title": "Azithromycin",
    "Text1": "Azithromycin is a semisynthetic macrolide antibiotic which is commonly used for a wide variety of mild-to-moderate bacterial infections. Azithromycin has been linked to rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548434/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697037.html"
},
{
    "Title": "Aztreonam",
    "Text1": "Aztreonam is a parenterally administered, synthetic monobactam antibiotic that is specifically active against aerobic gram-negative bacilli is resistant to many beta-lactamases. Aztreonam therapy is often accompanied by mild, asymptomatic elevations in serum aminotransferase levels, but it has not been reported to cause clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548462/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a687010.html"
},
{
    "Title": "Baclofen",
    "Text1": "Baclofen is a centrally acting muscle relaxant commonly prescribed for spasticity in patients with multiple sclerosis. Baclofen has not been linked to rare instances of mild, self-limited, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548081/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682530.html"
},
{
    "Title": "Baloxavir",
    "Text1": "Baloxavir is an inhibitor of the influenza cap-dependent endonuclease enzyme and is used as therapy of influenza A and B. Baloxavir is given as a single, one-time dose and has not been associated with serum enzyme elevations or with clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547923/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618062.html"
},
{
    "Title": "Baricitinib",
    "Text1": "Baricitinib is an orally available small molecule inhibitor of Janus kinases that is used to treat moderate-to-severe rheumatoid arthritis and in late 2020 was given emergency use authorization as therapy in combination with remdesivir for severe COVID-19. Baricitinib is associated with transient and usually mild elevations in serum aminotransferase levels during therapy but has yet to be linked to cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548012/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618033.html"
},
{
    "Title": "Basiliximab",
    "Text1": "Basiliximab is a chimeric mouse-human monoclonal antibody to CD25, the alpha subunit of the IL-2 receptor, which is found on the surface of T cells. Basiliximab has potent immunosuppressive activity and is used for prevention of organ transplant rejection. Basiliximab has not been linked to serum enzyme elevations during therapy or implicated in cases of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548587/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612013.html"
},
{
    "Title": "Basiliximab",
    "Text1": "Basiliximab is a chimeric mouse-human monoclonal antibody to CD25, the alpha subunit of the IL-2 receptor, which is found on the surface of T cells. Basiliximab has potent immunosuppressive activity and is used for prevention of organ transplant rejection. Basiliximab has not been linked to serum enzyme elevations during therapy or implicated in cases of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548587/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612013.html"
},
{
    "Title": "Bedaquiline",
    "Text1": "Bedaquiline is a diarylquinoline antimycobacterial drug used in combination with other antituberculosis medications in the treatment of multidrug resistant tuberculosis. The addition of bedaquiline to antituberculosis drug regimens has been linked to an increased rate of transient serum liver test abnormalities during treatment and to several instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548859/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613022.html"
},
{
    "Title": "Belimumab",
    "Text1": "Belimumab is a human monoclonal antibody to the soluble B-lymphocyte stimulator (BLsY) which is used in the therapy of systemic lupus erythematous. Belimumab has been linked to an uncommon incidence of transient serum enzyme elevations during therapy, but has yet to be linked to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548761/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611027.html"
},
{
    "Title": "Belinostat",
    "Text1": "Belinostat is an intravenously administered histone deacetylase inhibitor and antineoplastic agent that is approved for use in refractory or relapsed peripheral T cell lymphoma. Belinostat is associated with moderate rate of minor serum enzyme elevations during therapy and has been reported to cause clinically apparent fatal, acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548714/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614035.html"
},
{
    "Title": "Benazepril",
    "Text1": "Benazepril is an angiotensin-converting enzyme (ACE) inhibitor widely used in the therapy of hypertension. Benazepril is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548659/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a692011.html"
},
{
    "Title": "Bendamustine",
    "Text1": "Bendamustine is a parenterally administered alkylating agent used alone and in combination with other antineoplastic agents in the treatment of chronic lymphocytic leukemia and refractory forms of non-Hodgkin lymphoma. Bendamustine therapy is associated with minor transient serum enzyme elevations during treatment and to rare instances of clinically apparent liver injury, with jaundice generally arising as a part of a generalized hypersensitivity syndrome. Bendamustine also has potent immunosuppressive activity and can cause reactivation of chronic hepatitis B that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548108/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608034.html"
},
{
    "Title": "Benralizumab",
    "Text1": "Benralizumab is a humanized monoclonal antibody to the interleukin-5 (IL-5) receptor alpha which leads to a decrease in production and maturation of eosinophils and is used therapeutically to reduce allergic symptoms in patients with eosinophilic asthma. Benralizumab has not been associated with serum enzyme elevations during therapy or to instances of clinically apparent drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548640/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618002.html"
},
{
    "Title": "Benznidazole",
    "Text1": "Benznidazole is an orally available, broad spectrum antimicrobial agent used in the treatment of Chagas disease. Benznidazole is a nitroimidazole similar to metronidazole and is associated with serum enzyme elevations during therapy in up to 10% of patients but has not linked to cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548076/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617043.html"
},
{
    "Title": "Benztropine",
    "Text1": "Benztropine is an anticholinergic agent used predominantly in the symptomatic therapy of Parkinson disease and movement disorders. Benztropine has not been associated with serum enzyme elevations during treatment and has not been linked to cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548408/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682155.html"
},
{
    "Title": "Betaine",
    "Text1": "Betaine is a modified amino acid consisting of glycine with three methyl groups that serves as a methyl donor in several metabolic pathways and is used to treat the rare genetic causes of homocystinuria. Betaine has had only limited clinical use, but has not been linked to instances of serum enzyme elevations during therapy or to clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548774/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608012.html"
},
{
    "Title": "Betaxolol",
    "Text1": "Betaxolol is a cardioselective beta-blocker used in the treatment of hypertension. Betaxolol has not been linked to instances of clinically apparent drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548618/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a609023.html"
},
{
    "Title": "Betrixaban",
    "Text1": "Betrixaban is an oral anticoagulant and direct inhibitor of factor Xa which is used to decrease the risk of deep vein thrombosis and pulmonary embolus in hospitalized patients at high risk for venous thromboses. Betrixaban has been linked to a low rate of serum aminotransferase elevations during therapy, but has not been linked to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548444/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617050.html"
},
{
    "Title": "Bexarotene",
    "Text1": "Bexarotene is a retinoid analogue that is used to treat the skin manifestations of cutaneous T cell lymphoma (CTCL). Bexarotene therapy is associated with a high rate of serum enzyme elevations and rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548336/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608006.html"
},
{
    "Title": "Bezlotoxumab",
    "Text1": "Bezlotoxumab is a human monoclonal antibody to the Clostridium difficile toxin B that is used to reduce the risk of recurrence in high risk patients being treated for C. difficile infection. Bezlotoxumab has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548863/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617003.html"
},
{
    "Title": "Bicalutamide",
    "Text1": "Bicalutamide is a nonsteroidal antiandrogen similar in structure to flutamide that is used widely in the therapy of prostate cancer and has been linked to rare instances of liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547970/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697047.html"
},
{
    "Title": "Bictegravir",
    "Text1": "Bictegravir is a human immunodeficiency virus (HIV) integrase strand transfer inhibitor, the fourth in this class of agents that target the viral integrase. Bictegravir is used only in combination with other antiretroviral agents in the treatment of HIV infection and it has had limited use. Bictegravir is associated with a low rate of serum aminotransferase elevations during therapy, but has not been linked to instances of acute, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547914/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618012.html"
},
{
    "Title": "Bisacodyl",
    "Text1": "Bisacodyl is commonly used, over-the-counter laxative used to treat constipation or bowel irregularity. Bisacodyl has not been associated with serum enzyme elevations during therapy or with clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548124/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611051.html"
},
{
    "Title": "Bisoprolol",
    "Text1": "Bisoprolol is a cardioselective beta-blocker used in the treatment of hypertension. Bisoprolol has not been linked to instances of clinically apparent drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548471/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a693024.html"
},
{
    "Title": "Bleomycin",
    "Text1": "Bleomycin is a cystotoxic antibiotic that is used as an anticancer agent in the therapy of testicular and germ cell cancers, Hodgkin disease, lymphomas and tumors of the head and neck. Therapy with bleomycin in combination with other agents is often associated with mild-to-moderate serum enzyme elevations, but is a rare cause of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548499/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682125.html"
},
{
    "Title": "Blinatumomab",
    "Text1": "Blinatumomab is a recombinant mouse derived bispecific monoclonal antibody to the CD3 cell surface antigen found on T lymphocytes and the CD19 site for the targeted (malignant) B lymphocytes. Blinatumomab is approved for use as a second line treatment of relapsed or refractory B cell precursor related acute lymphoblastic leukemia (ALL). Blinatumomabis commonly associated with mild-to-moderate serum enzyme and bilirubin elevations during the first cycle of therapy, but it has not been linked to cases of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548198/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614061.html"
},
{
    "Title": "Boceprevir",
    "Text1": "Boceprevir is an oral, direct acting hepatitis C virus (HCV) protease inhibitor that is used in combination with other antiviral agents in the treatment of chronic hepatitis C, genotype 1. Boceprevir has not been linked to instances of acute liver injury during therapy but, when combined with peginterferon and ribavirin, has been associated with cases of hepatic decompensation in patients with preexisting cirrhosis.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548247/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611039.html"
},
{
    "Title": "Bortezomib",
    "Text1": "Bortezomib is a proteasome inhibitor and antineoplastic agent that is used in treatment of refractory multiple myeloma and certain lymphomas. Bortezomib is associated with a low rate of serum enzyme elevations during treatment and to rare instances of clinically apparent, acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548027/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607007.html"
},
{
    "Title": "Bosentan",
    "Text1": "Bosentan is an endothelin receptor antagonist used in the therapy of pulmonary arterial hypertension (PAH). Bosentan has been associated with serum enzyme elevations during therapy and with rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547999/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605001.html"
},
{
    "Title": "Bosutinib",
    "Text1": "Bosutinib is a dual kinase inhibitor of both the BCR-ABL and Src tyrosine kinases and is used in the therapy of Philadelphia chromosome-positive chronic myelogenous leukemia. Bosutinib therapy is associated with transient elevations in serum aminotransferase and bilirubin levels and rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547951/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613005.html"
},
{
    "Title": "Brentuximab Vedotin",
    "Text1": "Brentuximab vedotin is a chimeric mouse-human monoclonal antibody to CD30 conjugated to a microtubule inhibitor which is used in the therapy of Hodgkin lymphoma and anaplastic large cell lymphoma. Brentuximab vedotin has been linked to mild and transient serum enzyme elevations during therapy, but has not been implicated in cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548802/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611052.html"
},
{
    "Title": "Brexanolone",
    "Text1": "Brexanolone is a unique, intravenously administered, neuroactive steroidal antidepressant used in the therapy of moderate-to-severe postpartum depression. In prelicensure clinical trials, brexanolone therapy was not associated with an increased rate of serum aminotransferase elevations, and it has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548043/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619037.html"
},
{
    "Title": "Brexpiprazole",
    "Text1": "Brexpiprazole is an atypical antipsychotic used in the treatment of schizophrenia and major depressive disorders. Brexpiprazole has been associated with a low rate of serum aminotransferase elevations during therapy, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548464/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615046.html"
},
{
    "Title": "Brigatinib",
    "Text1": "Brigatinib is a tyrosine kinase receptor inhibitor and antineoplastic agent used in the therapy of selected forms of advanced non-small cell lung cancer. Brigatinib is associated with a moderate rate of transient elevations in serum aminotransferase levels during therapy but has yet to be linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548523/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617016.html"
},
{
    "Title": "Brivaracetam",
    "Text1": "Brivaracetam is a relatively unique anticonvulsant that is typically used in combination with other antiepileptic medications for partial onset seizures. Brivaracetam has been linked to rare instances of serum aminotransferase and alkaline phosphatase elevations during treatment and is suspected of causing rare cases of clinically apparent drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548532/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616027.html"
},
{
    "Title": "Brodalumab",
    "Text1": "Brodalumab is a human monoclonal antibody to the interleukin-17A receptor which acts as an immunosuppressant and is used to treat moderate-to-severe plaque psoriasis. Brodalumab has not been linked to serum enzyme elevations during therapy or to instances of idiosyncratic acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548013/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617009.html"
},
{
    "Title": "Bromocriptine",
    "Text1": "Bromocriptine is an oral dopamine receptor agonist used predominantly in the therapy of Parkinson disease, but which has other activities including inhibition of prolactin and growth hormone release which has led to its use in acromegaly, infertility and galactorrhea. Bromocriptine therapy is associated with low rate of transient serum enzyme elevations during treatment and has been implicated in rare cases of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548601/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682079.html"
},
{
    "Title": "Brompheniramine",
    "Text1": "Brompheniramine and chlorpheniramine maleate are first generation antihistamines that are widely used to treat symptoms of allergic rhinitis and the common cold. Clinically apparent liver injury from brompheniramine or chlorpheniramine must be exceeding rare, if it occurs at all.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548077/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682545.html"
},
{
    "Title": "Budesonide",
    "Text1": "Budesonide is a corticosteroid that undergoes high first pass elimination by the liver so that systemic levels after oral administration are minimal. Budesonide has been used orally for several immune mediated gastrointestinal and liver diseases and as nasal spray or by inhalation for allergic rhinitis, asthma and chronic obstructive lung disease. Neither inhalant nor oral budesonide has been linked to serum enzyme elevations during therapy or to convincing instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548351/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608007.html"
},
{
    "Title": "Buprenorphine",
    "Text1": "Buprenorphine is a sublingually and transdermally available, semisynthetic opioid analgesic, which is used as an analgesic and for management of opioid dependence. Therapy with buprenorphine is associated with mild and transient serum enzyme elevations, and with moderate-to-severe clinically apparent liver injury when abused by intravenous administration or the sublingual formations.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548871/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616019.html"
},
{
    "Title": "Bupropion",
    "Text1": "Bupropion is an aminoketone antidepressant that is widely used in therapy of depression and smoking cessation. Bupropion therapy can be associated with transient, usually asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548836/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a695033.html"
},
{
    "Title": "Burosumab",
    "Text1": "Burosumab is a human monoclonal antibody to fibroblast growth factor 23 (FGF23) which is used in the treatment of X-linked hypophosphatemia. Burosumab therapy has not been associated with serum enzyme elevations during therapy nor has it been implicated in cases of clinically apparent drug induced liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548478/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618034.html"
},
{
    "Title": "Buspirone",
    "Text1": "Buspirone is a psychoactive drug used for management of general anxiety disorders and alleviation of the symptoms of anxiety. Despite wide scale use, it is an infrequent cause of serum enzyme elevations and has not been linked to instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547966/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a688005.html"
},
{
    "Title": "Busulfan",
    "Text1": "Busulfan is an orally administered anticancer alkylating agent used in the treatment of chronic myelogenous leukemia, as well as a parenterally administered myeloablative agent used in preparation of hematopoietic cell transplantation (HCT). Busulfan has been linked to transient serum enzyme elevations during therapy, to rare cases of cholestatic hepatitis, instances of nodular regenerative hyperplasia and, when given in high doses, to sinusoidal obstruction syndrome which can be severe and fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548886/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682248.html"
},
{
    "Title": "Butorphanol",
    "Text1": "Butorphanol is a synthetic opioid which is used as a nasal spray for treatment of migraine headaches and parenterally as a narcotic analgesic for moderate-to-severe pain or as an adjunct to general anesthesia. Butorphanol has not been linked to serum enzyme elevations during therapy or to clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547902/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682667.html"
},
{
    "Title": "Cabazitaxel",
    "Text1": "Cabazitaxel is a taxane and antineoplastic agent which is currently used in the therapy of castration-resistant metastatic prostate cancer after failure of docetaxel. Therapy with cabazitaxel has been associated with a low rate of serum enzyme elevations, but has not been linked to cases of clinically apparent acute liver injury, although it can cause severe hypersensitivity infusion reactions which in some instances can be associated with acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548533/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611009.html"
},
{
    "Title": "Cabozantinib",
    "Text1": "Cabozantinib is orally available kinase inhibitor and antineoplastic agent that is used in treatment of advanced, metastatic medullary thyroid cancer and refractory renal cell carcinoma. Cabozantinib is associated with a low rate of serum enzyme elevations during treatment and has been implicated with rare instances of clinically apparent, acute liver injury, some of which have been severe.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548279/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616037.html"
},
{
    "Title": "Caffeine",
    "Text1": "Caffeine is xanthine alkaloid that occurs naturally in seeds, leaves and fruit of several plants and trees that acts as a natural pesticide. Caffeine is a major component of coffee, tea and chocolate and in humans acts as a central nervous system (CNS) stimulant. Consumption of caffeine, even in high doses, has not been associated with elevations in serum enzyme elevations or instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK559835/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601048.html"
},
{
    "Title": "Candesartan",
    "Text1": "Candesartan is an angiotensin II receptor blocker used widely in the therapy of hypertension and heart failure. Candesartan is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548409/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601033.html"
},
{
    "Title": "Cannabidiol",
    "Text1": "Cannabidiol is an orally available cannabinoid that is used to treat patients with refractory epilepsy due to Lennox-Gastaut or Dravet syndrome. Cannabidiol is associated with frequent serum enzyme elevations during therapy particularly with higher doses but has not been linked to cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548890/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618051.html"
},
{
    "Title": "Capecitabine",
    "Text1": "Capecitabine is a pyrimidine analogue used as an antineoplastic agent to treat metastatic and advanced forms of breast and colon cancer, often in combination with other agents. Capecitabine is associated with a low rate of transient serum aminotransferase elevations during therapy but has been only rarely implicated in cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547986/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699003.html"
},
{
    "Title": "Captopril",
    "Text1": "Captopril is an angiotensin-converting enzyme (ACE) inhibitor used in the therapy of hypertension and heart failure. Captopril is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548504/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682823.html"
},
{
    "Title": "Carbamazepine",
    "Text1": "Carbamazepine is an aromatic anticonvulsant that is widely used in therapy of epilepsy and trigeminal neuralgia and is a well established cause of clinically apparent liver injury which can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548097/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682237.html"
},
{
    "Title": "Carboplatin",
    "Text1": "Carboplatin is an intravenously administered platinum coordination complex and alkylating agent which is used as a chemotherapeutic agent for the treatment of various cancers, mainly ovarian, head and neck and lung cancers. Carboplatin therapy is associated with a low rate of transient serum aminotransferase elevations and with rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548565/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a695017.html"
},
{
    "Title": "Carfilzomib",
    "Text1": "Carfilzomib is an irreversible proteasome inhibitor and antineoplastic agent that is used in treatment of refractory multiple myeloma. Carfilzomib is associated with a low rate of serum enzyme elevations during treatment and has been implicated to rare instances of clinically apparent, acute liver injury some of which have been fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548814/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612031.html"
},
{
    "Title": "Cariprazine",
    "Text1": "Cariprazine is an atypical antipsychotic used in the treatment of schizophrenia and manic or mixed episodes of bipolar disorder. Cariprazine has been associated with a low rate of serum aminotransferase elevations during therapy, but it has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548595/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615050.html"
},
{
    "Title": "Carisoprodol",
    "Text1": "Carisoprodol is a centrally acting muscle relaxant that has been in use for more than fifty years without significant evidence for causing hepatic injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548829/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682578.html"
},
{
    "Title": "Carmustine",
    "Text1": "Carmustine (BCNU) is a parenterally administered alkylating agent used alone and in combination with other antineoplastic agents in the treatment of several forms of cancer including leukemias, lymphomas, and breast, testicular, ovarian, gastric and pancreatic cancer. Carmustine therapy is associated with minor transient serum enzyme elevations and has been linked to cases of acute liver injury including cholestatic hepatitis and acute veno-occlusive disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548307/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682060.html"
},
{
    "Title": "Carvedilol",
    "Text1": "Carvedilol is a unique antihypertensive medication with activity against both alpha- and beta-adrenergic receptors. Carvedilol has been linked to at least one instance of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548399/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697042.html"
},
{
    "Title": "Ceftriaxone",
    "Text1": "Ceftriaxone is a third generation cephalosporin antibiotic which has been associated with development of biliary sludge and biliary colic when given parenterally and in high doses. Ceftriaxone is also associated with rare instances of immunoallergic, usually cholestatic hepatitis similar to the injury associated with other cephalosporins.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548258/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a685032.html"
},
{
    "Title": "Celecoxib",
    "Text1": "Celecoxib is a nonsteroidal antiinflammatory drug (NSAID) with selectively for inhibition of cycloxgenase-2 (Cox-2), which is widely used in the therapy of arthritis. Celecoxib has been linked to rare instances of idiosyncratic drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548579/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699022.html"
},
{
    "Title": "Cemiplimab",
    "Text1": "Cemiplimab is a human monoclonal antibody to the programmed cell death receptor 1 (PD-1), a checkpoint inhibitor used in the immunotherapy of cancer. Cemiplimab therapy has many adverse events and particularly immune-related conditions including acute hepatitis, which can be serious and even life threatening.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548288/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618054.html"
},
{
    "Title": "Ceritinib",
    "Text1": "Ceritinib is a small molecule tyrosine kinase receptor inhibitor and antineoplastic agent that is used in the therapy of selected forms of advanced non-small cell lung cancer (NSCLC). Ceritinib is associated with a moderate rate of serum aminotransferase elevations during therapy and rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548045/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614027.html"
},
{
    "Title": "Certolizumab",
    "Text1": "Certolizumab is a Fab fragment of a monoclonal antibody to human tumor necrosis factor alpha (TNFa) which has potent antiinflammatory activity and is used in the therapy of severe rheumatoid arthritis and inflammatory bowel disease. Certolizumab has had limited use and has yet to be specifically linked to instances of idiosyncratic acute liver injury or reactivation of hepatitis B, but is likely to cause similar hepatic injury to what has been described for other TNFa antagonists such as infliximab and adalimumab.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548466/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608041.html"
},
{
    "Title": "Cetirizine",
    "Text1": "Cetirizine and its enantiomer levocetirizine are second generation antihistamines that are used for the treatment of allergic rhinitis, angioedema and chronic urticaria. Cetirizine and levocetirizine have been linked to rare, isolated instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548420/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a698026.html"
},
{
    "Title": "Cetuximab",
    "Text1": "Cetuximab is a chimeric mouse-human monoclonal antibody to the human epidermal growth factor (EGF) receptor which is used in the treatment of metastatic colon and head and neck cancers. Cetuximab has been linked to mild and transient serum enzyme elevations during therapy, but has not been implicated in cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547908/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607041.html"
},
{
    "Title": "Cevimeline",
    "Text1": "Cevimeline is an orally available cholinergic agonist that is used to treat symptoms of dry mouth in patients with keratoconjunctivitis sicca (Sjögren syndrome). Cevimeline has not been linked to serum enzyme elevations during therapy or to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548833/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608025.html"
},
{
    "Title": "Chloral hydrate",
    "Text1": "Chloral hydrate is a mild hypnotic that is used to treat simple insomnia. Despite many years of use, chloral hydrate has not been implicated in causing serum enzyme elevations or clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548377/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682201.html"
},
{
    "Title": "Chlorambucil",
    "Text1": "Chlorambucil is an orally administered alkylating agent which is currently used in the therapy of chronic lymphocytic leukemia, Hodgkin and non-Hodgkin lymphomas, and rarely in severe autoimmune conditions including rheumatoid arthritis, uveitis and nephrotic syndrome. Chlorambucil therapy has been associated with low rates of serum enzyme elevations during therapy and to rare instances of acute, clinically apparent injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548207/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682899.html"
},
{
    "Title": "Chloramphenicol",
    "Text1": "Chloramphenicol is a broad spectrum antibiotic introduced into clinical practice in 1948, but which was subsequently shown to cause serious and fatal aplastic anemia and is now used rarely and reserved for severe, life-threatening infections for which other antibiotics are not available. Chloramphenicol has also been linked to cases of acute, clinically apparent liver injury with jaundice, largely in association with aplastic anemia.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548105/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608008.html"
},
{
    "Title": "Chlordiazepoxide",
    "Text1": "Chlordiazepoxide is an orally available benzodiazepine used for therapy of anxiety and alcohol withdrawal syndromes. As with other benzodiazepines, chlordiazepoxide therapy is not associated with serum aminotransferase or alkaline phosphatase elevations, and clinically apparent liver injury from chlordiazepoxide has been reported, but is very rare.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548339/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682078.html"
},
{
    "Title": "Chloroquine",
    "Text1": "Chloroquine is an aminoquinoline used for the prevention and therapy of malaria. It is also effective in extraintestinal amebiasis and as an antiinflammatory agent for therapy of rheumatoid arthritis and lupus erythematosus. Chloroquine is not associated with serum enzyme elevations and is an extremely rare cause of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548224/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682318.html"
},
{
    "Title": "Chlorpromazine",
    "Text1": "Chlorpromazine is a phenothiazine that was once the most commonly prescribed antipsychotic agent, but that is now rarely used. Chlorpromazine can cause mild and transient serum enzyme elevations and is also a well known cause of clinically apparent acute and chronic cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548793/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682040.html"
},
{
    "Title": "Chlorzoxazone",
    "Text1": "Chlorzoxazone is a centrally acting muscle relaxant commonly used for low back pain. Chlorzoxazone has been linked to rare instances of acute liver injury, a few of which have been fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548137/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682577.html"
},
{
    "Title": "Cholestyramine",
    "Text1": "Cholestyramine is a nonabsorbed bile acid sequestrant that is used a therapy of hyperlipidemia and for the pruritus of chronic liver disease and biliary obstruction. Cholestyramine has been associated with mild and transient serum enzyme elevations during therapy, but has not been linked to cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548431/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682672.html"
},
{
    "Title": "Cholic Acid",
    "Text1": "Cholic acid is a naturally occurring bile acid that is used to treat patients with genetic deficiencies in the synthesis of bile acids. When given in high doses, cholic acid replacement therapy has been linked to minor elevations in serum aminotransferase levels, but it has not been linked to instances of clinically apparent acute liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548276/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615026.html"
},
{
    "Title": "Cidofovir",
    "Text1": "Cidofovir is a nucleoside analogue and antiviral agent which is used in therapy of serious cytomegalovirus infections in immunocompromised patients. Cidofovir has been associated with mild-to-moderate serum aminotransferase elevations during intravenous therapy, but has not been convincingly linked to cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548417/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a696037.html"
},
{
    "Title": "Cilostazol",
    "Text1": "Cilostazol is a quinolinone derivative that inhibits specific cellular phosphadiesterases, which cause arterial vasodilation and inhibition of platelet function and makes it a valuable as a therapy of intermittent claudication and as a means of secondary prevention of stroke. Cilostazol has not been associated with serum enzyme elevations during therapy or with published instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547957/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601038.html"
},
{
    "Title": "Cimetidine",
    "Text1": "Cimetidine is a histamine type 2 receptor antagonist (H2 blocker) which is widely used for treatment of acid-peptic disease and heartburn. Cimetidine has been linked to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548130/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682256.html"
},
{
    "Title": "Ciprofloxacin",
    "Text1": "Ciprofloxacin is a second generation fluoroquinolone antibiotic that is widely used in the therapy of mild-to-moderate urinary and respiratory tract infections caused by susceptible organisms. Ciprofloxacin has been linked to rare but convincing instances of liver injury that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548066/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618027.html"
},
{
    "Title": "Cisplatin",
    "Text1": "Cisplatin is the prototype platinum coordination complex classified as an alkylating agent and used intravenously in the treatment of several forms of cancer. Cisplatin has been associated with a low rate of serum enzyme elevations and with rare cases of clinically apparent, acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548160/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684036.html"
},
{
    "Title": "Citalopram",
    "Text1": "Citalopram and escitalopram are selective serotonin reuptake inhibitors (SSRIs) and widely used antidepressants. Citalopram is a racemic mixture, whereas escitalopram is its S-enantiomer. Both agents have similar profiles of clinical efficacy and side effects. Both have been associated with rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548395/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699001.html"
},
{
    "Title": "Cladribine",
    "Text1": "Cladribine is a purine analogue and antineoplastic agent used primarily in the therapy of hairy cell leukemia. Cladribine is typically given intravenously daily for 7 days, usually as a single course, and has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent acute liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548555/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a693015.html"
},
{
    "Title": "Clarithromycin",
    "Text1": "Clarithromycin is a semisynthetic macrolide antibiotic used for a wide variety of mild-to-moderate bacterial infections. Clarithromycin has been linked to rare instances of acute liver injury that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547886/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a692005.html"
},
{
    "Title": "Clemastine",
    "Text1": "Clemastine is a first generation antihistamine that is used for symptoms of allergic rhinitis and the common cold. Clemastine has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548709/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682542.html"
},
{
    "Title": "Clindamycin",
    "Text1": "Clindamycin is a broad spectrum antibiotic used orally, topically and parenterally for bacterial infections due to sensitive organisms. Clindamycin has been linked to rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548292/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a609005.html"
},
{
    "Title": "Clobazam",
    "Text1": "Clobazam is a benzodiazepine that is used as an anticonvulsant in the therapy of severe childhood epilepsy. Therapy with clobazam has not been associated with serum aminotransferase elevations, and clinically apparent liver injury from clobazam has yet to be reported and must be rare, if it occurs at all.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548865/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612008.html"
},
{
    "Title": "Clofarabine",
    "Text1": "Clofarabine is a purine analogue and antineoplastic agent used in the therapy of acute lymphoblastic leukemia (ALL) in children. Clofarabine is associated with frequent transient serum enzyme elevations during therapy, but they are usually asymptomatic and transient and it has only rarely been implicated in causing clinically apparent acute liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548185/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607012.html"
},
{
    "Title": "Clomiphene",
    "Text1": "Clomiphene is an oral agent used to treat infertility in women desiring pregnancy. Clomiphene has been linked to a low rate of transient serum aminotransferase elevations during therapy and to rare instances of clinically apparent liver injury, which can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548008/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682704.html"
},
{
    "Title": "Clomipramine",
    "Text1": "Clomipramine is a tricyclic antidepressant used in the therapy of obsessive-compulsive disorder. Clomipramine can cause mild and transient serum enzyme elevations and is rare cause of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548878/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697002.html"
},
{
    "Title": "Clonazepam",
    "Text1": "Clonazepam is a benzodiazepine used predominantly as an anticonvulsant as adjunctive therapy in management of epilepsy. Therapy with clonazepam is not associated with serum aminotransferase elevations, and clinically apparent liver injury from clonazepam, if it occurs at all, must be exceedingly rare.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548030/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682279.html"
},
{
    "Title": "Clonidine",
    "Text1": "Clonidine is a centrally active alpha-adrenergic agonist used predominantly as an antihypertensive agent, usually in combination with other agents. Despite wide scale use for many years, clonidine has not been linked definitively to either serum aminotransferase elevations or clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548329/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682243.html"
},
{
    "Title": "Clopidogrel",
    "Text1": "Clopidogrel is an inhibitor of platelet aggregation that is used to decrease the risk of myocardial infarction and stroke in patients known to have atherosclerosis. Clopidogrel has been linked to rare instances of idiosyncratic, clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547946/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601040.html"
},
{
    "Title": "Clorazepate",
    "Text1": "Clorazepate is a benzodiazepine used as an anticonvulsant as adjunctive therapy in management of epilepsy and as an anxiolytic for therapy of anxiety and alcohol withdrawal. Therapy with clorazepate is not associated with serum aminotransferase elevations, and cases of clinically apparent liver injury from clorazepate have been reported but are very rare.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548330/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682052.html"
},
{
    "Title": "Clotrimazole",
    "Text1": "Clotrimazole is an imidazole antifungal agent used primarily in the treatment of skin, oral and vaginal candida infections. Clotrimazole is typically given topically or as oral or vaginal troches and has only modest systemic absorption. Nevertheless, clotrimazole given orally or as troches has been associated with transient and asymptomatic serum aminotransferase elevations during therapy, but it has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548320/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618058.html"
},
{
    "Title": "Clozapine",
    "Text1": "Clozapine was the first atypical antipsychotic approved for treatment of schizophrenia. Because it is associated with severe and potentially fatal side effects (agranulocytosis), its use is restricted to refractory schizophrenia, and monitoring during therapy is required. Clozapine therapy is associated with serum aminotransferase elevations and in rare instances has been linked to clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548412/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a691001.html"
},
{
    "Title": "Cobimetinib",
    "Text1": "Cobimetinib is a tyrosine kinase receptor inhibitor that is used in combination with vemurafenib as therapy for selected forms of advanced malignant melanoma. The combination of cobimetinib and vemurafenib is commonly associated with serum enzyme elevations during therapy and to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548657/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615057.html"
},
{
    "Title": "Codeine",
    "Text1": "Codeine is one of the natural plant alkaloids found in extracts of opium and is commonly used to treat mild-to-moderate pain and cough. Codeine, like other opioids, has not been linked to serum enzyme elevations during therapy or to clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548359/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682065.html"
},
{
    "Title": "Colchicine",
    "Text1": "Colchicine is a plant alkaloid that is widely used for treatment of gout. Colchicine has not been associated with acute liver injury or liver test abnormalities except with serious overdoses.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548068/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682711.html"
},
{
    "Title": "Colesevelam",
    "Text1": "Colesevelam is a nonabsorbed bile acid sequestrant that is used a therapy of hyperlipidemia and for the pruritus of chronic liver disease and biliary obstruction. Colesevelam has not been associated with clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548873/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699050.html"
},
{
    "Title": "Colestipol",
    "Text1": "Colestipol is a nonabsorbed bile acid sequestrant that is used a therapy of hyperlipidemia and for the pruritus of chronic liver disease and biliary obstruction. Colestipol has not been associated with clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548432/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682157.html"
},
{
    "Title": "Copanlisib",
    "Text1": "Copanlisib is an intravenously administered phosphatidylinositol-3 kinase inhibitor that is used to treat relapsed and refractory follicular lymphoma. Copanlisib is associated with a high rate of minor serum enzyme elevations during therapy and has been reported to cause clinically apparent acute liver injury that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548413/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617044.html"
},
{
    "Title": "Crizotinib",
    "Text1": "Crizotinib is a selective tyrosine kinase receptor inhibitor used in the therapy of selected cases of advanced non-small cell lung cancer. Crizotinib is associated with transient elevations in serum aminotransferase levels during treatment and rare instances of clinically apparent acute liver injury that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548638/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612018.html"
},
{
    "Title": "Crofelemer",
    "Text1": "Crofelemer is an antidiarrheal agent derived from the red sap of the South American plant Croton lechleri, which is used to treat noninfectious diarrhea in HIV positive patients on antiretroviral therapy. Crofelemer is associated with occasional instances of serum enzyme elevations during therapy, but has not been linked to cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548325/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613016.html"
},
{
    "Title": "Cyclobenzaprine",
    "Text1": "Cyclobenzaprine is a centrally acting muscle relaxant closely related to the tricyclic antidepressants. Despite its similarity to tricyclic antidepressants, there is little evidence that cyclobenzaprine causes liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548894/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682514.html"
},
{
    "Title": "Cyclophosphamide",
    "Text1": "Cyclophosphamide is an alkylating agent used in the treatment of several forms of cancer including leukemias, lymphomas and breast cancer. Cyclophosphamide therapy is associated with minor transient serum enzyme elevations and has been linked to rare cases of acute liver injury. In addition, when given in high doses as a part of a myeloablative therapy, cyclophosphamide can cause acute sinusoidal obstruction syndrome.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548059/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611044.html"
},
{
    "Title": "Cyclosporine",
    "Text1": "Cyclosporine is a calcineurin inhibitor and potent immunosuppressive agent used largely as a means of prophylaxis against cellular rejection after solid organ transplantation. Cyclosporine therapy can be associated with mild elevations in serum bilirubin and transient serum enzyme elevations, and to rare instances of clinically apparent cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548753/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601207.html"
},
{
    "Title": "Cyproheptadine",
    "Text1": "Cyproheptadine is a first generation antihistamine used in the treatment of allergic rhinitis and urticaria and as an appetite stimulant. Cyproheptadine has been linked to rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548422/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682541.html"
},
{
    "Title": "Cytarabine",
    "Text1": "Cytarabine is a cytosine analogue and antineoplastic agent used largely in the therapy of acute leukemia. Cytarabine is associated with a low rate of transient serum enzyme and bilirubin elevations during therapy, but has only rarely been implicated in cases of clinically apparent acute liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548291/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682222.html"
},
{
    "Title": "Dabigatran",
    "Text1": "Dabigatran is a direct inhibitor of thrombin and anticoagulant which is used for prevention of stroke and venous embolism in patients with chronic atrial fibrillation. Dabigatran therapy has been associated with a low rate of serum enzyme elevations and rare instances of liver enzyme elevations and jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547924/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a610024.html"
},
{
    "Title": "Dabrafenib",
    "Text1": "Dabrafenib is a selective inhibitor of mutated forms of BRAF kinase and is used alone or in combination with trametinib in the treatment of advanced malignant melanoma. Dabrafenib therapy is associated with transient elevations in serum aminotransferase during therapy, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548234/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613038.html"
},
{
    "Title": "Dacarbazine",
    "Text1": "Dacarbazine (also known as DTIC) is an intravenously administered alkylating agent used in the therapy of Hodgkin disease and malignant melanoma. Dacarbazine therapy has been associated with serum enzyme elevations during therapy and occasional cases of severe and distinctive acute hepatic failure, probably caused by acute sinusoidal obstruction syndrome.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548913/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682750.html"
},
{
    "Title": "Daclatasvir",
    "Text1": "Daclatasvir is an orally available antiviral agent that inhibits the NS5A region of the hepatitis C virus (HCV) and is used in combination with other oral antiviral agents to treat chronic hepatitis C. Elevations in serum enzyme levels during daclatasvir therapy are uncommon, and it has yet to be convincingly implicated in cases of clinically apparent liver injury with jaundice. Nevertheless, and for unknown reasons, successful all-oral regimens of antiviral therapy in patients with chronic hepatitis C and cirrhosis is occasionally complicated by hepatic decompensation and may cause reactivation of hepatitis B in susceptible patients coinfected with the hepatitis B virus (HBV).",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547875/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615044.html"
},
{
    "Title": "Daclizumab",
    "Text1": "Daclizumab is a humanized monoclonal antibody to CD25, the alpha subunit of the IL2 receptor on T lymphocytes, which was used in the past to treat and prevent acute cellular rejection after solid organ transplantation and is currently approved as a second line therapy of refactory relapsing multiple sclerosis. Daclizumab has been linked to occasional mild-to-moderate serum enzyme elevations during therapy, and to rare but potentially severe and fatal instances of immune mediated, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548018/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616036.html"
},
{
    "Title": "Dacomitinib",
    "Text1": "Dacomitinib is a multi-kinase receptor inhibitor used in the therapy of cases of non-small cell lung cancer that harbor activating mutations in the epidermal growth factor receptor gene (EGFR). Dacomitinib is associated with high rate of transient serum aminotransferase elevations during therapy but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547996/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618055.html"
},
{
    "Title": "Dactinomycin",
    "Text1": "Dactinomycin is an intravenously administered, antineoplastic antibiotic that is used in the treatment of solid tumors in children and choriocarcinoma in adult women. In high doses, dactinomycin can cause severe liver injury including sinusoidal obstruction syndrome.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548778/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682224.html"
},
{
    "Title": "Dalfampridine",
    "Text1": "Dalfampridine is a pyrimidine analogue used in the treatment of relapsing multiple sclerosis. Dalfampridine has had limited clinical use, but has not been linked to serum enzyme elevations during treatment nor to instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548455/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611005.html"
},
{
    "Title": "Dantrolene",
    "Text1": "Dantrolene is a muscle relaxant used for treatment of chronic spasticity that differs from other commonly used muscle relaxants in acting peripherally on muscle, rather than centrally on the spinal cord or brain. Dantrolene can cause acute liver injury which can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548144/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682576.html"
},
{
    "Title": "Dapsone",
    "Text1": "Dapsone is a sulfonamide related drug used for the therapy of leprosy and dermatitis herpetiformis. Dapsone has been linked with rare cases of idiosyncratic liver injury, similar to that seen with the sulfonamides.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548936/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682128.html"
},
{
    "Title": "Daptomycin",
    "Text1": "Daptomycin is an intravenously administered, broad spectrum antibiotic used to treat complex skin and tissue infections, endocarditis and bacteremia. Daptomycin is associated with a low to modest rate of serum enzyme elevations during therapy, but is a very rare cause of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548746/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608045.html"
},
{
    "Title": "Daratumumab",
    "Text1": "Daratumumab is a human monoclonal antibody to CD38 which is used in combination with other antineoplastic agents in the therapy of multiple myeloma. Daratumumab has been implicated in instances of transient, mild-to-moderate serum enzyme elevations, but has not been linked to cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548759/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a620040.html"
},
{
    "Title": "Darifenacin",
    "Text1": "Darifenacin is an anticholinergic and antispasmotic agent used to treat urinary incontinence and overactive bladder syndrome. Darifenacin has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548798/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605039.html"
},
{
    "Title": "Darunavir",
    "Text1": "Darunavir is an antiretroviral protease inhibitor that is used in the therapy and prevention of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Darunavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent, acute liver injury. In HBV or HCV coinfected patients, highly active antiretroviral therapy with darunavir may result of an exacerbation of the underlying chronic hepatitis B or C.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547994/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607042.html"
},
{
    "Title": "Dasatinib",
    "Text1": "Dasatinib is a selective tyrosine kinase receptor inhibitor that is used in the therapy of chronic myelogenous leukemia (CML) positive for the Philadelphia chromosome. Dasatinib is commonly associated with transient elevations in serum aminotransferase levels during treatment, but with only rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548780/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607063.html"
},
{
    "Title": "Daunorubicin",
    "Text1": "Daunorubicin is an anthracycline antibiotic that has antineoplastic activity and is used in the therapy of acute leukemia and AIDS related Kaposi sarcoma. Daunorubicin is associated with a low rate of transient serum enzyme and bilirubin elevations during therapy, but has not been implicated in cases of clinically apparent acute liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548259/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682289.html"
},
{
    "Title": "Decitabine",
    "Text1": "Decitabine is a cytosine analogue and an intravenously administered antineoplastic agent used in the therapy of myelodysplastic syndromes. Decitabine is associated with a low rate of transient serum enzyme elevations during therapy, but has not been implicated in causing clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548668/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608009.html"
},
{
    "Title": "Deferasirox",
    "Text1": "Deferasirox is an oral iron chelating agent used to treat chronic iron overload. Deferasirox has been linked to a low rate of transient serum aminotransferase elevations during therapy and to rare instances of clinically apparent liver injury, which can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548039/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a606002.html"
},
{
    "Title": "Deferiprone",
    "Text1": "Deferiprone is an oral iron chelating agent used to treat transfusion related, chronic iron overload. Deferiprone has been linked to a low rate of transient serum aminotransferase elevations during therapy and to rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548086/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612016.html"
},
{
    "Title": "Defibrotide",
    "Text1": "Defibrotide is a complex mixture of single stranded polydeoxyribonucleotides derived from porcine intestinal mucosa that has antithrombotic and profibrinolytic activity and is used in the treatment of severe sinusoidal obstruction syndrome (SOS) after hematopoietic cell transplantation (HCT). Defibrotide is used in patients with severe liver injury and has not been associated with worsening of serum aminotransferase elevations during therapy and has not been linked to cases of clinically apparent, idiosyncratic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548496/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616024.html"
},
{
    "Title": "Degarelix",
    "Text1": "Degarelix is a parenterally administered, gonadotropin releasing hormone (GnRH) antagonist that effectively blocks androgen production and is used to treat advanced prostate cancer. Degarelix therapy is associated with serum enzyme elevations during therapy, but has yet to be linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548578/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a609022.html"
},
{
    "Title": "Delafloxacin",
    "Text1": "Delafloxacin is a fourth generation fluoroquinolone with expanded activity against gram-positive bacteria as well as atypical pathogens. Delafloxacin has been linked to mild ALT elevations during therapy, but has yet to be linked to instances of idiosyncratic acute liver injury with symptoms and jaundice as have been described with other fluoroquinolones.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548907/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617046.html"
},
{
    "Title": "Delavirdine",
    "Text1": "Delavirdine is a nonnucleoside reverse transcriptase inhibitor used in combination with other agents in the therapy of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Delavirdine is associated with a low rate of transient serum aminotransferase elevations during therapy and is a rare cause of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547899/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a600034.html"
},
{
    "Title": "Demeclocycline",
    "Text1": "Demeclocycline is a semisynthetic tetracycline derived from Streptococcus aureofaciens that is used as an antibiotic, but perhaps more frequently as an inhibitor of arginine vasopressin in the therapy of hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). While demeclocycline has not been linked specifically to liver injury in the published literature, it is an orally available semisynthetic tetracycline and is likely to cause injury similar to that described for tetracycline, oxytetracycline, and doxycycline. Because it is not commonly used, its potential for causing liver injury may not have been fully defined.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548848/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682103.html"
},
{
    "Title": "Denileukin Diftitox",
    "Text1": "Denileukin diftitox is a recombinant fusion protein of human interleukin-2 (IL-2) attached to diphtheria toxin fragments A and B that is used as an antineoplastic agent to treat cutaneous T cell lymphomas that express IL-2 receptors. High doses of denileukin diftitox can cause mild-to-moderate elevations in serum enzymes and bilirubin, but rarely result in clinically significant acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548436/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611024.html"
},
{
    "Title": "Denosumab",
    "Text1": "Denosumab is a monoclonal antibody to the RANK ligand which plays an important role in bone remodeling. Denosumab is used in the therapy of osteoporosis and for bone metastases and rare bone tumors. Denosumab therapy has not been associated with serum enzyme elevations during therapy, nor has it been convincingly implicated in cases of clinically apparent drug induced liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548424/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a610023.html"
},
{
    "Title": "Desipramine",
    "Text1": "Desipramine is an oral tricyclic antidepressant that widely used in the therapy of depression. Desipramine can cause mild and transient serum enzyme elevations and is rare cause of clinically apparent acute cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548233/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682387.html"
},
{
    "Title": "Diclofenac",
    "Text1": "Diclofenac is a commonly used nonsteroidal antiinflammatory drug (NSAID) used for the therapy of chronic forms of arthritis and mild-to-moderate acute pain. Therapy with diclofenac in full doses is frequently associated with mild serum aminotransferase elevations and, in rare instances, can lead to serious clinically apparent, acute or chronic liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547953/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a689002.html"
},
{
    "Title": "Dicloxacillin",
    "Text1": "Dicloxacillin is an oral, second generation penicillin antibiotic that is used to treat bacterial infections caused by penicillinase-resistant staphylococci. Dicloxacillin has been linked to rare instances of clinically apparent, idiosyncratic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548106/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a685017.html"
},
{
    "Title": "Dicyclomine",
    "Text1": "Dicyclomine is an anticholinergic agent used to treat gastrointestinal conditions such as acid peptic disease and irritable bowel syndrome. Dicyclomine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548892/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684007.html"
},
{
    "Title": "Didanosine",
    "Text1": "Didanosine is a purine nucleoside analogue and reverse transcriptase inhibitor that was previously widely used in combination with other agents in the therapy of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndromes (AIDS). Didanosine therapy is associated with an appreciable rate of serum enzyme elevations during therapy, and it is a well established cause of clinically apparent acute liver injury as well as mitochondrial injury to many organs which can be associated with severe liver injury, lactic acidosis and hepatic failure. Finally, long term therapy with didanosine can cause noncirrhotic portal hypertension due to hepatoportal sclerosis and nodular regenerative hyperplasia. Because of its many, potentially severe adverse events, didanosine has been largely replaced by better tolerated agents and is now rarely used.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548326/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a691006.html"
},
{
    "Title": "Diethylpropion",
    "Text1": "Diethylpropion is a sympathomimetic amine and anorectic agent used for the short-term therapy of obesity. Diethylpropion has not been linked to either serum enzyme elevations or to clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548787/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682037.html"
},
{
    "Title": "Diflunisal",
    "Text1": "Diflunisal is a salicylic acid derivative that is used in the therapy of chronic arthritis and mild to moderate acute pain. Diflunisal has been linked mild, transient elevations in serum aminotransferase levels during therapy as well as to rare instances of idiosyncratic drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548132/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684037.html"
},
{
    "Title": "Diltiazem",
    "Text1": "Diltiazem hydrochloride is a first generation calcium channel blocker that is widely used in the therapy of hypertension and angina pectoris. Diltiazem therapy is associated with serum enzyme elevations and has been linked to rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547898/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684027.html"
},
{
    "Title": "Dimenhydrinate",
    "Text1": "Dimenhydrinate is a first generation antihistamine that is used for treatment or prevention of motion sickness or symptoms of nausea and dizziness. Dimenhydrinate has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548215/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607046.html"
},
{
    "Title": "Dimethyl Fumarate",
    "Text1": "Dimethyl fumarate is an antiinflammatory and immunomodulatory agent that is used to treat relapsing multiple sclerosis. Dimethyl fumarate is associated with a low rate of transient serum enzyme elevations during treatment, but has not been linked to instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548484/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613028.html"
},
{
    "Title": "Dinutuximab",
    "Text1": "Dinutuximab is a recombinant chimeric monoclonal antibody to GD2 which is used as an anticancer agent in combination with other antineoplastic agents in the treatment of neuroblastoma. Transient asymptomatic elevations in serum aminotransferase levels are common during dinutuximab therapy, but it has not been linked to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548696/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615022.html"
},
{
    "Title": "Diphenhydramine",
    "Text1": "Diphenhydramine is a first generation antihistamine that is used for symptoms of allergic rhinitis and the common cold. It is also commonly used as a mild sleeping aid. Diphenhydramine has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548470/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682539.html"
},
{
    "Title": "Diphenoxylate",
    "Text1": "Diphenoxylate is synthetic opioid that primarily affects opiate receptors in the intestine and is used to treat diarrhea. Diphenoxylate has not been linked to serum enzyme elevations during therapy or to clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548367/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601045.html"
},
{
    "Title": "Dipyridamole",
    "Text1": "Dipyridamole is a vasodilator and inhibitor of platelet aggregation that is used to decrease the risk of thromboembolic complications and recurrence of stroke in patients known to have atherosclerotic cerebrovascular disease. Dipyridamole is associated with a low rate of serum enzyme elevations during treatment, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548123/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682830.html"
},
{
    "Title": "Disopyramide",
    "Text1": "Disopyramide is an oral antiarrhythmic agent that has been in wide use for several decades. Long term disopyramide therapy is associated with a low rate of serum enzyme elevations and is a rare cause of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548693/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682408.html"
},
{
    "Title": "Disulfiram",
    "Text1": "Disulfiram is an alcohol deterrent used as an adjunct to treatment of chronic alcoholism, based upon its ability to cause an aversive reaction when taken with alcohol. Disulfiram has been associated a low rate of with serum aminotransferase elevations during chronic therapy and has been linked to clinical apparent acute liver injury which can be severe and result in fatality.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548103/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682602.html"
},
{
    "Title": "Docetaxel",
    "Text1": "Docetaxel is an antineoplastic agent that has a unique mechanism of action as an inhibitor of cellular mitosis and that currently plays a central role in the therapy of many solid tumors including breast and lung cancer. Docetaxel therapy is frequently associated with serum enzyme elevations which are usually transient and mild, but more importantly has been linked to rapid onset, severe hypersensitivity reactions that can be associated with acute hepatic necrosis, liver failure and death.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548899/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a696031.html"
},
{
    "Title": "Dofetilide",
    "Text1": "Dofetilide is an oral class III antiarrhythmic agent used for treatment and prevention of atrial fibrillation and flutter. Dofetilide has had limited clinical use, but has not been linked to an increased rate of serum enzyme elevations during therapy or to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548635/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601235.html"
},
{
    "Title": "Dolutegravir",
    "Text1": "Dolutegravir is a human immunodeficiency virus (HIV) integrase inhibitor, the third in this class of agents that target the viral integrase. Dolutegravir is used only in combination with other antiretroviral agents in the treatment of HIV infection, and it has had limited use. Dolutegravir is associated with a low rate of serum aminotransferase elevations during therapy, but has not been linked to instances of acute, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548350/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613043.html"
},
{
    "Title": "Donepezil",
    "Text1": "Donepezil is an oral acetylcholinesterase inhibitor used for therapy of Alzheimer disease. Donepezil is associated with a minimal rate of serum enzyme elevations during therapy and has only rarely been implicated as a cause of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548197/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697032.html"
},
{
    "Title": "Doravirine",
    "Text1": "Doravirine is a nonnucleoside reverse transcriptase inhibitor used in combination with other antiretroviral agents in the therapy of human immunodeficiency virus (HIV) infection. Doravirine is associated with a low rate of transient serum aminotransferase elevations during therapy but has not been implicated in cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548267/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618049.html"
},
{
    "Title": "Doripenem",
    "Text1": "Doripenem is a broad spectrum carbapenem antibiotic used primarily for the treatment of aerobic gram-negative bacterial infections. Doripenem, like other carbapenems, is associated with transient and asymptomatic elevations in serum enzymes. The carbapenems have also been linked to rare instances of clinically apparent, acute cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548111/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608015.html"
},
{
    "Title": "Doxazosin",
    "Text1": "Doxazosin is a nonselective alpha-1 adrenergic antagonist (alpha-blocker) used in the therapy of hypertension and benign prostatic hypertrophy. Doxazosin is associated with a low rate of transient serum aminotransferase elevations, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548718/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a693045.html"
},
{
    "Title": "Doxepin",
    "Text1": "Doxepin is a tricyclic antidepressant that widely used in the therapy of depression. Doxepin can cause mild and transient serum enzyme elevations but is a rare cause of clinically apparent acute cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548035/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682390.html"
},
{
    "Title": "Doxorubicin",
    "Text1": "Doxorubicin, epirubicin, idarubicin and valrubicin are structurally related cytotoxic antineoplastic antibiotics used in the therapy of several forms of lymphoma, leukemia, sarcoma and solid organ cancers. Doxorubicin is associated with a high rate of transient serum enzyme during therapy and to rare instances of clinically apparent acute liver injury with jaundice that can be severe and even fatal. Epirubicin and idarubicin have similar profiles of activity and adverse events as doxorubicin, but have been less commonly used and their potential for causing liver injury has been less well defined. Valrubicin is instilled directly in the bladder as treatment of refractory urinary bladder cancer, has little systemic distribution, and has not been associated with serum enzyme elevations or clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548622/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612001.html"
},
{
    "Title": "Doxycycline",
    "Text1": "Doxycycline is a semisynthetic, tetracycline related bacteriostatic antibiotic that has been linked to rare instances of acute cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548353/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682063.html"
},
{
    "Title": "Doxylamine",
    "Text1": "Doxylamine is a first generation antihistamine that is used for symptoms of allergic rhinitis and the common cold and as a short acting sedative. Doxylamine has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548828/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613045.html"
},
{
    "Title": "Dronabinol",
    "Text1": "Dronabinol is an orally available cannabinoid agonist that is used to treat nausea and vomiting and to stimulate appetite, particularly in patients with wasting disease or cachexia. Dronabinol is associated with a minimal rate of serum enzyme elevations during therapy and has not been linked to cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548830/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607054.html"
},
{
    "Title": "Dronedarone",
    "Text1": "Dronedarone is an antiarrhythmic and a synthetic derivative of amiodarone that is used for maintaining sinus rhythm for patients with atrial fibrillation or flutter. Dronedarone is associated with a variable rate of serum enzyme elevations during therapy and to rare instances of clinically apparent liver injury, which can be severe and have resulted in deaths and need for liver transplantation.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548208/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a609034.html"
},
{
    "Title": "Droxidopa",
    "Text1": "Droxidopa is an orally available prodrug of norepinephrine that is used in the treatment of symptomatic orthostatic hypotension due to neurogenic causes of autonomic failure. Droxidopa has had limited clinical use, but has not been linked to serum enzyme elevations nor to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548446/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614025.html"
},
{
    "Title": "Dulaglutide",
    "Text1": "Dulaglutide is a recombinant DNA produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents. There have been no published reports of hepatotoxicity attributed to dulaglutide therapy.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547979/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614047.html"
},
{
    "Title": "Duloxetine",
    "Text1": "Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor widely used as an antidepressant and for neuropathic pain. Duloxetine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548820/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604030.html"
},
{
    "Title": "Dupilumab",
    "Text1": "Dupilumab is a human monoclonal antibody to the interleukin-4 (IL-4) receptor which leads to a decrease in production inflammatory mediators of allergic symptoms and is used in the therapy of atopic dermatitis. Dupilumab therapy has not been associated with serum enzyme elevations or to instances of clinically apparent drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548055/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617021.html"
},
{
    "Title": "Dupilumab",
    "Text1": "Dupilumab is a human monoclonal antibody to the interleukin-4 (IL-4) receptor which leads to a decrease in production inflammatory mediators of allergic symptoms and is used in the therapy of atopic dermatitis. Dupilumab therapy has not been associated with serum enzyme elevations or to instances of clinically apparent drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548055/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617021.html"
},
{
    "Title": "Durvalumab",
    "Text1": "Durvalumab is a human monoclonal antibody to programmed cell death receptor ligand 1 (PD-L1), which results in an increased immune reactivity which can break tolerance and is used in the immunotherapy of cancer. Durvalumab therapy has many adverse events and particularly immune related conditions, including acute liver injury which can be serious and even life threatening.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548150/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617030.html"
},
{
    "Title": "Dutasteride",
    "Text1": "Dutasteride is a 5-alpha reductase inhibitor used in the therapy of symptomatic benign prostatic hypertrophy. Dutasteride is associated with a low rate of transient serum aminotransferase elevations, but has yet to be linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548058/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a603001.html"
},
{
    "Title": "Duvelisib",
    "Text1": "Duvelisib is an oral inhibitor of phosphatidylinositol 3-kinase (PI3K) that is approved for use in relapsed or refractory chronic lymphocytic leukemia (CLL) and for follicular lymphoma. Duvelisib is associated with a high rate of serum enzyme elevations during therapy and with occasional concurrent rise in serum bilirubin and is a suspected but not proven cause of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548824/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618056.html"
},
{
    "Title": "Eculizumab",
    "Text1": "Eculizumab is a humanized monoclonal antibody to complement factor 5 which acts to block complement activation and is used to treat paroxysmal nocturnal hemoglobinuria and hemolytic uremic syndrome. Eculizumab has been linked to several instances of serum enzyme elevations after repeated infusions and to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547839/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612024.html"
},
{
    "Title": "Edaravone",
    "Text1": "Edaravone is a free radical scavenger and neuroprotective agent used for therapy of amyotrophic lateral sclerosis. Edaravone is associated with a low rate of serum aminotransferase elevations during therapy but has not been linked to instances of clinically apparent, acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548729/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617027.html"
},
{
    "Title": "Edoxaban",
    "Text1": "Edoxaban is an oral, small molecule inhibitor of factor Xa which is used as an anticoagulant to decrease the risk of venous thromboses, systemic embolization and stroke in patients with atrial fibrillation, and as treatment of deep vein thrombosis and pulmonary embolism to prevent thrombotic complications. Edoxaban has been linked to a low rate of serum aminotransferase elevations during therapy, but has not been implicated in cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548805/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614055.html"
},
{
    "Title": "Efavirenz",
    "Text1": "Efavirenz is a nonnucleoside reverse transcriptase inhibitor used in combination with other agents in the therapy of human immunodeficiency virus (HIV) infection. Efavirenz is associated with a low rate of serum enzyme elevations during therapy and is an uncommon, but well established cause of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548521/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699004.html"
},
{
    "Title": "Elagolix",
    "Text1": "Elagolix is an oral, nonsteroidal gonadotropin releasing hormone (GnRH) antagonist that decreases estrogen production and is used to treat painful forms of endometriosis in women. Elagolix therapy is associated with a low rate of serum enzyme elevations during therapy and has yet to be linked to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548061/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618044.html"
},
{
    "Title": "Eliglustat",
    "Text1": "Eliglustat is an oral inhibitor of glucosylceramide synthase which is used in the therapy of type 1 Gaucher disease. Clinical experience with eliglustat is limited, but it not been linked to serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548849/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618038.html"
},
{
    "Title": "Elotuzumab",
    "Text1": "Elotuzumab is a humanized monoclonal antibody to cell surface receptor SLAMF7 which is used in combination with other antineoplastic agents in the therapy of multiple myeloma. Elotuzumab has been implicated in rare instances of transient, marked serum enzyme elevations, but has not been linked to instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548728/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616001.html"
},
{
    "Title": "Eluxadoline",
    "Text1": "Eluxadoline is a mixed opioid receptor agonist (mu) and antagonist (delta) that is used to treat diarrhea-predominant irritable bowel disease. Eluxadoline is associated with a low rate of serum aminotransferase elevations that appear to be due to isolated instances of sphincter of Oddi spasm and/or pancreatitis that occurs most frequently in persons without a gallbladder.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548868/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615054.html"
},
{
    "Title": "Elvitegravir",
    "Text1": "Elvitegravir is a human immunodeficiency virus (HIV) integrase inhibitor which is used largely in a four drug combination with cobicistat, emtricitabine and tenofovir as therapy of HIV infection. Therapy with this elvitegravir based regimen is often associated with transient serum aminotransferase elevations during therapy, but has not been implicated in cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547911/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612035.html"
},
{
    "Title": "Elvitegravir",
    "Text1": "Elvitegravir is a human immunodeficiency virus (HIV) integrase inhibitor which is used largely in a four drug combination with cobicistat, emtricitabine and tenofovir as therapy of HIV infection. Therapy with this elvitegravir based regimen is often associated with transient serum aminotransferase elevations during therapy, but has not been implicated in cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547911/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612035.html"
},
{
    "Title": "Elvitegravir",
    "Text1": "Elvitegravir is a human immunodeficiency virus (HIV) integrase inhibitor which is used largely in a four drug combination with cobicistat, emtricitabine and tenofovir as therapy of HIV infection. Therapy with this elvitegravir based regimen is often associated with transient serum aminotransferase elevations during therapy, but has not been implicated in cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547911/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612035.html"
},
{
    "Title": "Emapalumab",
    "Text1": "Emapalumab is a human monoclonal antibody to interferon gamma which acts to block its binding to cell surface receptors and activation of inflammatory signals. Emapalumab is used to treat the severe inflammatory condition of hemophagocytic lymphohistiocytosis (HLH) in which serum gamma interferon levels are elevated. Emapalumab therapy is associated with mild and transient serum enzyme elevations during therapy, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547952/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619024.html"
},
{
    "Title": "Emtricitabine",
    "Text1": "Emtricitabine is a nucleoside analogue and reverse transcriptase inhibitor used in combination with other agents for treatment and prevention of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Emtricitabine does not appear to be a significant cause of drug induced liver injury, but may cause flares of disease in patients with underlying chronic hepatitis B virus (HBV) infection.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548261/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618045.html"
},
{
    "Title": "Enalapril",
    "Text1": "Enalapril is an angiotensin-converting enzyme (ACE) inhibitor widely used in the therapy of hypertension and heart failure. Enalapril is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547936/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a686022.html"
},
{
    "Title": "Enasidenib",
    "Text1": "Enasidenib is an orally available small molecule inhibitor of isocitrate dehydrogenase and antineoplastic agent that is used in the therapy of selected cases of acute myeloid leukemia (AML). Enasidenib is associated with a moderate rate of serum aminotransferase elevations during therapy and rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548492/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617040.html"
},
{
    "Title": "Encorafenib",
    "Text1": "Encorafenib is a selective inhibitor of BRAF kinase that is used in combination with binimetinib, an inhibitor of MEK, in the therapy of metastatic and advanced malignant melanoma. Encorafenib-binimetinib combination therapy is commonly associated with transient elevations in serum aminotransferase levels during therapy, but has yet to be linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547988/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618040.html"
},
{
    "Title": "Enfuvirtide",
    "Text1": "Enfuvirtide is an HIV fusion inhibitor, the first of this class of agents active against the human immunodeficiency virus (HIV). Enfuvirtide has not been associated with serum aminotransferase elevations during therapy or episodes of acute, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548862/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a603023.html"
},
{
    "Title": "Entacapone",
    "Text1": "Entacapone is a catechol-O-methyltransferase inhibitor used in the therapy of Parkinson disease as adjunctive therapy in combination with levodopa and carbidopa. Entacapone has been associated with a low rate of serum enzyme elevations during treatment, but has yet to be implicated in cases of clinically apparent acute liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548152/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601236.html"
},
{
    "Title": "Entecavir",
    "Text1": "Entecavir is a guanosine nucleoside analogue used in the treatment of chronic hepatitis B virus (HBV) infection. Entecavir therapy can be associated with flares of the underlying hepatitis B during or after therapy, but has not been linked to cases of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548075/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605028.html"
},
{
    "Title": "Enzalutamide",
    "Text1": "Enzalutamide is a nonsteroidal antiandrogen used to treat metastatic castration-resistant prostate cancer. Enzalutamide is associated with a low rate of serum enzyme elevation during therapy, but has not been linked to cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548070/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612033.html"
},
{
    "Title": "Eplerenone",
    "Text1": "Eplerenone is an aldosterone receptor antagonist and potassium-sparing diuretic used in the therapy of hypertension. Eplerenone therapy has been associated with transient elevations in serum aminotransferase levels, but has yet to be linked to cases of clinically apparent drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547930/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a603004.html"
},
{
    "Title": "Eprosartan",
    "Text1": "Eprosartan is an angiotensin II receptor blocker used in the therapy of hypertension. Eprosartan is associated with a low rate of transient serum aminotransferase elevations but has yet to be linked to instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548507/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601237.html"
},
{
    "Title": "Eravacycline",
    "Text1": "Eravacycline is a parenterally administered tetracycline-like antibiotic used to treat moderate-to-severe intraabdominal infections due to susceptible organisms. Eravacycline use has been associated with a low rate of serum enzyme elevations during therapy but has not been convincingly linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547847/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618047.html"
},
{
    "Title": "Erenumab",
    "Text1": "Erenumab is a monoclonal antibody to the receptor for calcitonin gene related peptide which plays a role in inducing migraine headaches. Erenumab is used for prevention of migraine in patients with episodic or chronic migraine headaches. Erenumab therapy has not been associated with serum enzyme elevations during therapy nor has it been implicated in cases of clinically apparent drug induced liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548079/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618029.html"
},
{
    "Title": "Eribulin",
    "Text1": "Eribulin mesylate is an inhibitor of microtubule function and is used as an antineoplastic agent for refractory, metastatic breast cancer and liposarcoma. Despite its cytotoxic activity against cancer cells, eribulin has rarely been implicated in causing clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548316/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611007.html"
},
{
    "Title": "Erlotinib",
    "Text1": "Erlotinib is a tyrosine kinase receptor inhibitor that is used in the therapy of advanced or metastatic pancreatic or non-small cell lung cancer. Erlotinib therapy is associated with transient elevations in serum aminotransferase levels during therapy and rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548407/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605008.html"
},
{
    "Title": "Erlotinib",
    "Text1": "Erlotinib is a tyrosine kinase receptor inhibitor that is used in the therapy of advanced or metastatic pancreatic or non-small cell lung cancer. Erlotinib therapy is associated with transient elevations in serum aminotransferase levels during therapy and rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548407/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605008.html"
},
{
    "Title": "Ertapenem",
    "Text1": "Ertapenem is a broad spectrum carbapenem antibiotic used primarily for the treatment of aerobic gram-negative bacterial infections. Ertapenem, like other carbapenems, is associated with transient and asymptomatic elevations in serum enzymes. The carbapenems have also been linked to rare instances of clinically apparent, acute cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548006/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614001.html"
},
{
    "Title": "Erythromycin",
    "Text1": "Erythromycin is an oral macrolide antibiotic that has been in common use since the 1950s. Erythromycin has been linked to rare instances of acute liver injury that are usually self-limited, but can result in severe injury and death.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547881/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682381.html"
},
{
    "Title": "Esketamine",
    "Text1": "Esketamine is unique antidepressant administered as an intranasal spray as therapy of treatment- resistant depression in adults. Esketamine has not been associated with serum enzyme elevations during treatment nor to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK551726/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619017.html"
},
{
    "Title": "Eslicarbazepine",
    "Text1": "Eslicarbazepine is an aromatic anticonvulsant similar to oxcarbazepine that is used in combination with other antiepileptic agents as therapy of partial onset seizures. Eslicarbazepine is associated with a low rate of transient serum enzyme elevations during therapy and has been implicated in rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548939/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614032.html"
},
{
    "Title": "Estazolam",
    "Text1": "Estazolam is an orally available benzodiazepine used to treat insomnia. As with most benzodiazepines, estazolam therapy has not associated with serum aminotransferase or alkaline phosphatase elevations, and clinically apparent liver injury from estazolam has not been reported and must be very rare, if it occurs at all.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548660/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a691003.html"
},
{
    "Title": "Eszopiclone",
    "Text1": "Eszopiclone is a benzodiazepine receptor agonist that is used for the treatment of insomnia. Eszopiclone has not been implicated in causing serum enzyme elevations or clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548047/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605009.html"
},
{
    "Title": "Etanercept",
    "Text1": "Etanercept is an antagonist of tumor necrosis factor alpha (TNFa) which has potent antiinflammatory activity and is used widely in severe forms of rheumatoid arthritis and psoriasis. Etanercept has been linked to rare instances of acute, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547838/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a602013.html"
},
{
    "Title": "Ethambutol",
    "Text1": "Ethambutol is a first line but adjunctive antituberculosis medication which is used only in combination with other agents such as isoniazid and rifampin. Ethambutol therapy has been associated with minor, transient and asymptomatic elevations in serum aminotransferase levels, and is a reported but rare cause of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548745/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682550.html"
},
{
    "Title": "Ethosuximide",
    "Text1": "Ethosuximide is an succinimide based anticonvulsant commonly used for absence (petit mal) seizures in both adults and children. Ethosuximide has been associated with rare instances of serum enzyme elevations during treatment, but has not been linked to cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547870/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682327.html"
},
{
    "Title": "Etodolac",
    "Text1": "Etodolac is a nonsteroidal antiinflammatory drug (NSAID) that is available by prescription only and is used long term for therapy of chronic arthritis and short term for acute pain. Etodolac has been linked to rare instances of clinically apparent drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548686/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a692015.html"
},
{
    "Title": "Etoposide",
    "Text1": "Etoposide and teniposide are semisynthetic analogues of podophyllotoxin that are used as antineoplastic agents in the therapy of several forms of solid tumors, leukemia and lymphoma, usually in combination with other agents. Both etoposide and teniposide are associated with an appreciable rate of serum enzyme elevations during therapy, and high doses have been implicated in causing clinically apparent acute liver injury including sinusoidal obstruction syndrome.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548102/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697011.html"
},
{
    "Title": "Etravirine",
    "Text1": "Etravirine is a nonnucleoside reverse transcriptase inhibitor used in combination with other agents in the therapy of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Etravirine has been associated with transient serum aminotransferase elevations and with hypersensitivity reactions that can be associated with liver injury including acute liver failure.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548290/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608016.html"
},
{
    "Title": "Everolimus",
    "Text1": "Everolimus is an inhibitor of cell proliferation and immunosuppressive agent that is used alone or in combination with calcineurin inhibitors to prevent cellular rejection after organ transplantation, and in combination with other anticancer agents as treatment of advanced renal cell and other cancers. Everolimus therapy can be associated with mild serum enzyme elevations, but has yet to be linked to instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548857/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a609032.html"
},
{
    "Title": "Evolocumab",
    "Text1": "Evolocumab is a human monoclonal antibody to PCSK9 (proprotein convertase subtilisin/kexin type 9), a circulating protein that modulates the activity of the LDL cholesterol receptor in the liver. The monoclonal antibody lowers serum LDL cholesterol and is used to treat severe hypercholesterolemia. Evolocumab therapy has been associated with a low rate of serum aminotransferase elevations and has yet to be linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548469/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615043.html"
},
{
    "Title": "Exemestane",
    "Text1": "Exemestane is a steroidal inhibitor of aromatase which effectively blocks estrogen synthesis in postmenopausal women and is used as therapy of estrogen receptor positive breast cancer, usually after resection and after failure of tamoxifen. Exemestane has been associated with a low rate of serum enzyme elevations during therapy and rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548926/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607006.html"
},
{
    "Title": "Exenatide",
    "Text1": "Exenatide is an analogue of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents. There have been no published reports of hepatotoxicity attributed to exenatide therapy.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548665/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605034.html"
},
{
    "Title": "Ezetimibe",
    "Text1": "Ezetimibe is an inhibitor of intestinal cholesterol absorption that is widely used in the therapy of hypercholesterolemia, usually in combination with other agents. Ezetimibe therapy is associated with a low rate of serum aminotransferase elevations and clinically apparent liver injury due to ezetimibe occurs, but is rare.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548095/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a603015.html"
},
{
    "Title": "Ezogabine",
    "Text1": "Ezogabine, which is known as retigabine in Europe, is a unique anticonvulsant used largely as an adjunctive agent in the treatment of partial seizures. Therapy with ezogabine has not been associated with serum aminotransferase elevations, and clinically apparent liver injury from ezogabine has yet to be reported and must be rare, if it occurs at all.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548304/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612028.html"
},
{
    "Title": "Famciclovir",
    "Text1": "Famciclovir is a nucleoside analogue and antiviral agent used in therapy of herpes zoster and simplex virus infections. Famciclovir is associated with a low rate of mild-to-moderate serum ALT elevations during therapy, but has not been associated with instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547978/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a694038.html"
},
{
    "Title": "Famotidine",
    "Text1": "Famotidine is a histamine type 2 receptor antagonist (H2 blocker) which is commonly used for treatment of acid-peptic disease and heartburn. Famotidine has been linked to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548228/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a687011.html"
},
{
    "Title": "Febuxostat",
    "Text1": "Febuxostat is a newly introduced nonpurine xanthine oxidase inhibitor used for the treatment of gout. Chronic febuxostat therapy has been associated with minor serum aminotransferase elevations, but has yet to be linked to cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548645/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a609020.html"
},
{
    "Title": "Felbamate",
    "Text1": "Felbamate is a dicarbamate derivative anticonvulsant that is typically used in combination with other antiepileptic medications for refractory partial onset or generalized seizures. Felbamate has been associated with multiple cases of aplastic anemia and acute liver failure and its use is now restricted.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548256/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a606011.html"
},
{
    "Title": "Felodipine",
    "Text1": "Felodipine is a second generation calcium channel blocker and commonly used antihypertensive agent. Felodipine therapy has been associated with a low rate of serum enzyme elevations, but has not been convincingly linked to instances of clinically apparent, acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548294/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a692016.html"
},
{
    "Title": "Fenofibrate",
    "Text1": "Fenofibrate is a fibric acid derivative used in the therapy of hypertriglyceridemia and dyslipidemia. Fenofibrate therapy is associated with mild and transient serum aminotransferase elevations and with rare instances of acute liver injury, which can be severe and prolonged and lead to significant hepatic fibrosis.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548607/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601052.html"
},
{
    "Title": "Fenoprofen",
    "Text1": "Fenoprofen is a nonsteroidal antiinflammatory drug (NSAID) used in the treatment of acute pain and chronic arthritis. Fenoprofen has been linked to a low rate of serum enzyme elevations during therapy and to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547969/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a681026.html"
},
{
    "Title": "Fentanyl",
    "Text1": "Fentanyl is a fully synthetic opioid that is more potent that morphine and is commonly used for management of severe pain and as an adjunct to general anesthesia. Alfentanil, remifentanil and sufentanil are phenylpiperidine analogues of fentanyl and have a similar spectrum of activity, but differ in their pharmacokinetics, potency and routes of administration, and are used only in anesthesia. None of the phenylpiperidine opioids have been implicated in causing serum enzyme elevations or clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548026/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601202.html"
},
{
    "Title": "Fesoterodine",
    "Text1": "Fesoterodine is an anticholinergic and antispasmotic agent used to treat urinary incontinence and overactive bladder syndrome. Fesoterodine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548810/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a609021.html"
},
{
    "Title": "Fexofenadine",
    "Text1": "Fexofenadine is a second generation antihistamine that is used for the treatment of allergic rhinitis, angioedema and chronic urticaria. Fexofenadine has not been linked to serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548571/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697035.html"
},
{
    "Title": "Fidaxomicin",
    "Text1": "Fidaxomicin is a semisynthetic macrolide antibiotic used to treat Clostridium difficile-associated diarrhea in adults. Fidaxomicin has minimal systemic absorption and has not been linked to serum enzyme elevations during therapy or to instances of clinically apparent, acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548928/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611040.html"
},
{
    "Title": "Finasteride",
    "Text1": "Finasteride is a 5-alpha reductase inhibitor used to treat symptoms of benign prostatic hypertrophy and male pattern baldness. Finasteride is associated with a low rate of transient serum aminotransferase elevations, but has yet to be linked to instances of clinically apparent, acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548319/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a698016.html"
},
{
    "Title": "Fingolimod",
    "Text1": "Fingolimod is an orally available immunomodulatory drug used to treat relapsing multiple sclerosis. Fingolimod is associated with transient serum enzyme elevations during therapy, but has not been linked to instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548384/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611006.html"
},
{
    "Title": "Flavoxate",
    "Text1": "Flavoxate is a synthetic anticholinergic agent that is used for treatment of urinary incontinence and overactive bladder syndrome. Flavoxate has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548911/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682706.html"
},
{
    "Title": "Flecainide",
    "Text1": "Flecainide is an oral antiarrhythmic agent that has been in use for several decades. Long term flecainide therapy is associated with a low rate of serum enzyme elevations and is a very rare cause of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548023/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608040.html"
},
{
    "Title": "Flibanserin",
    "Text1": "Flibanserin is a serotonergic antidepressant used to treat hypoactive sexual desire disorder. Flibanserin has been associated with a low rate of minor serum aminotransferase elevations during treatment, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548074/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615040.html"
},
{
    "Title": "Floxuridine",
    "Text1": "Floxuridine (FUDR) is a pyrimidine analogue used as an antineoplastic agent, usually as a continuous hepatic arterial infusion to treat hepatic metastases from colon cancer. Intraarterial floxuridine is associated with a very high rate of serum enzyme and bilirubin elevations during therapy, and with frequent biliary damage that can result in a secondary sclerosing cholangitis, which can be severe and lead to cirrhosis.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548421/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682006.html"
},
{
    "Title": "Fluconazole",
    "Text1": "Fluconazole is a triazole fungistatic agent used in the treatment of systemic and superficial fungal infections. Fluconazole therapy can cause transient mild-to-moderate serum aminotransferase elevations and is a known cause of clinically apparent acute drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548300/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a690002.html"
},
{
    "Title": "Fludarabine",
    "Text1": "Fludarabine is a purine analogue and antineoplastic agent used in the therapy of chronic lymphocytic leukemia (CLL) and in immunosuppressive regimens in preparation of hematopoietic cell transplantation (HCT). Fludarabine is associated with a low rate of transient serum enzyme elevations during therapy and has only rarely been implicated in cases of clinically apparent acute liver injury with jaundice. Fludarabine has potent immunosuppressive activity and has been associated with many cases of reactivation of hepatitis B.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548845/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a692003.html"
},
{
    "Title": "Fluorouracil",
    "Text1": "Fluorouracil (5-FU) is a pyrimidine analogue used as an antineoplastic agent to treat multiple solid tumors including colon, rectal, breast, gastric, pancreatic, ovarian, bladder and liver cancer. Fluorouracil is associated with a low rate of transient serum aminotransferase elevations during therapy and has been implicated in rare cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548781/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605010.html"
},
{
    "Title": "Fluoxetine",
    "Text1": "Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) widely used as an antidepressant. Fluoxetine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548010/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a689006.html"
},
{
    "Title": "Fluphenazine",
    "Text1": "Fluphenazine is a phenothiazine and antipsychotic agent which is no longer in common use. Fluphenazine can cause mild and transient serum enzyme elevations and has been linked to rare instances of clinically apparent cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548610/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682172.html"
},
{
    "Title": "Flurazepam",
    "Text1": "Flurazepam is an orally available benzodiazepine used for therapy of insomnia. As with most benzodiazepines, flurazepam therapy has not been associated with serum aminotransferase or alkaline phosphatase elevations; clinically apparent liver injury from flurazepam has been reported, but is very rare.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548683/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682051.html"
},
{
    "Title": "Flurbiprofen",
    "Text1": "Flurbiprofen is a nonsteroidal antiinflammatory drug (NSAID) used in treatment of mild-to-moderate pain and symptoms of chronic arthritis. Flurbiprofen has been linked to a low rate of serum enzyme elevations during therapy and to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548121/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a687005.html"
},
{
    "Title": "Flutamide",
    "Text1": "Flutamide is a nonsteroidal antiandrogen that acts by binding to and blocking intracellular androgen receptors in target tissues including testes, prostate, skin, and hair follicle. Flutamide is frequently associated with minor serum aminotransferase elevations and has been linked to numerous cases of acute liver injury, which are frequently severe and can be fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548908/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697045.html"
},
{
    "Title": "Fluvastatin",
    "Text1": "Fluvastatin is a commonly used cholesterol lowering agent (statin) that is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy and rarely with clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548435/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a694010.html"
},
{
    "Title": "Fluvoxamine",
    "Text1": "Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) used in the therapy of obsessive-compulsive disorder. Fluvoxamine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548905/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a695004.html"
},
{
    "Title": "Folic Acid",
    "Text1": "Folic acid is a water soluble vitamin found in many foods and particularly in leafy green vegetables that is essential for the critical biosynthetic pathways involving transfer of methyl groups to organic compounds. There is no evidence that folic acid, in physiologic or even super-physiologic, high doses, causes liver injury or jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548804/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682591.html"
},
{
    "Title": "Fondaparinux",
    "Text1": "Fondaparinux is a synthetic inhibitor of factor Xa which given by injection and is used as an anticoagulant to treat as well as prevent venous thromboembolism. Fondaparinux has been associated with a low rate of serum aminotransferase elevations during therapy, but has not been implicated in cases of clinically apparent, idiosyncratic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548551/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612026.html"
},
{
    "Title": "Fosamprenavir",
    "Text1": "Amprenavir is an antiretroviral protease inhibitor used in the therapy and prevention of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Fosamprenavir is a prodrug of amprenavir that has better oral bioavailability and that has largely replaced amprenavir in clinical use. Both amprenavir and fosamprenavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and are rare causes of clinically apparent, acute liver injury. In coinfected patients, hepatic injury during highly active antiretroviral therapy may be a result of exacerbation of the underlying chronic hepatitis B or C rather than a direct toxic effect of the medication.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548011/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604012.html"
},
{
    "Title": "Foscarnet",
    "Text1": "Foscarnet a simple pyrophosphate molecule which has antiviral activity against many viruses and is used intravenously in therapy of serious cytomegalovirus infections, largely in immunocompromised patients. Foscarnet has been associated with mild-to-moderate serum aminotransferase elevations during intravenous therapy, but not with episodes of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548522/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601144.html"
},
{
    "Title": "Fosfomycin",
    "Text1": "Fosfomycin is an orally available, broad spectrum antibiotic used largely for treatment of uncomplicated urinary tract infections. Fosfomycin is associated with a low rate of transient serum enzyme during therapy and with rare cases of clinically apparent acute liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547912/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697008.html"
},
{
    "Title": "Fosinopril",
    "Text1": "Fosinopril is an angiotensin-converting enzyme (ACE) inhibitor used in the therapy of hypertension and heart failure. Fosinopril is associated with a low rate of transient serum aminotransferase elevations during therapy and has been linked to rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548813/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a692020.html"
},
{
    "Title": "Fosphenytoin",
    "Text1": "Fosphenytoin is a prodrug of phenytoin available in parenteral forms only. While not specifically associated with cases of drug induced liver injury, fosphenytoin is converted to phenytoin which is a well known cause of acute idiosyncratic drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547879/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619063.html"
},
{
    "Title": "Fostamatinib",
    "Text1": "Fostamatinib is an orally available small molecule inhibitor of spleen tyrosine kinase that is used to treat chronic immune thrombocytopenia. Fostamatinib is associated with transient and usually mild elevations in serum aminotransferase levels during therapy but has yet to be linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548340/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618025.html"
},
{
    "Title": "Fremanezumab",
    "Text1": "Fremanezumab is a monoclonal antibody to the calcitonin gene related peptide which is used for prevention of migraine in patients with episodic or chronic migraine headaches. Fremanezumab has not been associated with serum enzyme elevations during therapy nor has it been implicated in cases of clinically apparent drug induced liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548782/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618053.html"
},
{
    "Title": "Fulvestrant",
    "Text1": "Fulvestrant is a steroidal antiestrogen that is used in the treatment of hormone-receptor positive metastatic breast cancer. Fulvestrant therapy can be associated with serum enzyme elevations, but has yet to be linked to instances of clinically apparent acute liver injury in the published literature.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548072/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607031.html"
},
{
    "Title": "Gabapentin",
    "Text1": "Gabapentin is a unique anticonvulsant that is used as adjunctive therapy in management of epilepsy and for neuropathic pain syndromes. Therapy with gabapentin is not associated with serum aminotransferase elevations, but several cases of clinically apparent liver injury from gabapentin have been reported.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548252/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a694007.html"
},
{
    "Title": "Galantamine",
    "Text1": "Galantamine is an oral acetylcholinesterase inhibitor used for therapy of Alzheimer disease. Galantamine is associated with a minimal rate of serum enzyme elevations during therapy and has not been implicated as a cause of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548544/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699058.html"
},
{
    "Title": "Galcanezumab",
    "Text1": "Galcanezumab is a monoclonal antibody to the calcitonin gene related peptide which is used for prevention of migraine in patients with episodic or chronic migraine headaches. Galcanezumab has not been associated with serum enzyme elevations during therapy nor has it been implicated in cases of clinically apparent drug induced liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548140/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618063.html"
},
{
    "Title": "Ganciclovir",
    "Text1": "Ganciclovir is a nucleoside analogue and antiviral agent used in therapy of cytomegalovirus infections. Valganciclovir is the valyl ester prodrug of ganciclovir which can be given orally. When given intravenously, ganciclovir can cause mild, transient and asymptomatic elevations in serum aminotransferase levels, but neither ganciclovir nor valganciclovir have been associated with clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548760/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605011.html"
},
{
    "Title": "Gefitinib",
    "Text1": "Gefitinib is a selective tyrosine kinase receptor inhibitor used in the therapy of non-small cell lung cancer. Gefitinib therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548839/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607002.html"
},
{
    "Title": "Gemcitabine",
    "Text1": "Gemcitabine is a cytosine analogue and intravenously administered antineoplastic agent used in the therapy of several forms of advanced, pancreatic, lung, breast, ovarian and bladder cancer. Gemcitabine is associated with a high rate of transient serum enzyme elevations during therapy but is a very rare cause of acute, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548575/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a696019.html"
},
{
    "Title": "Gemfibrozil",
    "Text1": "Gemfibrozil is a fibric acid derivative used in the therapy of hypertriglyceridemia and dyslipidemia. Gemfibrozil therapy is associated with mild and transient serum aminotransferase elevations and with rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547926/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a686002.html"
},
{
    "Title": "Gemifloxacin",
    "Text1": "Gemifloxacin is a fourth generation, oral fluoroquinolone antibiotic used in the therapy of mild-to-moderate respiratory tract infections caused by susceptible organisms. Gemifloxacin has been linked to rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548790/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604014.html"
},
{
    "Title": "Gemtuzumab Ozogamicin",
    "Text1": "Gemtuzumab ozogamicin is a humanized monoclonal antibody conjugate which is used in the therapy of acute myelogenous leukemia. Gemtuzumab ozogamicin has been linked to transient serum enzyme elevations during therapy and not uncommon instances of acute sinusoidal obstruction syndrome which can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548438/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618005.html"
},
{
    "Title": "Gentamicin",
    "Text1": "Gentamicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate to severe gram negative infections. Despite its wide use, gentamicin has not been definitively linked to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548706/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619033.html"
},
{
    "Title": "Gilteritinib",
    "Text1": "Gilteritinib is an orally available small molecule inhibitor of FMS-like tyrosine kinase 3 (FLT3) which is used as an antineoplastic agent in the treatment of acute myeloid leukemia with FLT3 mutations. Gilteritinib is associated with a moderate rate of serum aminotransferase elevations during therapy and is suspected to cause rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548423/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619003.html"
},
{
    "Title": "Glasdegib",
    "Text1": "Glasdegib is an orally available small molecule inhibitor of the signaling molecule hedgehog which is used as an antineoplastic agent in the treatment of acute myeloid leukemia. Glasdegib is associated with a moderate rate of serum aminotransferase elevations during therapy and is suspected to cause rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548156/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619004.html"
},
{
    "Title": "Glycopyrrolate",
    "Text1": "Glycopyrrolate is an anticholinergic agent used to treat gastrointestinal conditions associated with intestinal spasm and to decrease secretions during anesthesia. Glycopyrrolate has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548229/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a602014.html"
},
{
    "Title": "Golimumab",
    "Text1": "Golimumab is a human monoclonal antibody to tumor necrosis factor (TNF) alpha that is used in the treatment of rheumatoid arthritis and ulcerative colitis. Golimumab has been linked to a low rate of serum enzyme elevations during therapy, but has not been linked to cases of idiosyncratic, clinically apparent liver injury with jaundice. Because golimumab is a potent inhibitor of TNF alpha, it is likely to cause reactivation of chronic hepatitis B in susceptible patients.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548112/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a610010.html"
},
{
    "Title": "Goserelin",
    "Text1": "Goserelin is a parenterally administered, gonadotropin releasing hormone (GnRH) agonist which causes an inhibition of estrogen and androgen production and is used predominantly to treat prostate cancer. Goserelin has been associated with a modest rate of serum enzyme elevations during therapy, but has not been convincingly linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548740/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601002.html"
},
{
    "Title": "Griseofulvin",
    "Text1": "Griseofulvin is a fungistatic agent used to treat superficial fungal skin infections such as tinea capitis and pedis. Griseofulvin therapy can cause transient mild-to-moderate serum aminotransferase elevations and has very rarely been linked to clinically apparent acute drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548177/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682295.html"
},
{
    "Title": "Guanfacine",
    "Text1": "Guanfacine is a selective alpha-adrenergic receptor agonist used for the treatment of hypertension and attention deficit hyperactivity disorder in adults and children. Guanfacine has not been linked to serum enzyme elevations during treatment or to cases of acute, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548586/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601059.html"
},
{
    "Title": "Guselkumab",
    "Text1": "Guselkumab is human monoclonal antibody to interleukin-23 and is used to treat severe psoriasis. Guselkumab is associated with a low rate of transient and asymptomatic serum enzyme elevations during therapy, but has not been linked to cases of idiosyncratic, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548270/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617036.html"
},
{
    "Title": "Haloperidol",
    "Text1": "Haloperidol is a conventional antipsychotic agent used in the treatment of acute and chronic psychosis. Haloperidol therapy is commonly associated with minor serum aminotransferase elevations and in very rare instances has been linked to clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548393/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615023.html"
},
{
    "Title": "Heparin",
    "Text1": "Standard or unfractionated heparin is a complex mixture of naturally occurring glycosaminoglycans and is used as an anticoagulant to treat venous thrombosis or to prevent thrombosis in high risk patients. Heparin therapy is associated with frequent elevations in serum aminotransferase levels that are typically transient and not associated with clinical symptoms or significant liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548126/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682826.html"
},
{
    "Title": "Histrelin",
    "Text1": "Histrelin is a gonadotropin releasing hormone (GnRH) agonist that is a potent inhibitor of production of testosterone (in men) and estrogen (in women) and is used predominantly to treat advanced prostate cancer. Histrelin is associated with a low rate of transient serum enzyme elevations during therapy, but has not been linked convincingly to cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548064/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601146.html"
},
{
    "Title": "Hydralazine",
    "Text1": "Hydralazine is a commonly used oral antihypertensive agent that acts by inducing peripheral vasodilation. Hydralazine has been linked to several forms of acute liver injury as well as a lupus-like syndrome.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548580/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682246.html"
},
{
    "Title": "Hydrocodone",
    "Text1": "Hydrocodone is a semisynthetic, moderately potent, orally available opioid that, in combination with acetaminophen, is widely used for treatment of acute or chronic pain, and in combination with antihistamines or anticholinergics used to treat cough. Hydrocodone by itself has not been linked to serum enzyme elevations during therapy or to clinically apparent liver injury, but the combination with acetaminophen has been linked to many cases of acute liver failure due to unintentional overdose with acetaminophen.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548700/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601006.html"
},
{
    "Title": "Hydromorphone",
    "Text1": "Hydromorphone and oxymorphone are semisynthetic derivatives of morphine and potent opiate agonists which are used predominantly to treat moderate-to-severe pain. Neither hydromorphone nor oxymorphone have been linked to serum enzyme elevations during therapy or to clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548775/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682013.html"
},
{
    "Title": "Hydroxychloroquine",
    "Text1": "Hydroxychloroquine is a derivative of chloroquine that has both antimalarial and antiinflammatory activities and is now most often used as an antirheumatologic agent in systemic lupus erythematosis and rheumatoid arthritis. Hydroxychloroquine therapy has not been associated with liver function abnormalities and is an extremely rare cause of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548738/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601240.html"
},
{
    "Title": "Hydroxyurea",
    "Text1": "Hydroxyurea is an antimetabolite that is used in the treatment of cancer and to stimulate fetal hemoglobin production in sickle cell disease. Hydroxyurea is associated with a low rate of transient serum enzyme and bilirubin elevations during therapy, and has been implicated in rare cases of clinically apparent acute liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548724/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682004.html"
},
{
    "Title": "Hydroxyzine",
    "Text1": "Hydroxyzine is a first generation antihistamine that is used largely for symptoms of itching, nausea, anxiety and tension. Hydroxyzine has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548128/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682866.html"
},
{
    "Title": "Hyoscyamine",
    "Text1": "Hyoscyamine as a natural plant alkaloid derivative and anticholinergic that is used to treat mild to moderate nausea, motion sickness, hyperactive bladder and allergic rhinitis. Hyoscyamine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548870/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684010.html"
},
{
    "Title": "Ibalizumab",
    "Text1": "Ibalizumab is a humanized monoclonal antibody to CD4, the cell surface receptor for the HIV-1 envelope glycoprotein (gp120), which is used to treat patients with multidrug resistant HIV-1 infection. Ibalizumab therapy has not been associated with serum enzyme elevations or to instances of clinically apparent drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548305/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618020.html"
},
{
    "Title": "Ibrutinib",
    "Text1": "Ibrutinib is an oral inhibitor of Bruton’s tyrosine kinase that is used in the therapy of refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. Ibrutinib has not been associated with serum enzyme elevations during therapy, but has been linked to rare cases of clinically apparent acute liver injury and to reactivation of hepatitis B.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548449/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614007.html"
},
{
    "Title": "Ibuprofen",
    "Text1": "Ibuprofen is a commonly used nonsteroidal antiinflammatory (NSAID) drug which is available both by prescription and over-the-counter. Ibuprofen is considered to be among the safest NSAIDs and is generally well tolerated but can, nevertheless, rarely cause clinically apparent and serious acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547845/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682159.html"
},
{
    "Title": "Idelalisib",
    "Text1": "Idelalisib is an oral kinase inhibitor that is approved for use in combination with rituximab in relapsed or refractory chronic lymphocytic leukemia (CLL) and as monotherapy for relapsed follicular B cell and small lymphocytic lymphoma. Idelalisib is associated with a high rate of minor serum enzyme elevations during therapy and has been reported to cause clinically apparent acute liver injury that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548840/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614040.html"
},
{
    "Title": "Ifosfamide",
    "Text1": "Ifosfamide is a parenterally administered alkylating agent similar to cyclophosphamide that is used in the treatment of several forms of cancer including lymphomas, sarcoma and advanced forms of solid organ cancer such as breast, testicular, ovarian, gastric and lung cancer. Ifosfamide therapy is associated with minor transient serum enzyme elevations and has been linked to cases of acute liver injury, including acute cholestatic hepatitis and veno-occlusive disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548567/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a695023.html"
},
{
    "Title": "Iloperidone",
    "Text1": "Iloperidone is a second generation (atypical) antipsychotic agent that is used for treatment of schizophrenia. Iloperidone is associated with a low rate of serum aminotransferase elevations during therapy, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548669/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a609026.html"
},
{
    "Title": "Imatinib",
    "Text1": "Imatinib is specific tyrosine kinase receptor inhibitor that is used in the therapy of Philadelphia chromosome-positive chronic myelogenous leukemia and gastrointestinal stromal tumors, both of which are marked by an abnormal, constitutively expressed tyrosine kinase that causes unregulated cell growth. Imatinib therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent acute liver injury which can be severe and sometimes fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547959/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a606018.html"
},
{
    "Title": "Imipramine",
    "Text1": "Imipramine is a tricyclic antidepressant that continues to be widely used in the therapy of depression. Imipramine can cause mild and transient serum enzyme elevations and is rare cause of clinically apparent acute cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547884/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682389.html"
},
{
    "Title": "Indinavir",
    "Text1": "Indinavir is an antiretroviral protease inhibitor used in the therapy and prevention of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Indinavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and mild elevations in indirect bilirubin concentration. Indinavir is a rare cause of clinically apparent, acute liver injury. In HBV or HCV coinfected patients, antiretroviral therapy with indinavir may result in an exacerbation of the underlying chronic hepatitis B or C.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548674/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a696028.html"
},
{
    "Title": "Indomethacin",
    "Text1": "Indomethacin is a potent nonsteroidal antiinflammatory drug (NSAID) typically used for chronic inflammatory arthritis. Indomethacin has been associated with rare cases of idiosyncratic drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548001/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a681027.html"
},
{
    "Title": "Infliximab",
    "Text1": "Infliximab is a monoclonal antibody to human tumor necrosis factor alpha (TNFa) which has potent antiinflammatory activity and is used in the therapy of severe inflammatory bowel disease and rheumatoid arthritis. Infliximab has been linked to many instances of idiosyncratic acute liver injury and is a well known cause of reactivation of hepatitis B.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548203/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604023.html"
},
{
    "Title": "Inotuzumab Ozogamicin",
    "Text1": "Inotuzumab ozogamicin is a humanized monoclonal antibody-cytotoxin conjugate which is used in the therapy of refractory or relapsed acute lymphoblastic leukemia. Inotuzumab ozogamicin has been linked to frequent serum enzyme elevations during therapy and with instances of clinically apparent acute liver injury, including acute sinusoidal obstruction syndrome which can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547906/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617041.html"
},
{
    "Title": "Insulin",
    "Text1": "Insulin is a pancreatic hormone that plays an essential role in regulation of blood glucose as well as lipid and carbohydrate metabolism. Both natural and recombinant forms of insulin are used therapeutically to treat type 1 diabetes. While insulin itself is not hepatotoxic and has not been linked to serum enzyme elevations or instances of clinically apparent liver injury, high doses including overdoses of insulin and glucose can result in hepatic glycogenosis and serum aminotransferase elevations.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548016/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605013.html"
},
{
    "Title": "Interferon Gamma",
    "Text1": "Interferon gamma is a recombinant cytokine with a multitude of actions including stimulation of T cell immunity, increase in innate immune responses, induction of Class II major histocompatibility complex molecules, and inhibition of fibrosis. Interferon gamma is used for its immune enhancing properties as therapy of chronic granulomatous disease of childhood and is used experimentally for its anti-fibrotic actions. Therapy with interferon gamma can cause mild elevations in serum enzymes, but has not been linked to cases of clinically significant liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548199/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601152.html"
},
{
    "Title": "Ipilimumab",
    "Text1": "Ipilimumab is a human monoclonal antibody to cytotoxic T lymphocyte antigen-4 which acts as an immune checkpoint inhibitor increases immune reactivity and is used to treat metastatic malignant melanoma. Ipilimumab has major side effects, many of which can be serious and life threatening including acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548335/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611023.html"
},
{
    "Title": "Ipratropium",
    "Text1": "Ipratropium is a synthetic anticholinergic agent that is used as an inhalant for treatment of acute bronchospasm due to chronic bronchitis and emphysema. Ipratropium has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548667/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618013.html"
},
{
    "Title": "Irbesartan",
    "Text1": "Irbesartan is an angiotensin II receptor blocker used alone or in combination with other agents in the therapy of hypertension and diabetic nephropathy. Irbesartan is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548450/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a698009.html"
},
{
    "Title": "Irinotecan",
    "Text1": "Irinotecan and topotecan are semisynthetic derivatives of the plant alkaloid camptothecin and are used as antineoplastic agents in the therapy of colorectal, ovarian and non-small cell lung cancer. Both irinotecan and topotecan are associated with an appreciable rate of serum enzyme elevations during therapy, and irinotecan has been implicated in causing steatohepatitis when given as cyclic anticancer therapy.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548037/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608043.html"
},
{
    "Title": "Iron",
    "Text1": "Iron is an essential heavy metal that is included in many over-the-counter multivitamin and mineral supplements and is used therapeutically in higher doses to treat or prevent iron deficiency anemia. When taken at the usual recommended daily allowance or in replacement doses, iron has little or no adverse effect on the liver. In high doses and in intentional or accidental overdoses, iron causes serious toxicities, one component of which is acute liver damage.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548214/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682778.html"
},
{
    "Title": "Isavuconazonium",
    "Text1": "Isavuconazonium is a triazole antifungal agent used primarily in the treatment of invasive aspergillosis and mucormycosis infections. Isavuconazonium is associated with a low rate of transient and asymptomatic serum aminotransferase elevations during therapy, but has not been linked to instances of clinically apparent acute drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548643/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615031.html"
},
{
    "Title": "Isocarboxazid",
    "Text1": "Isocarboxazid is a monoamine oxidase inhibitor (MAO inhibitor) used in therapy of severe depression. Isocarboxazid therapy is associated with rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548518/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605036.html"
},
{
    "Title": "Isoniazid",
    "Text1": "Isoniazid is the most reliable and most commonly used medication for tuberculosis. Isoniazid therapy is often associated with minor, transient and asymptomatic elevations in serum aminotransferase levels but, more importantly, isoniazid is a well known cause of acute clinically apparent liver injury which can be severe and is sometimes fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548754/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682401.html"
},
{
    "Title": "Isotretinoin",
    "Text1": "Isotretinoin is a retinoid and vitamin A derivative used in the treatment of severe acne and some forms of skin, head and neck cancer. Isotretinoin, like many retinoids, can lead to increase in serum aminotransferase levels, but, unlike acitretin and etretinate, isotretinoin has not been clearly implicated in cases of clinically apparent acute liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547857/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a681043.html"
},
{
    "Title": "Isradipine",
    "Text1": "Isradipine is a second generation calcium channel blocker that is used to treat hypertension. Isradipine is associated with a low rate of serum enzyme elevations during therapy, but has not been linked convincingly to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548193/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a693048.html"
},
{
    "Title": "Itraconazole",
    "Text1": "Itraconazole is a orally administered, triazole antifungal agent used in the treatment of systemic and superficial fungal infections. Itraconazole therapy is associated with transient, mild-to-moderate serum elevations and can lead to clinically apparent acute drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548273/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a692049.html"
},
{
    "Title": "Ivabradine",
    "Text1": "Ivabradine is a small molecule inhibitor of the If ion channel which is used to decrease the heart rate in patients with symptomatic heart failure who have a resting heart rate above 70 beats per minute despite optimal doses or intolerance of beta blockers. Ivabradine has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548107/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615027.html"
},
{
    "Title": "Ivermectin",
    "Text1": "Ivermectin is an antiinfective agent with activity against several parasitic nematodes and scabies and is the treatment of choice for onchocerciasis (river blindness). It is typically given as one or two oral doses. Ivermectin therapy has been associated with minor, self-limiting serum aminotransferase elevations and very rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548921/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607069.html"
},
{
    "Title": "Ivosidenib",
    "Text1": "Ivosidenib is an orally available small molecule inhibitor of isocitrate dehydrogenase 2 which is used as an antineoplastic agent in the treatment of selected cases of acute myeloid leukemia (AML). Ivosidenib is associated with a moderate rate of serum aminotransferase elevations during therapy and is suspected to be the cause of rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548827/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618042.html"
},
{
    "Title": "Ixabepilone",
    "Text1": "Ixabepilone is a semisynthetic epothilone analogue that acts to stabilize microtubules thereby preventing mitosis and causing growth arrest in cancer cells. Ixabepilone is approved for use in refractory cases of advanced breast cancer. Its use is associated with a low rate of serum enzyme elevation, but ixabepilone has not been linked to cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547985/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608042.html"
},
{
    "Title": "Ixazomib",
    "Text1": "Ixazomib is a small molecule proteasome inhibitor that is used in combination with other antineoplastic agents to treat refractory multiple myeloma. Ixazomib is associated with a low rate of serum enzyme elevations during treatment and to rare instances of clinically apparent, acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548002/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616008.html"
},
{
    "Title": "Ixekizumab",
    "Text1": "Ixekizumab is a humanized monoclonal antibody to interleukin-17A which acts as an antiinflammatory agent and is used to treat moderate-to-severe plaque psoriasis. Ixekizumab has not been linked to serum enzyme elevations during therapy or to instances of idiosyncratic acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548925/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616025.html"
},
{
    "Title": "Ketamine",
    "Text1": "Ketamine is a parenterally administered, general anesthetic used largely for short term diagnostic and surgical procedures, but which has been limited in use because of its psychological side effects including vivid hallucinations, agitation and confusion. Ketamine also has major abuse potential and is used illicitly as a recreational drug. Long term ketamine use can cause inflammation and irritation to the urinary bladder and urethra, and similar changes have recently been described in the biliary tract, resulting in an acute or chronic cholestatic liver injury that can resemble sclerosing cholangitis.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548337/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619017.html"
},
{
    "Title": "Ketoconazole",
    "Text1": "Ketoconazole is an imidazole fungicidal agent with a very broad spectrum of activity against many fungal species that is used for treatment of superficial and systemic fungal infections. Ketoconazole is a well documented cause of clinically apparent acute drug induced liver injury and is no longer recommended as a first line antifungal agent.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547869/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605014.html"
},
{
    "Title": "Ketoprofen",
    "Text1": "Ketoprofen is a nonsteroidal antiinflammatory drug (NSAID) used in treatment of acute pain and chronic arthritis. Ketoprofen has been linked to a low rate of serum enzyme elevations during therapy and to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548678/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a686014.html"
},
{
    "Title": "Ketorolac",
    "Text1": "Ketorolac is a potent, short acting nonsteroidal antiinflammatory drug (NSAID) that is available in both parenteral and oral forms. Ketorolac is generally given for a few days only, and has not been linked to instances of idiosyncratic drug induced liver disease in the published literature.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548459/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a693001.html"
},
{
    "Title": "Labetalol",
    "Text1": "Labetalol is an antihypertensive agent with both alpha- and beta-adrenergic receptor blocking activity. Labetalol has been linked to several cases of clinically apparent drug induced liver disease, some of which have been severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547846/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a685034.html"
},
{
    "Title": "Lacosamide",
    "Text1": "Lacosamide is an amino acid derivative with a unique anticonvulsant activity that is used in combination with other agents as therapy of partial onset seizures. Lacosamide therapy is associated with a low rate of transient serum enzyme elevations and has been linked to rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547940/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a609028.html"
},
{
    "Title": "Lamivudine",
    "Text1": "Lamivudine is a nucleoside analogue and reverse transcriptase inhibitor used in the therapy of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infection. Lamivudine is a very rare cause of clinically apparent drug induced liver injury, but is associated with flares of underlying hepatitis B during therapy or with abrupt withdrawal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548553/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a696011.html"
},
{
    "Title": "Lamotrigine",
    "Text1": "Lamotrigine is a widely used antiseizure medication that is a rare but well known cause of idiosyncratic liver injury, that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548562/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a695007.html"
},
{
    "Title": "Lanreotide",
    "Text1": "Lanreotide is a synthetic polypeptide analogue of somatostatin that resembles the native hormone in its ability to suppress levels and activity of growth hormone, insulin, glucagon and many other gastrointestinal peptides. Because its half-life is longer than somatostatin, lanreotide can be used clinically to treat neuroendocrine tumors that secrete excessive amounts of growth hormone (acromegaly) or other active hormones or neuropeptides. Lanreotide has many side effects including suppression of gall bladder contractility and bile production, and maintenance therapy may cause cholelithiasis and pancreatitis as well accompanying liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548368/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615007.html"
},
{
    "Title": "Lansoprazole",
    "Text1": "Lansoprazole is a proton pump inhibitor (PPI) and a potent inhibitor of gastric acidity which is widely used in the therapy of gastroesophageal reflux and peptic ulcer disease. Dexlansoprazole is an isomer of lansoprazole that has a similar spectrum of activity and toxicities. Lansoprazole therapy is associated with a low rate of transient and asymptomatic serum aminotransferase elevations and is a reported, but very rare cause of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548452/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a695020.html"
},
{
    "Title": "Lapatinib",
    "Text1": "Lapatinib is a small molecule inhibitor of several tyrosine kinase receptors involved in tumor cell growth that is used in the therapy of advanced breast cancer and other solid tumors. Lapatinib therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547971/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607055.html"
},
{
    "Title": "Larotrectinib",
    "Text1": "Larotrectinib is a selective inhibitor of neurotrophin receptor kinase (NTRK) that is used in the therapy of solid tumors harboring NTRK gene fusions. Larotrectinib is associated with a high rate of serum aminotransferase elevations during therapy but has not been linked to instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548088/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619006.html"
},
{
    "Title": "Lefamulin",
    "Text1": "Lefamulin is a new and relatively unique antibiotic used for treatment of community acquired pneumonia. Lefamulin has not been linked to an increased rate of transient serum liver test abnormalities during treatment or to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK551728/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619059.html"
},
{
    "Title": "Leflunomide",
    "Text1": "Leflunomide is an immunomodulatory agent used in the therapy of rheumatoid arthritis and psoriatic arthritis. Leflunomide therapy is associated with frequent elevations in serum aminotransferase levels and with rare instances of clinically apparent acute liver injury which can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548725/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a600032.html"
},
{
    "Title": "Lenvatinib",
    "Text1": "Lenvatinib is orally available multi-kinase inhibitor and antineoplastic agent that is used in treatment of advanced, metastatic medullary thyroid cancer and refractory renal cell carcinoma. Lenvatinib is associated with a modest rate of serum enzyme elevations during treatment and has been implicated to rare instances of clinically apparent, acute liver injury some of which have been fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547897/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615015.html"
},
{
    "Title": "Lesinurad",
    "Text1": "Lesinurad is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout. Lesinurad has had limited clinical use, but has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547982/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616015.html"
},
{
    "Title": "Letermovir",
    "Text1": "Letermovir is an antiviral agent which targets the DNA terminal transferase complex of the cytomegalovirus (CMV) and which is used to prevent CMV reactivation in immunocompromised patients. Letermovir has been associated with mild-to-moderate serum aminotransferase elevations during therapy but has not been linked to cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548861/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618006.html"
},
{
    "Title": "Letrozole",
    "Text1": "Letrozole is a nonsteroidal inhibitor of aromatase which effectively blocks estrogen synthesis in postmenopausal women and is used as therapy of estrogen receptor positive breast cancer, usually after resection and after failure of tamoxifen. Letrozole has been associated with a low rate of serum enzyme elevations during therapy and rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548381/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a698004.html"
},
{
    "Title": "Leuprolide",
    "Text1": "Leuprolide is a parenterally administered, gonadotropin releasing hormone (GnRH) agonist which causes an inhibition of estrogen and androgen production and is used predominantly to treat advanced prostate cancer. Leuprolide has been associated with a modest rate of serum enzyme elevations during therapy, but has not been convincingly linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548676/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a685040.html"
},
{
    "Title": "Levetiracetam",
    "Text1": "Levetiracetam is a relatively unique anticonvulsant that is typically used in combination with other antiepileptic medications for partial onset seizures. Levetiracetam has been linked to rare instances of serum aminotransferase and alkaline phosphatase elevations during treatment and to rare cases of clinically apparent drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548785/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699059.html"
},
{
    "Title": "Levodopa",
    "Text1": "Levodopa (L-Dopa) is an amino acid precursor of dopamine and is the most effective and commonly used drug in the treatment of Parkinson disease. Levodopa is usually combined with carbidopa, which is an inhibitor of L-amino acid decarboxylase, the plasma enzyme that metabolizes levodopa peripherally. Treatment with the combination of levodopa and carbidopa has been associated with mild and transient increases in serum enzymes in a proportion of patients and with very rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548734/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619018.html"
},
{
    "Title": "Levofloxacin",
    "Text1": "Levofloxacin is a third generation fluoroquinolone that is widely used in the treatment of mild-to-moderate respiratory and urinary tract infections due to sensitive organisms. Levofloxacin has been linked to rare instances of clinically apparent hepatic injury marked by a short latency period and a hepatocellular pattern of enzyme elevations, similar to what has been described with ciprofloxacin.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548357/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697040.html"
},
{
    "Title": "Levorphanol",
    "Text1": "Levorphanol is a synthetic opioid which is used as a narcotic analgesic for moderate-to-severe pain or as a preoperative medication. Levorphanol has not been linked to serum enzyme elevations during therapy or to clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547967/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682020.html"
},
{
    "Title": "Linaclotide",
    "Text1": "Linaclotide is small peptide agonist of guanylate cyclase C receptors in the intestine and is used orally as treatment of chronic constipation and irritable bowel syndrome. Linaclotide has not been linked to serum enzyme elevations during treatment or to episodes of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548021/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613007.html"
},
{
    "Title": "Linagliptin",
    "Text1": "Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other oral hypoglycemic agents. Linagliptin has been linked to rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548554/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611036.html"
},
{
    "Title": "Linezolid",
    "Text1": "Linezolid is an oxazolidinone class antibiotic that is used for serious or problematic infections caused by resistant enterococcal or staphylococcal organisms. Prolonged therapy with linezolid has been linked to rare instances of lactic acidosis and liver injury probably as a result of hepatic mitochondrial toxicity.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548245/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a602004.html"
},
{
    "Title": "Liraglutide",
    "Text1": "Liraglutide is a recombinant DNA produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents. There have been no published reports of hepatotoxicity attributed to liraglutide therapy.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548472/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611003.html"
},
{
    "Title": "Lisinopril",
    "Text1": "Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor widely used in the therapy of hypertension and heart failure. Lisinopril is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548860/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a692051.html"
},
{
    "Title": "Lithium",
    "Text1": "Lithium is a simple alkali metal, the salt of which acts as a mood stabilizing agent which has been extensively used for the treatment of mania for more than 50 years. Lithium has been associated with rare instances of mild serum aminotransferase elevations, but has not been convincingly linked to clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547877/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a681039.html"
},
{
    "Title": "Lixisenatide",
    "Text1": "Lixisenatide is a recombinant DNA produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents. Therapy with lixisenatide has not been associated with serum enzyme elevations or with episodes of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548285/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617005.html"
},
{
    "Title": "Lomitapide",
    "Text1": "Lomitapide is a cholesterol lowering agent that acts by inhibition of the microsomal triglyceride transfer protein and is used to treat the severe lipid abnormalities of familial hypercholesterolemia. Lomitapide is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy that are usually accompanied by an increase in hepatic fat. Long term therapy with lomitapide has been linked to development of steatohepatitis and hepatic fibrosis.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548458/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614008.html"
},
{
    "Title": "Lomustine",
    "Text1": "Lomustine is an orally administered alkylating agent used alone and in combination with other antineoplastic agents in the treatment of several malignancies including Hodgkin disease, lymphoma, and brain cancer. Lomustine therapy is associated with minor transient serum enzyme elevations and has been linked to rare cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548631/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682207.html"
},
{
    "Title": "Loperamide",
    "Text1": "Loperamide is synthetic opioid that primarily affects opiate receptors in the intestine and is used to treat diarrhea. Loperamide has not been linked to serum enzyme elevations during therapy or to clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547935/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682280.html"
},
{
    "Title": "Lopinavir",
    "Text1": "Lopinavir is an antiretroviral protease inhibitor used in combination with ritonavir in the therapy and prevention of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Lopinavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and, rarely, clinically apparent, acute liver injury. In HBV or HCV coinfected patients, highly active antiretroviral therapy with lopinavir may result of an exacerbation of the underlying chronic hepatitis B or C.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547961/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a602015.html"
},
{
    "Title": "Loratadine",
    "Text1": "Loratadine and its metabolic derivative desloratadine are second generation antihistamines that are used for the treatment of allergic rhinitis, angioedema and chronic urticaria. Loratadine and desloratadine have been linked to rare, isolated instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548831/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697038.html"
},
{
    "Title": "Lorazepam",
    "Text1": "Lorazepam is an orally available benzodiazepine used widely in the therapy of anxiety and insomnia. As with most benzodiazepines, lorazepam therapy has not been associated with serum aminotransferase or alkaline phosphatase elevations, and clinically apparent liver injury from lorazepam has not been reported and must be very rare, if it occurs at all.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548563/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682053.html"
},
{
    "Title": "Lorcaserin",
    "Text1": "Lorcaserin is a selective serotonin agonist that was used as a weight loss agent. Lorcaserin was in clinical use for eight years when it was withdrawn because of concerns regarding an excess in cancer risk after long term use. In prelicensure studies and while in clinical use, lorcaserin was not found to be associated with serum enzyme elevations during therapy or to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548834/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613014.html"
},
{
    "Title": "Lorlatinib",
    "Text1": "Lorlatinib is a selective tyrosine kinase receptor inhibitor used in the therapy of selected cases of advanced non-small cell lung cancer. Lorlatinib is associated with transient elevations in serum aminotransferase levels during treatment but has not been linked to instances of clinically apparent acute liver injury that have been described with other similar kinase inhibitors.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548564/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619005.html"
},
{
    "Title": "Losartan",
    "Text1": "Losartan is an angiotensin II receptor blocker used in the therapy of hypertension and diabetic nephropathy. Losartan is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547842/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a695008.html"
},
{
    "Title": "Lovastatin",
    "Text1": "Lovastatin is a commonly used cholesterol lowering agent (statin) that is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy and rarely with clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548670/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a688006.html"
},
{
    "Title": "Loxapine",
    "Text1": "Loxapine is a conventional antipsychotic used in the therapy of schizophrenia. Loxapine therapy is commonly associated with minor serum aminotransferase elevations and in very rare instances has been linked to clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548875/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682311.html"
},
{
    "Title": "Lubiprostone",
    "Text1": "Lubiprostone is an activator of chloride channels (ClC-2) in the intestine and is used for treatment of chronic constipation and irritable bowel syndrome. Lubiprostone has not been linked to serum enzyme elevations during treatment or to episodes of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548000/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607034.html"
},
{
    "Title": "Lurasidone",
    "Text1": "Lurasidone is a second generation (atypical) antipsychotic agent that is used in the treatment of schizophrenia and bipolar depression. Lurasidone is associated with a low rate of serum aminotransferase elevations during therapy, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548303/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611016.html"
},
{
    "Title": "Maca",
    "Text1": "Maca is a vegetable and food as well as a traditional herbal medicine derived from the roots of a perennial plant (Lepidium meyenii) that grows in high altitudes of Peru and is used to promote health and improve wellness, sexual function and fertility. Maca has not been implicated in causing liver injury either in the form of transient serum enzyme elevations or clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548552/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615037.html"
},
{
    "Title": "Macitentan",
    "Text1": "Macitentan is an endothelin receptor antagonist that is used in the therapy of pulmonary arterial hypertension (PAH). Macitentan has been associated with a low rate of serum enzyme elevations during therapy, but has yet to be implicated in cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548062/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615033.html"
},
{
    "Title": "Maraviroc",
    "Text1": "Maraviroc is a chemokine co-receptor 5 (CCR5) antagonist, the first of a new class of agents active against the human immunodeficiency virus (HIV) and the acquired immunodeficiency syndrome (AIDS). Maraviroc was approved for use in the United States in 2007 but has had limited use. Maraviroc has been associated with elevations in serum aminotransferase levels and to several cases of acute, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548266/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607076.html"
},
{
    "Title": "Mebendazole",
    "Text1": "Mebendazole is an anthelmintic agent used commonly for roundworm (pinworm and hookworm) infections, trichinosis, capillariasis and toxocariasis and other parasitic worm infections. Mebendazole when given for prolonged periods in high doses has been associated with elevations in serum enzyme levels, and rare instances of acute, clinically apparent liver injury have been linked to its use.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547885/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682315.html"
},
{
    "Title": "Mechlorethamine",
    "Text1": "Mechlorethamine is a nitrogen mustard and antineoplastic agent that has been in clinical use for more than 60 years, given systemically in combination with other antineoplastic agents to treat Hodgkin disease, chronic leukemias, lung cancer and polycythemia vera. Currently, however, it is used largely as a topical gel for therapy of cutaneous T-cell lymphomas and mycosis fungoides. Given parenterally in combination with other antineoplastic agents it was associated with low rates of serum enzyme elevations during therapy, but mechlorethamine has not been implicated specifically in cases of acute, clinically apparent injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548509/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682223.html"
},
{
    "Title": "Meclizine",
    "Text1": "Meclizine is a first generation antihistamine that is used largely to treat vertigo and motion sickness. Meclizine has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547895/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682548.html"
},
{
    "Title": "Mefenamic Acid",
    "Text1": "Mefenamic acid is a nonsteroidal antiinflammatory drug (NSAID) used largely for acute treatment of pain. Mefanamic acid has been linked to rare instances of clinically apparent, acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548029/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a681028.html"
},
{
    "Title": "Mefloquine",
    "Text1": "Mefloquine is a quinoline derivative used for the prevention and therapy of P. falciparum malaria. Mefloquine therapy is associated with a low rate of transient and asymptomatic serum enzyme elevations and is a rare cause of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548541/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a603030.html"
},
{
    "Title": "Meloxicam",
    "Text1": "Meloxicam is a long acting nonsteroidal antiinflammatory drug (NSAID) available by prescription only and used in therapy of chronic arthritis. Meloxicam has been linked to rare instances of acute, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548278/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601242.html"
},
{
    "Title": "Melphalan",
    "Text1": "Melphalan is an orally and parenterally administered nitrogen mustard-like alkylating agent used in the therapy of multiple myeloma and ovarian cancer. Melphalan therapy has been associated with low rates of serum enzyme elevations during therapy, but when used in high doses as myeloablative therapy in preparation for hematopoietic cell transplantation, it is associated with high rates of enzyme elevations and acute liver injury due to sinusoidal obstruction syndrome.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548280/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682220.html"
},
{
    "Title": "Memantine",
    "Text1": "Memantine is an oral N-methyl-D-aspartate glutamate receptor antagonist used in the therapy of Alzheimer disease and dementia. Memantine is associated with a minimal rate of serum enzyme elevations during therapy and has only rarely been implicated as a cause of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547981/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604006.html"
},
{
    "Title": "Meperidine",
    "Text1": "Meperidine is a synthetic opioid which has been used widely for therapy of moderate-to-severe pain. Meperidine has not been linked to serum enzyme elevations during therapy or to clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548764/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682117.html"
},
{
    "Title": "Mepolizumab",
    "Text1": "Mepolizumab is a humanized monoclonal antibody to interleukin-5 (IL-5) which leads to a decrease in production and maturation of eosinophils and results in a reduction in allergic symptoms of asthma and hypereosinophilic syndromes. Mepolizumab has not been associated with serum enzyme elevations during therapy or to instances of clinically apparent drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548052/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615058.html"
},
{
    "Title": "Meprobamate",
    "Text1": "Meprobamate is a sedative used for anxiety and insomnia first made available in the 1950s when it became very popular, but which is now rarely used. Meprobamate therapy was not associated with liver enzyme elevations and has not been linked to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548721/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682077.html"
},
{
    "Title": "Mercaptopurine",
    "Text1": "Mercaptopurine (also referred to as 6-mercaptopurine or 6-MP) is a purine analogue that is effective both as an anticancer and an immunosuppressive agent, and is used to treat leukemia and autoimmune diseases as a corticosteroid-sparing agent. Mercaptopurine therapy is associated with a high rate of serum aminotransferase elevations which can be accompanied by jaundice. In addition, mercaptopurine has been linked to instances of clinically apparent acute liver injury and long term therapy to nodular regenerative hyperplasia.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548546/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682653.html"
},
{
    "Title": "Meropenem",
    "Text1": "Meropenem is a carbapenem antibiotic with broad spectrum of activity that is administered intravenously and used for severe bacterial infections due to sensitive agents. Meropenem is a common cause of mild transient aminotransferase elevations and can rarely result in clinically apparent, cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547861/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617048.html"
},
{
    "Title": "Mesalamine",
    "Text1": "Mesalamine, also known as mesalazine and 5-aminosalicylate, is an orally available, antiinflammatory agent used for the treatment of ulcerative colitis to both induce and maintain remissions in disease. Mesalamine therapy has been associated with a low rate of serum enzyme elevations during therapy and with rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547995/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a688021.html"
},
{
    "Title": "Metaxalone",
    "Text1": "Metaxalone is a centrally acting skeletal muscle relaxant that has been in use for more than 40 years. Metaxalone has not been associated with serum aminotransferase elevations during therapy or with clinically apparent hepatic injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548838/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682010.html"
},
{
    "Title": "Metformin",
    "Text1": "Metformin is a first line agent for the treatment of type 2 diabetes that can be used alone or in combination with sulfonylureas, thiazolidinediones, incretin-based drugs, sodium glucose cotransporter-2 inhibitors, or other hypoglycemic agents. Metformin has not been linked to serum enzyme elevations during therapy and is an exceeding rare cause of idiosyncratic clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548726/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a696005.html"
},
{
    "Title": "Methadone",
    "Text1": "Methadone is a synthetic opioid which is used widely as an analgesic as well as maintenance therapy for persons with opioid dependency. Patients on chronic methadone therapy for opioid dependency often have underlying chronic viral hepatitis, but methadone itself has not been linked to serum enzyme elevations during therapy or to clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548084/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682134.html"
},
{
    "Title": "Methenamine",
    "Text1": "Methenamine is a urinary tract antiseptic that is used as suppressive therapy for chronic or recurrent urinary tract infections. Methenamine has not been linked to serum enzyme elevations or to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK567340/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682296.html"
},
{
    "Title": "Methimazole",
    "Text1": "Methimazole is an antithyroid medication which is now considered the first line agent for medical therapy of hyperthyroidism and Graves disease. Methimazole has been linked to serum aminotransferase elevations during therapy as well as to a clinically apparent, idiosyncratic liver injury that is typically cholestatic and self-limited in course.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548406/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682464.html"
},
{
    "Title": "Methocarbamol",
    "Text1": "Methocarbamol is a commonly used, centrally acting muscle relaxant and has not been linked to instances of liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548286/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682579.html"
},
{
    "Title": "Methotrexate",
    "Text1": "Methotrexate is an antineoplastic and immunosuppressive agent widely used in the therapy of leukemia, lymphoma, solid tumors, psoriasis and rheumatoid arthritis. When given in high intravenous doses, methotrexate can cause acute elevations in serum enzymes, and long term methotrexate therapy has been associated with frequent but mild elevations in serum liver enzymes and, more importantly, with development of chronic liver injury, progressive fibrosis, cirrhosis and portal hypertension.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548219/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682019.html"
},
{
    "Title": "Methsuximide",
    "Text1": "Methsuximide is a succinimide-based anticonvulsant similar to ethosuximide that is used for absence (petit mal) seizures in both adults and children. Methsuximide was associated with hepatic injury in experimental animals, but has not been linked to serum enzyme elevations during treatment or to cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548535/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682028.html"
},
{
    "Title": "Methyldopa",
    "Text1": "Methyldopa (alpha-methyldopa or a-methyldopa) is a centrally active sympatholytic agent that has been used for more than 50 years for the treatment of hypertension. Methyldopa has been clearly linked to instances of acute and chronic liver injury that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548173/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682242.html"
},
{
    "Title": "Methylphenidate",
    "Text1": "Methylphenidate is a central nervous system stimulant used for the therapy of attention deficit disorder and narcolepsy. Methylphenidate has been linked to a low rate of serum aminotransferase elevations during therapy and to rare instances of acute, clinically apparent liver injury, generally after its intravenous abuse.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547941/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682188.html"
},
{
    "Title": "Metoclopramide",
    "Text1": "Metoclopramide is an oral prokinetic and antiemetic agent used in the therapy of gastroesophageal reflux disease, gastroparesis and severe or chemotherapy induced nausea. Metoclopramide has been linked to rare instances of clinically apparent liver injury that are typically cholestatic and can be associated with bile duct loss.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548630/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684035.html"
},
{
    "Title": "Metoprolol",
    "Text1": "Metoprolol is a cardioselective beta-blocker that is widely used in the treatment of hypertension and angina pectoris. Metoprolol has been linked to rare cases of drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547984/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682864.html"
},
{
    "Title": "Metronidazole",
    "Text1": "Metronidazole is a nitroimidazole derivative bactericidal agent widely used in the treatment of many anaerobic and certain protozoan and parasitic infections. Metronidazole has been linked to rare instances of acute, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548609/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601028.html"
},
{
    "Title": "Mexiletine",
    "Text1": "Mexiletine is an oral antiarrhythmic agent that is used for suppression of ventricular arrhythmias. Long term mexiletine therapy is associated with a low rate of serum enzyme elevations and is a rare cause of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548651/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607064.html"
},
{
    "Title": "Midazolam",
    "Text1": "Midazolam is a benzodiazepine used intravenously as an anesthetic for conscious sedation or as an adjunct for general anesthesia. Midazolam therapy has not been associated with serum aminotransferase elevations and has not been linked to cases of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548691/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a609003.html"
},
{
    "Title": "Midostaurin",
    "Text1": "Midostaurin is an orally available small molecule inhibitor of FMS-like tyrosine kinase 3 (FLT3) which is used as an antineoplastic agent in the treatment of acute myeloid leukemia with FLT3 mutations. Midostaurin is associated with a moderate rate of serum aminotransferase elevations during therapy and is suspected to cause rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548874/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617033.html"
},
{
    "Title": "Mifepristone",
    "Text1": "Mifepristone, also known as RU-486, is a potent synthetic steroidal antiprogesterone which is used as a single dose in combination with misoprostol, a prostaglandin analogue, to induce medical abortion. Mifepristone with misoprostol have not been associated with serum enzyme elevations or with clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548328/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614005.html"
},
{
    "Title": "Miglitol",
    "Text1": "Miglitol is an alpha glucosidase inhibitor which delays intestinal absorption of carbohydrates and is used as an adjunctive therapy in the management of type 2 diabetes. Miglitol has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547878/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601079.html"
},
{
    "Title": "Miglustat",
    "Text1": "Miglustat is an oral inhibitor of glucosylceramide synthase which is used in the therapy of type 1 Gaucher disease. Clinical experience with miglustat is limited, but it has not been linked to serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548240/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604015.html"
},
{
    "Title": "Milnacipran",
    "Text1": "Levomilnacipran is a serotonin and norepinephrine reuptake inhibitor used to treat major depressive disorders. Levomilnacipran is an enantiomer of milnacipran, which is used to treat fibromyalgia. Levomilnacipran and milnacipran have been associated with a low rate of transient elevations in serum aminotransferase levels during treatment and with rare instances of clinically apparent acute liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547960/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613048.html"
},
{
    "Title": "Minocycline",
    "Text1": "Minocycline is a tetracycline antibiotic with excellent absorption and tissue penetration that is used for several bacterial infections as well as treatment of acne. Minocycline can cause both an acute hepatitis-like syndrome occurring within 1 to 3 months of starting therapy or a more insidious chronic hepatitis with autoimmune features typically after long term treatment.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547956/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682101.html"
},
{
    "Title": "Minoxidil",
    "Text1": "Minoxidil is an antihypertensive agent that is used largely for patients with severe and refractory hypertension not responding to conventional therapies. Minoxidil is also used topically to treat male pattern baldness. Despite its use for many years, minoxidil has not been convincingly linked to cases of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548394/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682608.html"
},
{
    "Title": "Mirabegron",
    "Text1": "Mirabegron is a beta-3 adrenergic agonist that is used for treatment of overactive bladder syndrome. Mirabegron has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547887/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612038.html"
},
{
    "Title": "Mirtazapine",
    "Text1": "Mirtazapine is a tetracyclic antidepressant with a somewhat unique mechanism of action. Mirtazapine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548216/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697009.html"
},
{
    "Title": "Mitomycin",
    "Text1": "Mitomycin is a cytotoxic antibiotic which is used as anticancer therapy of advanced cancers of the stomach and pancreas. Mitomycin in combination with other anticancer agents frequently causes mild-to-moderate serum enzyme elevations during therapy and is capable of causing sinusoidal obstruction syndrome, but mitomycin by itself has not been specifically linked to instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547991/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a620027.html"
},
{
    "Title": "Mitotane",
    "Text1": "Mitotane is a unique antineoplastic agent used solely in the therapy of metastatic, unresectable adrenocortical carcinoma. Mitotane has been associated with a high rate of serum enzyme elevation during therapy, but has had limited clinical use and has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548445/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608050.html"
},
{
    "Title": "Mitoxantrone",
    "Text1": "Mitoxantrone is an antineoplastic antibiotic that is used in the treatment of acute leukemia, lymphoma, and prostate and breast cancer, but also for late stage, severe multiple sclerosis. Mitoxantrone therapy is often accompanied by mild to moderate elevations in serum aminotransferase levels, but in typical doses it rarely causes clinically apparent, acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547931/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608019.html"
},
{
    "Title": "Modafinil",
    "Text1": "Modafinil and its R-enantiomer armodafinil are central nervous system stimulants used to improve wakefulness in patients with excessive sleepiness. Both modafinil and armodafinil are associated with a low rate of serum aminotransferase elevations during therapy, but they have not been implicated in cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548274/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a602016.html"
},
{
    "Title": "Moexipril",
    "Text1": "Moexipril is an angiotensin-converting enzyme (ACE) inhibitor which is used in the therapy of hypertension. Moexipril is associated with a low rate of transient serum aminotransferase elevations, but has yet to be linked to instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547904/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a695018.html"
},
{
    "Title": "Mogamulizumab",
    "Text1": "Mogamulizumab is a humanized monoclonal antibody to the T cell CC chemokine receptor 4 which is used to treat peripheral and cutaneous T-cell lymphomas. Mogamulizumab is associated with a low rate of serum enzyme elevations during treatment and has been linked to several instances of reactivation of hepatitis B.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547933/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618064.html"
},
{
    "Title": "Molindone",
    "Text1": "Molindone is a conventional antipsychotic agent used in the therapy of schizophrenia. Molindone therapy is commonly associated with minor serum aminotransferase elevations but has rarely been linked to cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548468/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682238.html"
},
{
    "Title": "Montelukast",
    "Text1": "Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma and has been linked to rare cases of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548264/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a600014.html"
},
{
    "Title": "Morphine",
    "Text1": "Morphine is one of the natural plant alkaloids found in opium and is the prototype opiate, against which other derivatives are measured in terms of analgesic effects and side effects. Morphine has not been linked to serum enzyme elevations during therapy or to clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548230/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601161.html"
},
{
    "Title": "Moxetumomab Pasudotox",
    "Text1": "Moxetumomab pasudotox is a mouse monoclonal antibody to CD22 conjugated with a toxic fragment of Pseudomonas exotoxin A which is used in the therapy of resistant forms of hairy cell leukemia. Moxetumomab pasudotox has been linked to transient serum enzyme elevations during therapy, but has not been linked to instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548901/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618052.html"
},
{
    "Title": "Moxifloxacin",
    "Text1": "Moxifloxacin is a fourth generation fluoroquinolone with expanded activity against gram-positive bacteria as well as atypical pathogens. Moxifloxacin has been linked to mild ALT elevations during therapy and to rare instances of idiosyncratic acute liver injury with symptoms and jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548166/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605016.html"
},
{
    "Title": "Mycophenolate",
    "Text1": "Mycophenolate mofetil is an antimetabolite and potent immunosuppressive agent used as adjunctive therapy in prevention of allograft rejection and in the treatment of serious autoimmune diseases. Mycophenolate therapy can be associated with mild serum enzyme elevations and it has been linked to rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548945/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601081.html"
},
{
    "Title": "Nabilone",
    "Text1": "Nabilone is an orally available cannabinoid agonist that is used to treat nausea and vomiting and to stimulate appetite, particularly in patients with wasting disease or cachexia. Nabilone is associated with a minimal rate of serum enzyme elevations during therapy and has not been linked to cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547865/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607048.html"
},
{
    "Title": "Nabumetone",
    "Text1": "Nabumetone is a long acting nonsteroidal antiinflammatory drug (NSAID) that is available by prescription only and is used in therapy of chronic arthritis. Nabumetone has been linked to rare instances of clinically apparent, idiosyncratic drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548909/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a692022.html"
},
{
    "Title": "Nadolol",
    "Text1": "Nadolol is a nonselective beta-adrenergic receptor blocker that is widely used for the therapy of hypertension, angina pectoris and vascular headaches. Nadolol has yet to be convincingly associated with clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548739/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682666.html"
},
{
    "Title": "Nafcillin",
    "Text1": "Nafcillin is a parenteral, second generation penicillinase-resistant penicillin antibiotic used largely to treat moderate to severe staphylococcal infections. Nafcillin has been linked to rare occurrences of clinically apparent, idiosyncratic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548403/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a685019.html"
},
{
    "Title": "Naldemedine",
    "Text1": "Naldemedine is a peripherally acting opioid antagonist which is used to treat constipation caused by chronic opioid use. Naldemedine has not been linked to serum enzyme elevations during therapy or to clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548373/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617031.html"
},
{
    "Title": "Naloxegol",
    "Text1": "Naloxegol is a peripherally acting opioid antagonist which is used to treat constipation caused by chronic opioid use for noncancer pain. Naloxegol has not been linked to serum enzyme elevations during therapy or to clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548612/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615016.html"
},
{
    "Title": "Naloxone",
    "Text1": "Naloxone is an opiate antagonist which is used intravenously in emergency situations to reverse the respiratory depression caused by overdoses of heroin, morphine or other opioids. Naloxone has not been linked to serum enzyme elevations during therapy or to clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548244/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612022.html"
},
{
    "Title": "Naltrexone",
    "Text1": "Naltrexone is a synthetic opioid antagonist used in prevention of relapse of opiate addiction and alcoholism. Naltrexone has been associated with low rates of serum enzyme elevations during therapy and with rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548583/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616047.html"
},
{
    "Title": "Naproxen",
    "Text1": "Naproxen is a popular over-the-counter nonsteroidal antiinflammatory drug (NSAID) that is widely used for therapy of mild-to-moderate pain and arthritis. Naproxen has been associated with rare cases of clinically apparent drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548159/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a681029.html"
},
{
    "Title": "Natalizumab",
    "Text1": "Natalizumab is a monoclonal antibody to human alpha-4 integrin which has potent immune suppressive activity and is used in the therapy of severe inflammatory bowel disease and relapsing multiple sclerosis. Natalizumab has been linked to rare instances of idiosyncratic acute liver injury that has features of autoimmunity and seen largely in patients being treated for multiple sclerosis.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548623/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605006.html"
},
{
    "Title": "Nateglinide",
    "Text1": "Nateglinide is an oral hypoglycemic agent and amino acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Nateglinide has been linked to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548227/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699057.html"
},
{
    "Title": "Nebivolol",
    "Text1": "Nebivolol is a beta-blocker and antihypertensive medication that has additional vasodilatory activity mediated by nitric oxide release. Nebivolol has yet to be linked to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548386/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608029.html"
},
{
    "Title": "Necitumumab",
    "Text1": "Necitumumab is a human monoclonal antibody to the epidermal growth factor (EGF) receptor and is an anti-angiogenesis agent used in the therapy of advanced non-small cell lung cancer. Necitumumab has not been linked to serum enzyme elevations during therapy or to idiosyncratic acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548481/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616009.html"
},
{
    "Title": "Nefazodone",
    "Text1": "Nefazodone is a serotoninergic modulating antidepressant that is used in therapy of depression, aggressive behavior and panic disorder. Nefazodone therapy has been associated with transient, usually asymptomatic elevations in serum aminotransferase levels and has been linked to several instances of clinically apparent acute liver injury some of which have been fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548179/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a695005.html"
},
{
    "Title": "Nelarabine",
    "Text1": "Nelarabine is a purine analogue and antineoplastic agent used in the therapy of T cell lymphoblastic leukemia or lymphoma. Nelarabine is associated with a low rate of transient serum enzyme elevations during therapy and has been linked to rare instances of clinically apparent acute liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548515/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607077.html"
},
{
    "Title": "Nelfinavir",
    "Text1": "Nelfinavir is an antiretroviral protease inhibitor used in the therapy and prevention of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Nelfinavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and is a rare cause of clinically apparent, acute liver injury. In HBV or HCV coinfected patients, hepatic injury during antiretroviral therapy that includes nelfinavir may be a result of exacerbation of the underlying chronic hepatitis B or C, rather than a direct effect of the medication.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548311/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697034.html"
},
{
    "Title": "Neomycin",
    "Text1": "Neomycin is a broad spectrum aminoglycoside antibiotic whose current use is limited to oral and topical administration. Neomycin has minimal oral absorption and its use has not been linked to instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547874/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682274.html"
},
{
    "Title": "Neratinib",
    "Text1": "Neratinib is an orally available tyrosine kinase receptor inhibitor that is used in the extended adjuvant therapy of early stage breast cancer. Neratinib is associated with a low rate of transient elevations in serum aminotransferase levels during therapy, but has not been convincingly linked to cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548937/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617034.html"
},
{
    "Title": "Nevirapine",
    "Text1": "Nevirapine is a nonnucleoside reverse transcriptase inhibitor used in combination with other agents in the therapy of human immunodeficiency virus (HIV) infection and the acquired immune deficiency syndrome (AIDS). Nevirapine is associated with a high rate of serum aminotransferase elevations during therapy and is a well established cause of acute, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548895/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a600035.html"
},
{
    "Title": "Niacin",
    "Text1": "Niacin, also known as nicotinic acid and vitamin B3, is a water soluble, essential B vitamin that, when given in high doses, is effective in lowering low density lipoprotein (LDL) cholesterol and raising high density lipoprotein (HDL) cholesterol, which makes this agent of unique value in the therapy of dyslipidemia. Niacin can cause mild-to-moderate serum aminotransferase elevations and high doses and certain formulations of niacin have been linked to clinically apparent, acute liver injury which can be severe as well as fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548176/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682518.html"
},
{
    "Title": "Nicardipine",
    "Text1": "Nicardipine is a second generation calcium channel blocker used in the treatment of hypertension and stable angina pectoris. Nicardipene therapy has been associated with a low rate of transient serum enzyme elevations, but has not been linked convincingly to instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548755/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a695032.html"
},
{
    "Title": "Nicotine",
    "Text1": "Nicotine is a natural alkyloid that is a major component of cigarettes and is used therapeutically to help with smoking cessation. Nicotine has not been associated with liver test abnormalities or with clinically apparent hepatotoxicity.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548698/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601084.html"
},
{
    "Title": "Nifedipine",
    "Text1": "Nifedipine is a first generation calcium channel blocker used to treat hypertension and angina pectoris. Nifedipine therapy is associated with a low rate of serum enzyme elevations and has been linked to several instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548324/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684028.html"
},
{
    "Title": "Nilotinib",
    "Text1": "Nilotinib is a selective tyrosine kinase receptor inhibitor used in the therapy of chronic myelogenous leukemia. Nilotinib therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548443/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608002.html"
},
{
    "Title": "Nilutamide",
    "Text1": "Nilutamide is an oral nonsteroidal antiandrogen similar in structure to flutamide that is used widely in the therapy of prostate cancer and has been linked to rare instances of liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548158/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697044.html"
},
{
    "Title": "Nimodipine",
    "Text1": "Nimodipine is a second generation calcium channel blocker used in the treatment of cerebral vasospasm after subarachnoid hemorrhage. Nimodipine is not widely used and has not been implicated in causing clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548041/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a689010.html"
},
{
    "Title": "Nintedanib",
    "Text1": "Nintedanib is an orally available tyrosine kinase receptor antagonist that inhibits collagen formation and is used to treat idiopathic pulmonary fibrosis. Elevations in serum enzyme levels during nintedanib therapy are not uncommon, but it has yet to be implicated in cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548135/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615009.html"
},
{
    "Title": "Niraparib",
    "Text1": "Niraparib is a small molecule inhibitor of poly ADP-ribose polymerase that is used in the therapy of selected patients with refractory and advanced ovarian carcinoma. Niraparib therapy is associated with a low rate of transient elevations in serum aminotransferase during therapy, but has not been linked to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548333/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617007.html"
},
{
    "Title": "Nisoldipine",
    "Text1": "Nisoldipine is a second generation calcium channel blocker and commonly used antihypertensive agent. Nisoldipine therapy is associated with a low rate of serum enzyme elevations, but has not been specifically linked to instances of clinical apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548364/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a696009.html"
},
{
    "Title": "Nitazoxanide",
    "Text1": "Nitazoxanide is an antimicrobial with activity against several parasitic worms and protozoa that is used predominantly in the United States in treatment of giardiasis and cryptosporidiosis. Nitazoxanide therapy has not been reported to cause serum aminotransferase elevations during therapy or clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548943/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a603017.html"
},
{
    "Title": "Nitrofurantoin",
    "Text1": "Nitrofurantoin is an oral antibiotic widely used either short term to treat acute urinary tract infections or long term as chronic prophylaxis against recurrent infections. Nitrofurantoin is one of the most common causes of drug induced liver disease and can cause either an acute or a chronic hepatitis-like syndrome that can be severe and lead to liver failure or cirrhosis.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548318/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682291.html"
},
{
    "Title": "Nivolumab",
    "Text1": "Nivolumab is a human monoclonal antibody to programmed cell death receptor 1 (PD-1), which modulates T cell immune reactivity and is used in the immunotherapy of cancer. Nivolumab has major side effects and particularly immune related conditions, including acute liver injury which can be serious and even life threatening.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548206/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614056.html"
},
{
    "Title": "Nizatidine",
    "Text1": "Nizatidine is a histamine type 2 receptor antagonist (H2 blocker) which is widely used for treatment of acid-peptic disease and heartburn. Nizatidine has been linked to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548387/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a694030.html"
},
{
    "Title": "Noni",
    "Text1": "Noni is a tropic fruit tree, the juice, roots, stems, bark, leaves and flowers of which have been used as medicinal remedies in Polynesia for centuries and recently in the Western world for a wide range of medical problems from cancer and diabetes to AIDs. A small number of isolated case reports of clinically apparent liver injury have been attributed to noni.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548374/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601054.html"
},
{
    "Title": "Nortriptyline",
    "Text1": "Nortriptyline is a tricyclic antidepressant that is also used in smoking cessation. Nortriptyline can cause mild and transient serum enzyme elevations and is rare cause of clinically apparent acute and chronic cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548526/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682620.html"
},
{
    "Title": "Nystatin",
    "Text1": "Nystatin is a topical and oral antifungal agent with activity against many species of yeast and candida albicans, which is used largely to treat skin and oropharyngeal candidiasis. Nystatin is not absorbed orally and has not been linked to drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548581/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601087.html"
},
{
    "Title": "Obeticholic Acid",
    "Text1": "Obeticholic acid (OCA) is a synthetically modified bile acid and potent agonist of the farnesoid X nuclear receptor (FXR) that is used to treat liver diseases including primary biliary cholangitis. Obeticholic acid has not been linked to elevations in serum enzyme levels during therapy, but has been linked to an increased rate of severe liver related adverse events such as ascites, jaundice and liver failure.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548806/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616033.html"
},
{
    "Title": "Ocrelizumab",
    "Text1": "Ocrelizumab is a humanized monoclonal antibody to CD20 which is used as therapy of multiple sclerosis. Ocrelizumab has not been associated with serum enzyme elevations during therapy nor with instances of idiosyncratic liver injury, but has been linked to cases of reactivation of hepatitis B in susceptible patients.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548145/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617026.html"
},
{
    "Title": "Octreotide",
    "Text1": "Octreotide is a synthetic somatostatin analogue that resembles the native polypeptide in its activity in suppressing levels and activity of growth hormone, insulin, glucagon and many other gastrointestinal peptides. Because its half-life is longer than somatostatin, octreotide can be used clinically to treat neuroendocrine tumors that secrete excessive amounts of growth hormone (acromegaly) or other active hormones or neuropeptides. Octreotide has many side effects including suppression of gall bladder contractility and bile production, and maintenance therapy can cause cholelithiasis, pancreatitis as well as clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547947/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a620051.html"
},
{
    "Title": "Ofatumumab",
    "Text1": "Ofatumumab is a recombinant human monoclonal antibody to CD20 a cell surface antigen found on pre-B and mature B lymphocytes and which is approved for use in resistant chronic lymphocytic leukemia. Ofatumumab therapy has not been associated with serum enzyme elevations during therapy or to cases of idiosyncratic, clinically apparent liver injury. However, ofatumumab has potent immunosuppressive activity and its use has been reported to be associated with cases of reactivation of inactive hepatitis B which can be severe and can result in fatality.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548649/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a610009.html"
},
{
    "Title": "Ofloxacin",
    "Text1": "Ofloxacin is a second generation fluoroquinolone that was previously used widely for therapy of mild-to-moderate bacterial infections, but which has been replaced by more potent and less toxic fluoroquinolones and is now used largely topically as eye and ear drops. Ofloxacin has been linked to rare instances of acute hepatocellular injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548923/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697040.html"
},
{
    "Title": "Olanzapine",
    "Text1": "Olanzapine is an atypical antipsychotic that is used currently in the treatment of schizophrenia and bipolar illness. Olanzapine is not infrequently associated with serum aminotransferase elevations during therapy and there have been rare instances of clinically apparent acute liver injury linked to its use.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548842/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601213.html"
},
{
    "Title": "Olaparib",
    "Text1": "Olaparib is a small molecule inhibitor of poly ADP-ribose polymerase and is used as an antineoplastic agent in the therapy of refractory and advanced ovarian carcinoma. Olaparib therapy is associated with a low rate of transient elevations in serum aminotransferase during therapy and has not been linked to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547873/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614060.html"
},
{
    "Title": "Olaratumab",
    "Text1": "Olaratumab is a human monoclonal antibody to the platelet-derived growth factor (PDGF) receptor alpha and an antineoplastic agent used in the therapy of advanced soft tissue sarcoma. Olaratumab has not been linked to serum enzyme elevations during therapy or to idiosyncratic acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548940/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616053.html"
},
{
    "Title": "Olmesartan",
    "Text1": "Olmesartan is an angiotensin II receptor blocker used in the therapy of hypertension. Olmesartan is associated with a low rate of transient serum aminotransferase elevations, but has yet to be linked to instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548153/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a603006.html"
},
{
    "Title": "Omacetaxine",
    "Text1": "Omacetaxine is a semisynthetic cephataxine that acts as a protein translation inhibitor and is used to treated chronic myeloid leukemia that is resistant to tyrosine kinase receptor antagonists. Omacetaxine is associated with a low rate of serum enzyme elevation during therapy, but has not been linked to cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548034/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613012.html"
},
{
    "Title": "Omadacycline",
    "Text1": "Omadacycline is an oral, tetracycline-like antibiotic used to treat moderate-to-severe infections including community-acquired pneumonia and acute bacterial skin and skin structure infections caused by susceptible organisms. Oral omadacycline use has been associated with serum enzyme elevations during therapy but has not been implicated in cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547890/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618066.html"
},
{
    "Title": "Omalizumab",
    "Text1": "Omalizumab is a monoclonal antibody to human immunoglobulin E (IgE), which leads to a decrease in IgE binding to mast cells and basophils and a reduction in allergic symptoms of asthma and seasonal rhinitis. Omalizumab therapy has not been associated with serum enzyme elevations during therapy and has yet to be implicated in cases of clinically apparent drug induced liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548822/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a603031.html"
},
{
    "Title": "Omega-3 Fatty Acids",
    "Text1": "Omega-3 fatty acids are essential polyunsaturated fatty acids that have diverse functions in normal metabolism and health and are used as nutritional supplements for general health and for disease prevention and as prescription drugs for treatment of hypertriglyceridemia. The omega-3 fatty acids are generally safe and well tolerated and have not been implicated in causing serum enzyme elevations or clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548910/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607065.html"
},
{
    "Title": "Omeprazole",
    "Text1": "Omeprazole and esomeprazole are proton pump inhibitors (PPIs) and potent inhibitor of gastric acidity which are widely used in the therapy of gastroesophageal reflux and peptic ulcer disease. Omeprazole and esomeprazole therapy are both associated with a low rate of transient and asymptomatic serum aminotransferase elevations and are rare causes of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548771/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699054.html"
},
{
    "Title": "Orlistat",
    "Text1": "Orlistat is an inhibitor of pancreatic and gastric lipase and a commonly used weight loss agent that is available both by prescription and over-the-counter. Orlistat has been linked to rare instances of acute liver injury, some of which have been severe.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548898/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601244.html"
},
{
    "Title": "Orphenadrine",
    "Text1": "Orphenadrine is a centrally acting muscle relaxant that has been in clinical use for more than 50 years and has not been linked to liver injury or clinically apparent drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548850/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682162.html"
},
{
    "Title": "Oseltamivir",
    "Text1": "Oseltamivir is an inhibitor of the influenza neuraminidase enzyme and is used as therapy and prophylaxis against influenza A and B. Oseltamivir has not been associated with clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548268/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699040.html"
},
{
    "Title": "Osimertinib",
    "Text1": "Osimertinib is a small molecule tyrosine kinase receptor inhibitor and antineoplastic agent that is used in the therapy of selected forms of advanced non-small cell lung cancer (NSCLC). Osimertinib is associated with a moderate rate of serum aminotransferase elevations during therapy and rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548495/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616005.html"
},
{
    "Title": "Oxacillin",
    "Text1": "Oxacillin is a parenteral, second generation penicillin antibiotic that is used to treat moderate-to-severe, penicillinase-resistant staphylococcal infections. Oxacillin has been linked to rare instances of clinically apparent, idiosyncratic liver injury, but it more commonly causes transient elevations in serum aminotransferases without jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548078/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a685020.html"
},
{
    "Title": "Oxaliplatin",
    "Text1": "Oxaliplatin is an intravenously administered platinum containing alkylating agent which is used for the treatment of advanced colorectal cancer. Oxaliplatin therapy is associated with a low rate of transient serum aminotransferase elevations, but is commonly associated with sinusoidal and vascular injury to the liver which can lead to sinusoidal obstruction syndrome and to nodular regenerative hyperplasia with noncirrhotic portal hypertension.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548456/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607035.html"
},
{
    "Title": "Oxaprozin",
    "Text1": "Oxaprozin is a long acting nonsteroidal antiinflammatory drug (NSAID) available by prescription only which is used for therapy of chronic arthritis. Oxaprozin has been linked to rare instances of idiosyncratic drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548334/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a693002.html"
},
{
    "Title": "Oxazepam",
    "Text1": "Oxazepam is an orally available benzodiazepine used in the therapy of anxiety and acute alcohol withdrawal syndromes. As with most benzodiazepines, oxazepam therapy has not been associated with serum aminotransferase or alkaline phosphatase elevations, and clinically apparent liver injury from oxazepam has not been reported and must be very rare, if it occurs at all.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548104/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682050.html"
},
{
    "Title": "Oxcarbazepine",
    "Text1": "Oxcarbazepine is a keto analogue of carbamazepine and, like the parent drug, is a potent anticonvulsant used alone or in combination with other agents in the therapy of partial seizures. Oxcarbazepine has been linked to rare instances of clinically apparent acute drug induced liver injury which resembles carbamazepine hepatotoxicity.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548414/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601245.html"
},
{
    "Title": "Oxybate",
    "Text1": "Oxybate is a small, neuroactive molecule (gamma-hydroxybutyrate) that is used to treat catalepse and daytime sleepiness in patients with narcolepsy. Oxybate has been reported to cause serum enzyme elevations during therapy, but has not been implicated in instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548588/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605032.html"
},
{
    "Title": "Oxybutynin",
    "Text1": "Oxybutynin is a synthetic anticholinergic agent that is used for treatment of urinary incontinence and overactive bladder syndrome. Oxybutynin has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548652/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682141.html"
},
{
    "Title": "Oxycodone",
    "Text1": "Oxycodone is a semisynthetic, moderately potent, orally available opioid that is widely used for acute or chronic management of moderate- or moderately severe pain either alone or in combination with acetaminophen. Oxycodone by itself has not been linked to serum enzyme elevations during therapy or to clinically apparent liver injury. However, the combination of oxycodone with acetaminophen has been linked to many cases of acute liver failure caused by unintentional overdose with acetaminophen.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547955/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682132.html"
},
{
    "Title": "Paclitaxel",
    "Text1": "Paclitaxel is an antineoplastic agent which acts by inhibitor of cellular mitosis and which currently plays a central role in the therapy of ovarian, breast, and lung cancer. Therapy with paclitaxel has been associated with a low rate of serum enzyme elevations, but has not been clearly linked to cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548093/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619008.html"
},
{
    "Title": "Palbociclib",
    "Text1": "Palbociclib is a unique cyclin-dependent kinase inhibitor that is used in combination with aromatase inhibitors in the treatment of postmenopausal women with metastatic breast cancer. Palbociclib is associated with transient and usually mild elevations in serum aminotransferase during therapy and to an unusual form of liver injury called pseudocirrhosis caused by shrinkage of tumor metastases in the liver combined with desmoplastic changes and vascular damage, that can be severe, progressive and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547882/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615013.html"
},
{
    "Title": "Paliperidone",
    "Text1": "Paliperidone is a second generation (atypical) antipsychotic agent that is available in both oral and long acting parenteral forms and is used in the treatment of schizophrenia. Paliperidone is associated with a low rate of serum aminotransferase elevations during therapy, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548506/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607005.html"
},
{
    "Title": "Panitumumab",
    "Text1": "Panitumumab is a human monoclonal antibody to the epidermal growth factor (EGF) receptor, which is used in the treatment of refractory metastatic colorectal cancer. Panitumumab has been linked to minor serum enzyme elevations during therapy, but has not been implicated in cases of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548182/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607066.html"
},
{
    "Title": "Panobinostat",
    "Text1": "Panobinostat is an oral histone deacetylase inhibitor and antineoplastic agent that is approved for use in combination with other agents in refractory or relapsed multiple myeloma. Panobinostat is associated with modest rate of minor serum enzyme elevations during therapy, but has not been linked to cases of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548331/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615020.html"
},
{
    "Title": "Pantoprazole",
    "Text1": "Pantoprazole is a proton pump inhibitor (PPI) and a potent inhibitor of gastric acidity which is widely used in the therapy of gastroesophageal reflux and peptic ulcer disease. Pantoprazole therapy is associated with a low rate of transient and asymptomatic serum aminotransferase elevations and is a rare cause of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548461/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601246.html"
},
{
    "Title": "Paroxetine",
    "Text1": "Paroxetine is a selective serotonin reuptake inhibitor (SSRI) used in the therapy of depression, anxiety disorders and obsessive-compulsive disorder. Paroxetine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548306/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a698032.html"
},
{
    "Title": "Pazopanib",
    "Text1": "Pazopanib is a multi-kinase inhibitor active against vascular endothelial growth factor receptors-1, -2 and -3 that is used in the therapy of advanced renal cell carcinoma and soft tissue sarcomas. Pazopanib therapy is commonly associated with transient elevations in serum aminotransferase during therapy and has been linked to rare, but occasionally severe and even fatal cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548110/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a610013.html"
},
{
    "Title": "Pegloticase",
    "Text1": "Pegloticase is a pegylated, recombinant urate oxidase enzyme that is used to treat patients with chronic refractory and symptomatic gout. Pegloticase has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548768/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611015.html"
},
{
    "Title": "Pegloticase",
    "Text1": "Pegloticase is a pegylated, recombinant urate oxidase enzyme that is used to treat patients with chronic refractory and symptomatic gout. Pegloticase has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548768/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611015.html"
},
{
    "Title": "Pembrolizumab",
    "Text1": "Pembrolizumab is a humanized monoclonal antibody to programmed cell death receptor 1 (PD-1), which results in an increased immune reactivity that can break tolerance and is used in the immunotherapy of cancer. Pembrolizumab therapy has many adverse events and particularly immune related conditions, including acute hepatitis and acute liver injury which can be serious and even life threatening.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548050/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614048.html"
},
{
    "Title": "Pemetrexed",
    "Text1": "Pemetrexed is a parenterally administered folate antagonist and antineoplastic agent, used in the treatment of non-small cell lung cancer and malignant mesothelioma. Pemetrexed therapy has been associated with moderate rates of serum enzyme elevations during therapy, but has not been convincingly linked to instances of acute, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548117/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607043.html"
},
{
    "Title": "Penbutolol",
    "Text1": "Penbutolol is a nonselective beta-adrenergic receptor blocker (beta-blocker) used for the therapy of hypertension. Penbutolol has yet to be convincingly associated with clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548494/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601091.html"
},
{
    "Title": "Penicillamine",
    "Text1": "Penicillamine is chelating agent used to decrease copper stores in Wilson disease, which also has immunomodulatory activity in rheumatic diseases such as rheumatoid arthritis, scleroderma and systemic lupus erythematosus. Penicillamine is capable of causing hypersensitivity reactions, some of which are accompanied by liver injury which is typically cholestatic.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548246/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618021.html"
},
{
    "Title": "Pentamidine",
    "Text1": "Pentamidine is a potent, broad spectrum antiinfective agent with activity against several parasitic worms, protozoa and fungi that has been used mainly in the treatment and the prophylaxis of Pneumocystis jiroveci (formerly carinii) infection in immunocompromised persons. Pentamidine is relatively toxic and therapy requires careful monitoring. Pentamidine has been associated with transient serum aminotransferase elevations during therapy and with rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548946/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601208.html"
},
{
    "Title": "Pentazocine",
    "Text1": "Pentazocine is a synthetic opioid with both agonist and antagonist activity against opiate receptors which was previously used in oral and parenteral forms as an analgesic for moderate-to-severe pain. Currently, it is only available in tablet form in combination with either acetaminophen or naloxone. Pentazocine has not been linked to serum enzyme elevations during therapy or to clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548498/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601092.html"
},
{
    "Title": "Pentostatin",
    "Text1": "Pentostatin is a purine analogue and antineoplastic agent used in the therapy of hairy cell leukemia and T cell lymphomas. Pentostatin is associated with a low rate of serum enzyme elevations during therapy and has been linked to rare instances of severe acute liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548172/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a692004.html"
},
{
    "Title": "Pentoxifylline",
    "Text1": "Pentoxifylline is a xanthine derivative that decreases the viscosity of blood and is used to treat symptoms of intermittent claudication due to peripheral vascular disease. Pentoxifylline has not been associated with serum enzyme elevations during therapy, but in several isolated case reports has been linked to clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548672/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a685027.html"
},
{
    "Title": "Peramivir",
    "Text1": "Peramivir is an inhibitor of the influenza neuraminidase enzyme and is used as therapy of acute symptomatic influenza A and B. Peramivir has not been associated with serum enzyme elevations during therapy or with clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547844/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614062.html"
},
{
    "Title": "Perampanel",
    "Text1": "Perampanel is glutamate receptor antagonist that is used as an anticonvulsant in the therapy of partial onset seizures. Perampanel has not been associated with serum aminotransferase elevations during therapy, and clinically apparent liver injury from perampanel has yet to be reported and must be rare, if it occurs at all.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548508/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614006.html"
},
{
    "Title": "Perindopril",
    "Text1": "Perindopril is an angiotensin-converting enzyme (ACE) inhibitor used in the therapy of hypertension and stable coronary artery disease. Perindopril is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547980/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a602017.html"
},
{
    "Title": "Perphenazine",
    "Text1": "Perphenazine is a phenothiazine and antipsychotic agent, now rarely used in clinical practice. Perphenazine can cause mild and transient serum enzyme elevations and is a rare cause of clinically apparent acute and chronic cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548366/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682165.html"
},
{
    "Title": "Pertuzumab",
    "Text1": "Pertuzumab is a humanized monoclonal antibody to the human epidermal growth factor receptor 2 (HER2) which is used in combination with other antineoplastic agents in the therapy of refractory, advanced breast cancer. Pertuzumab has been implicated in rare instances of transient, occasionally marked serum enzyme elevations, but has not been linked to instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548576/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612027.html"
},
{
    "Title": "Pexidartinib",
    "Text1": "Pexidartinib is an orally available small molecule multi-kinase inhibitor that is used as an antineoplastic agent in the treatment of tenosynovial giant cell tumors. Pexidartinib is associated with a high rates of serum aminotransferase and alkaline phosphatase elevations during therapy and has been implicated in several cases of clinically apparent liver injury marked by progressive intrahepatic bile duct injury, some of which resulted in liver transplantation or were fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK551730/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619050.html"
},
{
    "Title": "Phenelzine",
    "Text1": "Phenelzine is a monoamine oxidase inhibitor (MAO inhibitor) used in therapy of moderate-to-severe depression. Phenelzine therapy is associated with rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548402/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682089.html"
},
{
    "Title": "Phenobarbital",
    "Text1": "Phenobarbital is a barbiturate that is widely used as a sedative and an antiseizure medication. Phenobarbital has been linked to rare instances of idiosyncratic liver injury that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548269/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601024.html"
},
{
    "Title": "Phentermine",
    "Text1": "Phentermine is a sympathomimetic amine and anorectic agent used for the short term therapy of obesity. Phentermine which has been in clinical use for more than 50 years has not been linked convincingly to either serum enzyme elevations during therapy or to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547916/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682187.html"
},
{
    "Title": "Phenytoin",
    "Text1": "Phenytoin, formerly known as diphenylhydantoin, is a potent anticonvulsant used to treat and prevent generalized grand mal seizures, complex partial seizures and status epilepticus. Phenytoin was formerly the most commonly used anticonvulsant agent but is now declining in use, having been replaced by more modern, better tolerated agents. Phenytoin is an uncommon but well known cause of acute idiosyncratic drug induced liver disease that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548889/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682022.html"
},
{
    "Title": "Pilocarpine",
    "Text1": "Pilocarpine is an orally available cholinergic agonist that is used to treat symptoms of dry mouth in patients with keratoconjunctivitis sicca (Sjögren syndrome) or with xerostomia (dry mouth) due to local irradiation. Pilocarpine has not been linked to serum enzyme elevations during therapy or to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548815/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608039.html"
},
{
    "Title": "Pimavanserin",
    "Text1": "Pimavanserin is an atypical antipsychotic used in the treatment of hallucinations and psychosis in patients with Parkinson disease. Use of pimavanserin is associated with a low rate of serum enzyme elevations during therapy, and it has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548120/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616032.html"
},
{
    "Title": "Pimozide",
    "Text1": "Pimozide is a conventional antipsychotic used largely in the therapy of Tourette syndrome. Pimozide therapy has not been associated with serum aminotransferase elevations nor with cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548846/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a686018.html"
},
{
    "Title": "Pindolol",
    "Text1": "Pindolol is a nonselective beta adrenergic receptor blocker that is widely used for the therapy of hypertension and angina pectoris. Pindolol has yet to be convincingly associated with clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548489/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684032.html"
},
{
    "Title": "Pioglitazone",
    "Text1": "Pioglitazone is an insulin sensitizing agent and thiazolidinedione that is indicated for the treatment of type 2 diabetes. Pioglitazone has been linked to rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548327/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699016.html"
},
{
    "Title": "Piperacillin",
    "Text1": "Piperacillin is an extended spectrum ureidopenicillin and is used to treat moderate-to-severe infections due to susceptible organisms. Piperacillin has been linked with idiosyncratic liver injury, but only rarely and in isolated case reports.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548463/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a694003.html"
},
{
    "Title": "Pirfenidone",
    "Text1": "Pirfenidone is an orally available pyridinone derivative that inhibits collagen formation and is used to treat idiopathic pulmonary fibrosis. Elevations in serum enzyme levels during pirfenidone therapy are not uncommon, but it has yet to be implicated in cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548769/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615008.html"
},
{
    "Title": "Piroxicam",
    "Text1": "Piroxicam is a commonly used nonsteroidal antiinflammatory drug (NSAID) that is available by prescription only and is used in therapy of chronic arthritis. Piroxicam can cause mild serum aminotransferase elevations and, in rare instances, leads to clinically apparent acute liver injury that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548425/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684045.html"
},
{
    "Title": "Pitavastatin",
    "Text1": "Pitavastatin is a relatively newly developed cholesterol lowering agent (statin) that is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy, but has had limited use and has yet to be linked with clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548065/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a610018.html"
},
{
    "Title": "Plazomicin",
    "Text1": "Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis. Plazomicin has had limited clinical use but has not been linked to serum enzyme elevations during therapy or to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548540/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618037.html"
},
{
    "Title": "Plecanatide",
    "Text1": "Plecanatide is a minimally absorbed agonist of guanylate cyclase C receptors in the intestine and is used for treatment of chronic constipation and irritable bowel syndrome. Plecanatide has not been linked to serum enzyme elevations during treatment or to episodes of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548762/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617020.html"
},
{
    "Title": "Plerixafor",
    "Text1": "Plerixafor is a small molecular antagonist of the cell-surface CXCR4 receptor that plays an important role in mobilization of hematopoietic stem and progenitor cells to the stroma of the bone marrow; blocking the receptor helps to mobilize stem cells from the marrow to peripheral blood allowing for collection of these cells by apheresis for hematopoietic cell transplantation. Plerixafor is generally well tolerated and has not been linked to serum enzyme elevations or to clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548453/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a609018.html"
},
{
    "Title": "Pomalidomide",
    "Text1": "Pomalidomide is an immunomodulatory and antineoplastic agent that is used in the therapy of multiple myeloma. Pomalidomide, like the structurally related agents thalidomide and lenalidomide, is associated with a low rate of serum aminotransferase elevations during therapy and has been implicated in causing rare instances of clinically apparent liver injury which can be severe.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548343/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613030.html"
},
{
    "Title": "Ponatinib",
    "Text1": "Ponatinib is a tyrosine kinase receptor inhibitor that is used in the therapy of refractory chronic myelogenous leukemia (CML) positive for the Philadelphia chromosome. Ponatinib is commonly associated with transient elevations in serum aminotransferase levels during treatment, but with only rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548131/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613029.html"
},
{
    "Title": "Posaconazole",
    "Text1": "Posaconazole is a potent triazole antifungal agent used in the prevention of invasive fungal infections due to aspergillosis and candida in high risk patients. Posaconazole therapy is associated with transient, asymptomatic serum aminotransferase elevations and is a suspected but rare cause of clinically apparent acute drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548934/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607036.html"
},
{
    "Title": "Pralatrexate",
    "Text1": "Pralatrexate is a parenterally administered folate antagonist and antineoplastic agent, used in the treatment of peripheral T cell lymphomas. Pralatrexate has been associated with a modest rate of serum enzyme elevations during therapy, but has not been convincingly linked to instances of acute, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547901/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a610001.html"
},
{
    "Title": "Pramipexole",
    "Text1": "Pramipexole is a selective dopamine receptor agonist used in the therapy of Parkinson disease. Pramipexole therapy is associated with a low rate of transient serum enzyme elevations during treatment, but has not been implicated in cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547968/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697029.html"
},
{
    "Title": "Pramlintide",
    "Text1": "Pramlintide is a recombinant DNA produced polypeptide analogue of human amylin that is used in combination with insulin in the therapy of diabetes. Pramlintide has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548949/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605031.html"
},
{
    "Title": "Prasugrel",
    "Text1": "Prasugrel is an inhibitor of platelet aggregation that is used to decrease the risk of myocardial infarction and stroke in patients with acute coronary syndromes. Prasugrel has been linked to mild and transient serum enzyme elevations during therapy and to rare instances of hypersensitivity reactions accompanied by mild liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547965/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a609027.html"
},
{
    "Title": "Pravastatin",
    "Text1": "Pravastatin is a commonly used cholesterol lowering agent (statin) that is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy, and rarely with clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548653/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a692025.html"
},
{
    "Title": "Praziquantel",
    "Text1": "Praziquantel is an anthelmintic agent with activity against a broad spectrum of trematodes and cestodes that is used predominantly in the therapy of schistosomiasis, liver flukes, and cysticercosis. Praziquantel therapy has been reported to cause serum aminotransferase elevations during therapy, but clinically apparent liver injury after its use is rare if it occurs at all.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548916/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608048.html"
},
{
    "Title": "Prazosin",
    "Text1": "Prazosin is a nonselective alpha-adrenergic antagonist (alpha-blocker) used in the therapy of hypertension. Prazosin is associated with a low rate of transient serum aminotransferase elevations and has not been clearly linked to clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548699/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682245.html"
},
{
    "Title": "Pregabalin",
    "Text1": "Pregabalin is an inhibitor of neuronal activity used for therapy of painful neuropathy and as an anticonvulsant. Therapy with pregabalin is not associated with serum aminotransferase elevations, and clinically apparent liver injury from pregabalin has been reported but appears to be quite rare.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548053/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605045.html"
},
{
    "Title": "Pretomanid",
    "Text1": "Pretomanid is a nitroimidazooxazine antimycobacterial agent used in combination with other antituberculosis drugs in the treatment of multidrug resistant tuberculosis. The addition of pretomanid to antituberculosis drug regimens has been linked to an increased rate of transient serum liver test abnormalities during treatment and to several instances of mild, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK551729/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619056.html"
},
{
    "Title": "Primaquine",
    "Text1": "Primaquine is an aminoquinoline that has been used for the prevention and therapy of malaria for more than 50 years. Primaquine is not associated with serum enzyme elevations during therapy and has yet to be linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548031/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607037.html"
},
{
    "Title": "Primidone",
    "Text1": "Primidone is an aromatic anticonvulsant used to treat complex, partial and generalized seizures. Therapy with primidone can be associated with increases in gamma glutamyltranspeptidase levels, but is not associated with serum aminotransferase elevations, and despite its similarity in structure to phenobarbital and phenytoin, clinically apparent liver injury from primidone has not been reported and must be quite rare if it occurs at all.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548512/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682023.html"
},
{
    "Title": "Probenecid",
    "Text1": "Probenecid is a uricosuric agent used for the treatment of gout usually in combination with other agents. Probenecid has been associated with minor serum aminotransferase elevations and very rarely with hypersensitivity reactions which, even more rarely, can be accompanied by acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548599/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682395.html"
},
{
    "Title": "Procainamide",
    "Text1": "Procainamide is an oral antiarrhythmic agent that has been in use for more than 60 years. Long term procainamide therapy is known to induce hypersensitivity reactions, autoantibody formation and a lupus-like syndrome but is a rare cause of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548477/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682398.html"
},
{
    "Title": "Procarbazine",
    "Text1": "Procarbazine is an orally administered alkylating agent used in combination with other antineoplastic agents in the therapy of Hodgkin’s disease and malignant melanoma. Procarbazine therapy has been associated with serum enzyme elevations during therapy and with rare cases of idiosyncratic, clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548411/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682094.html"
},
{
    "Title": "Prochlorperazine",
    "Text1": "Prochlorperazine is a phenothiazine used primarily as an antiemetic agent. In rare instances, prochlorperazine can cause clinically apparent acute and chronic cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548122/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682116.html"
},
{
    "Title": "Promethazine",
    "Text1": "Promethazine is first generation antihistamine that belongs to the phenothiazine class and is used predominantly as an antiemetic to treat nausea and vomiting and prevent motion sickness. Despite its phenothiazine structure, promethazine has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548427/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682284.html"
},
{
    "Title": "Propafenone",
    "Text1": "Propafenone is an oral antiarrhythmic agent that has been in wide use for several decades. Long term propafenone therapy is associated with a low rate of serum aminotransferase elevations and therapy rarely can cause a self limited, acute cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548005/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a698002.html"
},
{
    "Title": "Propantheline",
    "Text1": "Propantheline is an anticholinergic agent used to treat gastrointestinal conditions associated with intestinal spasm and to decrease secretions during anesthesia. Propantheline has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548063/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684020.html"
},
{
    "Title": "Propranolol",
    "Text1": "Propranolol is a nonselective beta-adrenergic receptor blocker (beta-blocker) that is widely used for the therapy of hypertension, cardiac arrhythmias, angina pectoris and hyperthyroidism. Propranolol has yet to be convincingly associated with clinically apparent liver injury and is often used in patients with liver disease and cirrhosis.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548218/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682607.html"
},
{
    "Title": "Propylthiouracil",
    "Text1": "Propylthiouracil is an antithyroid medication used in the therapy of hyperthyroidism and Graves disease. Propylthiouracil has been linked to serum aminotransferase elevations during therapy as well as to a clinically apparent, idiosyncratic liver injury that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547973/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682465.html"
},
{
    "Title": "Protriptyline",
    "Text1": "Protriptyline is a tricyclic antidepressant that was previously widely used in the therapy of major depression. Most of the tricyclic antidepressants have been shown to cause a low rate of mild and transient serum enzyme elevations and rare cases of clinically apparent acute cholestatic liver injury. The potential hepatotoxicity specifically of protriptyline, however, has not been well defined.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548310/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604025.html"
},
{
    "Title": "Prucalopride",
    "Text1": "Prucalopride is a serotonin type 4 (5-HT4) receptor agonist that has potent prokinetic activity and is used as therapy for chronic idiopathic constipation. Prucalopride has been associated with a minimal rate of transient serum enzyme elevations during therapy and has not been implicated in cases of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548650/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619011.html"
},
{
    "Title": "Pyrantel",
    "Text1": "Pyrantel is a nonabsorbed anthelmintic agent with activity against intestinal nematodes such as pinworms and roundworms. Pyrantel therapy has not been reported to cause serum aminotransferase elevations or clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548238/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682820.html"
},
{
    "Title": "Pyrazinamide",
    "Text1": "Pyrazinamide is a first line antituberculosis medication, but is used only in combination with other antituberculosis medications such as isoniazid or rifampin. Pyrazinamide is associated with transient and asymptomatic elevations in serum aminotransferase levels and is a well known cause of clinically apparent, acute liver injury that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547856/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682402.html"
},
{
    "Title": "Pyrazinamide",
    "Text1": "Pyrazinamide is a first line antituberculosis medication, but is used only in combination with other antituberculosis medications such as isoniazid or rifampin. Pyrazinamide is associated with transient and asymptomatic elevations in serum aminotransferase levels and is a well known cause of clinically apparent, acute liver injury that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547856/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682402.html"
},
{
    "Title": "Quetiapine",
    "Text1": "Quetiapine is an atypical antipsychotic used in the treatment of schizophrenia and bipolar disorder. Use of quetiapine has been associated with serum aminotransferase elevations and in rare instances with clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548616/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a698019.html"
},
{
    "Title": "Quinapril",
    "Text1": "Quinapril is an angiotensin-converting enzyme (ACE) inhibitor used in the therapy of hypertension and congestive heart failure. Quinapril is associated with a low rate of transient serum aminotransferase elevations, but has yet to be linked to instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548451/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a692026.html"
},
{
    "Title": "Quinidine",
    "Text1": "Quinidine is a natural cinchona alkaloid which has potent antiarrhythmic activity and has been used for decades in the treatment of atrial and ventricular arrhythmias. Quinidine has been associated with fever, mild jaundice and clinically apparent liver injury in up to 2% of treated patients.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548869/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611048.html"
},
{
    "Title": "Quinine",
    "Text1": "Quinine is a natural cinchona alkaloid that has been used for centuries in the prevention and therapy of malaria. Quinine is also used for idiopathic muscle cramps. Quinine therapy has been associated with rare instances of hypersensitivity reactions which can be accompanied by hepatitis and mild jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548596/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682322.html"
},
{
    "Title": "Rabeprazole",
    "Text1": "Rabeprazole is a proton pump inhibitor (PPI) and a potent inhibitor of gastric acidity used in the therapy of gastroesophageal reflux and peptic ulcer disease. Rabeprazole therapy is associated with a low rate of transient and asymptomatic serum aminotransferase elevations and is a rare cause of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548154/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699060.html"
},
{
    "Title": "Raltegravir",
    "Text1": "Raltegravir is an integrase inhibitor, the first of the class of antiviral agents active against the human immunodeficiency virus (HIV) that targets the viral integrase. Raltegravir is used in combination with other antiretroviral agents in the treatment of HIV infection. Raltegravir has not been linked convincingly to serum aminotransferase elevations during therapy or to episodes of acute, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548313/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608004.html"
},
{
    "Title": "Ramelteon",
    "Text1": "Ramelteon is a melatonin receptor agonist that is used for the treatment of insomnia. Ramelteon has not been implicated in causing serum enzyme elevations or clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548437/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605038.html"
},
{
    "Title": "Ramipril",
    "Text1": "Ramipril is an angiotensin-converting enzyme (ACE) inhibitor used in the therapy of hypertension and heart failure. Ramipril is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548689/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a692027.html"
},
{
    "Title": "Ramucirumab",
    "Text1": "Ramucirumab is a human monoclonal antibody to the vascular endothelial growth factor (VEGF) receptor 2 and is an antiangiogenesis agent used in the therapy of advanced colorectal, gastric and lung cancers. Ramucirumab has not been linked to serum enzyme elevations during therapy or to instances of idiosyncratic acute liver injury, but has been reported to worsen liver failure in patients with decompensated cirrhosis (Child Class B or C).",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547992/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614026.html"
},
{
    "Title": "Ranitidine",
    "Text1": "Ranitidine is a histamine type 2 receptor antagonist (H2 blocker) which is widely used for treatment of acid-peptic disease and heartburn. Ranitidine has been linked to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548867/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601106.html"
},
{
    "Title": "Ranolazine",
    "Text1": "Ranolazine is a unique, orally available antiangina agent. Chronic ranolazine therapy has not been associated with serum enzyme elevations, but has been linked to rare cases of mild, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547932/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a606015.html"
},
{
    "Title": "Rasagiline",
    "Text1": "Rasagiline is an inhibitor of monamine oxidase used as adjunctive therapy in combination with levodopa and carbidopa in the management of Parkinson’s disease. Rasagiline has been associated with a low rate of serum enzyme elevations during treatment, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547919/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a606017.html"
},
{
    "Title": "Rasburicase",
    "Text1": "Rasburicase is a parenterally administered, recombinant urate oxidase that is used in combination with xanthine oxidase inhibitors in the therapy of severe hyperuricemia due to tumor lysis syndrome after initiation of cancer chemotherapy in treatment of malignant diseases. Rasburicase has been associated with serum enzyme elevations during therapy and to rare instances of hypersensitivity reactions that can be accompanied by liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548485/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a610008.html"
},
{
    "Title": "Ravulizumab",
    "Text1": "Ravulizumab is a humanized monoclonal antibody to complement factor 5 which acts to block complement activation and is used to treat paroxysmal nocturnal hemoglobinuria. Ravulizumab has not been linked to serum enzyme elevations during therapy or to instances of idiosyncratic acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548476/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619014.html"
},
{
    "Title": "Regorafenib",
    "Text1": "Regorafenib is an oral multi-kinase inhibitor that is used in the therapy of refractory metastatic colorectal cancer, hepatocellular carcinoma and gastrointestinal stromal tumor. Regorafenib has been associated with frequent serum aminotransferase elevations during therapy and with rare, but sometimes severe and even fatal instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548608/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613004.html"
},
{
    "Title": "Remdesivir",
    "Text1": "Remdesivir is an antiviral nucleotide analogue used for therapy of severe novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS) coronavirus 2 (CoV-2) infection. Remdesivir therapy is given intravenously for 5 to 10 days and is frequently accompanied by transient, reversible mild-to-moderate elevations in serum aminotransferase levels but has been only rarely linked to instances of clinically apparent liver injury, its hepatic effects being overshadowed by the systemic effects of COVID-19.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK564049/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a620033.html"
},
{
    "Title": "Repaglinide",
    "Text1": "Repaglinide is a benzoic acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Repaglinide has been linked to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548879/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a600010.html"
},
{
    "Title": "Reserpine",
    "Text1": "Reserpine is an oral antihypertensive medication that acts through inhibitor of alpha-adrenergic transmission and was one of the first antihypertensive agents introduced into clinical practice. Despite widescale use for many years, reserpine has not been shown to cause clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548348/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601107.html"
},
{
    "Title": "Reslizumab",
    "Text1": "Reslizumab is a humanized monoclonal antibody to interleukin-5 (IL-5) which leads to a decrease in production and maturation of eosinophils and is used therapeutically to reduce allergic symptoms of asthma in patients with an eosinophilic phenotype. Reslizumab has not been associated with serum enzyme elevations during therapy or to instances of clinically apparent drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548383/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616023.html"
},
{
    "Title": "Revefenacin",
    "Text1": "Revefenacin is a synthetic anticholinergic agent that is used as a once daily, nebulized inhalant for maintenance treatment of patients with chronic obstructive pulmonary disease. Revefenacin has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548918/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619009.html"
},
{
    "Title": "Ribavirin",
    "Text1": "Ribavirin is a nucleoside analogue and antiviral agent used in therapy of chronic hepatitis C and other flavivirus infections. Ribavirin has not been associated with clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548115/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605018.html"
},
{
    "Title": "Ribociclib",
    "Text1": "Ribociclib is a unique cyclin-dependent kinase inhibitor that is used in combination with aromatase inhibitors in the treatment of postmenopausal women with metastatic breast cancer. Ribociclib is associated with a moderate rate of serum aminotransferase elevations during therapy, and to clinically apparent liver injury in a proportion of these.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548818/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617008.html"
},
{
    "Title": "Rifabutin",
    "Text1": "Rifabutin is a rifamycin antibiotic that is similar in structure and activity to rifampin and rifapentine and which is used largely in the prevention of Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection. Rifabutin is associated with transient and asymptomatic elevations in serum aminotransferase and is a likely cause of clinically apparent, acute liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547975/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a693009.html"
},
{
    "Title": "Rifampin",
    "Text1": "Rifampin (also referred to as rifampicin) is a macrocyclic antibiotic with major activity against mycobacteria, commonly used in combination with other agents as therapy of tuberculosis. Rifampin is associated with transient and asymptomatic elevations in serum aminotransferase and bilirubin levels and is a well known cause of clinically apparent, acute liver disease that can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548314/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682403.html"
},
{
    "Title": "Rifamycin",
    "Text1": "Rifamycin is a nonabsorbable rifampin-like antibacterial agent that is used as treatment of travelers’ diarrhea. Rifamycin has minimal oral absorption and has not been implicated in causing liver test abnormalities or clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548896/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619010.html"
},
{
    "Title": "Rifapentine",
    "Text1": "Rifapentine is a rifamycin antibiotic that is similar in structure and activity to rifampin and rifabutin and that is used in combination with other agents as therapy of tuberculosis, particularly in once or twice weekly regimens. Rifapentine is associated with transient and asymptomatic elevations in serum aminotransferase and is a likely cause of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548547/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616011.html"
},
{
    "Title": "Rifaximin",
    "Text1": "Rifaximin is a nonabsorbable antibiotic that is used as treatment and prevention of travelers’ diarrhea and, in higher doses, for prevention of hepatic encephalopathy in patients with advanced liver disease and to treat diarrhea in patients with irritable bowel syndrome. Rifaximin has minimal oral absorption and has not been implicated in causing liver test abnormalities or clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548082/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604027.html"
},
{
    "Title": "Rilpivirine",
    "Text1": "Rilpivirine is a nonnucleoside reverse transcriptase inhibitor used in combination with other antiretroviral agents in the therapy of human immunodeficiency virus (HIV) infection. Rilpivirine is associated with a low rate of transient serum aminotransferase elevations during therapy and has been implicated in rare cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548514/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616021.html"
},
{
    "Title": "Riluzole",
    "Text1": "Riluzole is a neuroprotective agent used for therapy of amyotrophic lateral sclerosis. Riluzole is associated with a low rate of serum aminotransferase elevations during therapy and has been linked to rare instances of clinically apparent, acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548919/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a696013.html"
},
{
    "Title": "Rimantadine",
    "Text1": "Rimantadine is an antiviral agent used as therapy for influenza A. Rimantadine has not been associated with clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547927/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a698029.html"
},
{
    "Title": "Riociguat",
    "Text1": "Riociguat is a stimulator of guanylate cyclase which causes relaxation of vascular smooth muscle and is used to treat severe pulmonary arterial hypertension. Riociguat has not been linked to significant serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548167/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615005.html"
},
{
    "Title": "Risperidone",
    "Text1": "Risperidone is an atypical antipsychotic that is used widely in the treatment of mania and schizophrenia. Risperidone therapy is associated with serum aminotransferase elevations and in rare instances has been linked to clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548906/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615012.html"
},
{
    "Title": "Ritonavir",
    "Text1": "Ritonavir is an antiretroviral protease inhibitor that is widely used in combination with other protease inhibitors in the therapy and prevention of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Ritonavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and, rarely, can lead to clinically apparent acute liver injury. In HBV or HCV coinfected patients, highly active antiretroviral therapy with ritonavir may result of an exacerbation of the underlying chronic hepatitis B or C.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548301/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a696029.html"
},
{
    "Title": "Rituximab",
    "Text1": "Rituximab is a chimeric mouse/human monoclonal antibody to CD20 a cell surface antigen found on pre-B and mature B lymphocytes and which is approved for use in non-Hodgkin lymphoma and chronic lymphocytic leukemia as well as in several autoimmune conditions, including rheumatoid arthritis and Wegener granulomatous. Rituximab has been linked to many cases of severe and even fatal liver injury as a result of reactivation of inactive or previously resolved hepatitis B.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548249/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607038.html"
},
{
    "Title": "Rivaroxaban",
    "Text1": "Rivaroxaban is a recently developed oral anticoagulant and direct factor Xa inhibitor which is used in the prevention of stroke and venous embolism in patients with chronic atrial fibrillation, as well as treatment and prevention of deep venous thromboses and pulmonary embolism. Rivaroxaban has been associated with a low rate of serum enzyme elevations during treatment and with rare instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548015/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611049.html"
},
{
    "Title": "Rivastigmine",
    "Text1": "Rivastigmine is an oral acetylcholinesterase inhibitor used for therapy of Alzheimer disease. Rivastigmine is associated with a minimal rate of serum enzyme elevations during therapy and is a rare cause of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548942/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a602009.html"
},
{
    "Title": "Roflumilast",
    "Text1": "Roflumilast is a selective inhibitor of phosphodiesterase-4 (PDE-4) that has unique antiinflammatory activity and is used to treat and prevent exacerbations of chronic obstructive pulmonary disease (COPD). Roflumilast has not been linked to significant serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548195/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611034.html"
},
{
    "Title": "Rolapitant",
    "Text1": "Rolapitant is an orally available antiemetic agent that is used to prevent cancer chemotherapy related nausea and vomiting. Rolapitant therapy has not been associated with serum enzyme elevations or with instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548209/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615041.html"
},
{
    "Title": "Romidepsin",
    "Text1": "Romidepsin is an intravenously administered histone deacetylase inhibitor and antineoplastic agent that is approved for use in refractory or relapsed cutaneous and peripheral T cell lymphomas. Romidepsin is associated with modest rate of minor serum enzyme elevations during therapy but has not been linked to cases of clinically apparent liver injury, although it has been reported to cause reactivation of hepatitis B.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548380/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a610005.html"
},
{
    "Title": "Ropinirole",
    "Text1": "Ropinirole is a selective dopamine receptor agonist used in the therapy of Parkinson disease. Ropinirole therapy is associated with low rate of transient serum enzyme elevations during treatment and has been implicated in rare cases of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548175/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a698013.html"
},
{
    "Title": "Rosiglitazone",
    "Text1": "Rosiglitazone is an insulin sensitizing agent and thiazolidinedione that is indicated for the treatment of type 2 diabetes. Rosiglitazone has been linked to rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548114/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699023.html"
},
{
    "Title": "Rosuvastatin",
    "Text1": "Rosuvastatin is a commonly used cholesterol lowering agent (statin) that is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy, and rarely with clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548620/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a603033.html"
},
{
    "Title": "Rotigotine",
    "Text1": "Rotigotine is a non-ergot dopamine receptor agonist used in the therapy of Parkinson disease and restless leg syndrome. Administered as a once daily transdermal patch, rotigotine has not been associated with serum enzyme elevations during treatment or with episodes of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547939/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607059.html"
},
{
    "Title": "Rucaparib",
    "Text1": "Rucaparib is a small molecule inhibitor of poly ADP-ribose polymerase that is used in the therapy of selected patients with refractory and advanced ovarian carcinoma. Rucaparib therapy is associated with a moderate rate of transient elevations in serum aminotransferase during therapy, but has not been linked to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548767/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617002.html"
},
{
    "Title": "Rufinamide",
    "Text1": "Rufinamide is a unique anticonvulsant that is used in combination with other agents as therapy of severe forms of seizure disorders. Rufinamide therapy is associated with a low rate of transient serum enzyme elevations and with rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548457/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a609001.html"
},
{
    "Title": "Ruxolitinib",
    "Text1": "Ruxolitinib is a small molecule Janus kinase inhibitor that is used in the treatment of intermediate or high risk myelofibrosis and resistant forms of polycythemia vera and graft-vs-host disease. Ruxolitinib is associated with transient and usually mild elevations in serum aminotransferase during therapy and to rare instances of self-limited, clinically apparent idiosyncratic acute liver injury as well as to cases of reactivation of hepatitis B in susceptible individuals.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548534/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612006.html"
},
{
    "Title": "Safinamide",
    "Text1": "Safinamide is an inhibitor of monoamine oxidase used as adjunctive therapy in combination with levodopa and carbidopa in the management of Parkinson’s disease. Safinamide has been associated with a low rate of serum enzyme elevations during treatment, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548819/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617025.html"
},
{
    "Title": "Salsalate",
    "Text1": "Salsalate is a nonacetylated dimer of salicylic acid that is used in the treatment of chronic arthritis as an analgesic and antipyretic. Salsalate can cause moderate serum aminotransferase elevations when given in high doses in a manner similar to aspirin.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548843/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682880.html"
},
{
    "Title": "Saquinavir",
    "Text1": "Saquinavir is an antiretroviral protease inhibitor that is used in the therapy and prevention of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Saquinavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and, rarely, can lead to clinically apparent acute liver injury. In HBV or HCV coinfected patients, highly active antiretroviral therapy with saquinavir may result of an exacerbation of the underlying chronic hepatitis B or C.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548019/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a696001.html"
},
{
    "Title": "Sarecycline",
    "Text1": "Sarecycline is an oral, once daily, narrow spectrum tetracycline used to treat moderate-to-severe acne. Oral sarecycline use has been rarely linked to serum enzyme elevations during therapy and, although suspected of causing liver injury, it has yet to be linked to clinically apparent acute hepatic injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548293/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618068.html"
},
{
    "Title": "Sarilumab",
    "Text1": "Sarilumab is a human monoclonal IgG1 antibody to the interleukin-6 (IL-6) receptor which is used in the therapy of rheumatoid arthritis and other autoinflammatory conditions. Sarilumab commonly causes mild serum aminotransferase elevations which are usually short lived and asymptomatic and has also been linked to rare instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547964/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617032.html"
},
{
    "Title": "Saxagliptin",
    "Text1": "Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other oral hypoglycemic agents. Saxagliptin is a relatively new medication and has yet to be implicated in causing clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548688/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a610003.html"
},
{
    "Title": "Scopolamine",
    "Text1": "Scopolamine as a natural plant alkaloid that has potent anticholinergic effects and is used to treat mild to moderate nausea, motion sickness and allergic rhinitis. Scopolamine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548835/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682509.html"
},
{
    "Title": "Secnidazole",
    "Text1": "Secnidazole is an orally available, broad spectrum antimicrobial agent used in the treatment of bacterial vaginosis. Secnidazole is a nitroimidazole similar to metronidazole but is used as a single dose and, unlike metronidazole, has not been linked to serum enzyme elevations during therapy or to cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548222/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617052.html"
},
{
    "Title": "Secukinumab",
    "Text1": "Secukinumab is a human monoclonal antibody to interleukin-17A which acts as an immunosuppressant agent and is used to treat moderate-to-severe plaque psoriasis. Secukinumab has not been linked to serum enzyme elevations during therapy or to instances of idiosyncratic acute liver injury, but is capable of causing reactivation of hepatitis B in susceptible persons.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548346/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615011.html"
},
{
    "Title": "Selegiline",
    "Text1": "Selegiline is an inhibitor of monamine oxidase used in the treatment of depression and as adjunctive therapy in combination with levodopa and carbidopa in the therapy of Parkinson disease. Selegiline has been associated with a low rate of serum enzyme elevations during treatment, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548891/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697046.html"
},
{
    "Title": "Selexipag",
    "Text1": "Selexipag is prostacyclin receptor agonist that causes vasodilation in pulmonary vasculature and is used in the therapy of pulmonary arterial hypertension (PAH). Selexipag has been associated with a low rate of serum enzyme elevations during therapy, but has yet to be implicated in cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548742/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616031.html"
},
{
    "Title": "Selumetinib",
    "Text1": "Selumetinib is an oral, small molecule inhibitor of the mitogen activated protein kinase 1 and 2 (MEK1/2) that is used to treat symptomatic, refractory fibromas in neurofibromatosis type 1. Selumetinib is associated with transient and usually mild elevations in serum aminotransferase levels during therapy, but has not been linked to cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK569419/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a620030.html"
},
{
    "Title": "Semaglutide",
    "Text1": "Semaglutide is a recombinant DNA produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents. There have been no published reports of hepatotoxicity attributed to semaglutide therapy.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548574/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618008.html"
},
{
    "Title": "Senna",
    "Text1": "Senna (Cassia species) is a popular herbal laxative that is available without prescription. Senna is generally safe and well tolerated, but can cause adverse events including clinically apparent liver injury when used in high doses for longer than recommended periods.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547922/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601112.html"
},
{
    "Title": "Sertraline",
    "Text1": "Sertraline is a selective serotonin reuptake inhibitor (SSRI) used in the therapy of depression, anxiety disorders and obsessive-compulsive disorder. Sertraline therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548513/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697048.html"
},
{
    "Title": "Sildenafil",
    "Text1": "Sildenafil functions as a selective and competitive inhibitor of type 5 phosphodiesterases (PDE5) on smooth muscle cells in the penis and pulmonary vasculature, and is used extensively for erectile dysfunction and less commonly for pulmonary hypertension. Sildenafil has been associated with rare instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548510/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699015.html"
},
{
    "Title": "Silodosin",
    "Text1": "Silodosin is a selective alpha-1a adrenergic antagonist used in the therapy of benign prostatic hypertrophy. Silodosin is associated with a low rate of serum aminotransferase elevations and to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548170/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a609002.html"
},
{
    "Title": "Siltuximab",
    "Text1": "Siltuximab is a chimeric human-mouse monoclonal antibody to interleukin-6 which is used in the therapy of Castleman disease. Siltuximab commonly causes mild serum aminotransferase elevations which are usually short lived and asymptomatic, but it has not been linked to instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548932/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614028.html"
},
{
    "Title": "Simeprevir",
    "Text1": "Simeprevir is an oral, direct acting hepatitis C virus (HCV) protease inhibitor that is used in combination with other antiviral agents in the treatment of chronic hepatitis C, genotypes 1 and 4. Simeprevir has been linked to isolated, rare instances of mild, acute liver injury during treatment and to occasional cases of hepatic decompensation in patients with preexisting cirrhosis.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548277/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614013.html"
},
{
    "Title": "Simvastatin",
    "Text1": "Simvastatin is a commonly used cholesterol lowering agent (statin) that is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy, and rarely with clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548720/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a692030.html"
},
{
    "Title": "Siponimod",
    "Text1": "Siponimod is an orally available immunomodulatory drug used to treat relapsing forms of multiple sclerosis. Siponimod is associated with transient serum enzyme elevations during therapy but has not been linked to instances of clinically apparent liver injury with jaundice, although experience with its use has been limited.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK553312/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619027.html"
},
{
    "Title": "Sirolimus",
    "Text1": "Sirolimus is macrocyclic antibiotic with potent immunosuppressive activity that is used alone or in combination with calcineurin inhibitors and corticosteroids to prevent cellular rejection after renal transplantation. Sirolimus therapy can be associated with mild serum enzyme elevations and it has been linked to rare instances of clinically apparent cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548028/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a602026.html"
},
{
    "Title": "Sitagliptin",
    "Text1": "Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other oral hypoglycemic agents. Only rare isolated reports of liver injury due to sitagliptin have been published.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548083/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a606023.html"
},
{
    "Title": "Sofosbuvir",
    "Text1": "Sofosbuvir is an oral nucleoside analogue and potent inhibitor of the hepatitis C virus (HCV) RNA polymerase that is used in combination with other antiviral agents to treat chronic hepatitis C. Elevations in serum enzyme levels during sofosbuvir therapy are uncommon, and it has not been implicated convincingly in cases of clinically apparent liver injury with jaundice. Nevertheless, and for unknown reasons, successful antiviral therapy of hepatitis C with sofosbuvir and other direct acting agents in patients with cirrhosis is occasionally complicated by hepatic decompensation; furthermore, treatment can cause reactivation of hepatitis B in susceptible patients coinfected with the hepatitis B virus (HBV).",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548823/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614014.html"
},
{
    "Title": "Solifenacin",
    "Text1": "Solifenacin is an anticholinergic and antispasmodic agent used to treat urinary incontinence and the overactive bladder syndrome. Solifenacin has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548716/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605019.html"
},
{
    "Title": "Sonidegib",
    "Text1": "Sonidegib is a small molecule kinase inhibitor that blocks signaling in the hedgehog pathway and is used in the therapy of unresectable or metastatic basal cell carcinoma. Sonidegib therapy is associated with a low rate or transient serum aminotransferase elevations during therapy, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548922/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615034.html"
},
{
    "Title": "Sorafenib",
    "Text1": "Sorafenib is an oral multi-kinase inhibitor that is used in the therapy of advanced renal cell, liver and thyroid cancer. Sorafenib has been associated with a low rate of transient elevations in serum aminotransferase levels during therapy that are generally mild and asymptomatic. Sorafenib has also been linked to rare instances of clinically apparent liver injury which can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548944/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607051.html"
},
{
    "Title": "Sotalol",
    "Text1": "Sotalol is a nonselective beta-adrenergic blocker used largely in the therapy cardiac arrhythmias. Sotalol has been linked to at least one instance of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548262/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a693010.html"
},
{
    "Title": "Spironolactone",
    "Text1": "Spironolactone is an aldosterone receptor antagonist and potassium-sparing diuretic widely used in the therapy of edema, particularly in patients with cirrhosis in which hyperaldosteronism appears to play a major role. Spironolactone has been linked to rare cases of clinically apparent drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547921/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682627.html"
},
{
    "Title": "Stavudine",
    "Text1": "Stavudine is a first generation nucleoside analogue and reverse transcriptase inhibitor used in combination with other agents in the therapy of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Stavudine is an uncommon, but well established cause of clinically apparent acute and chronic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548694/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a694033.html"
},
{
    "Title": "Stiripentol",
    "Text1": "Stiripentol is a structurally unique anticonvulsant that has been introduced as adjuvant therapy of Dravet syndrome, a rare form of severe childhood epilepsy. There is limited information on the safety of stiripentol, but it has not been associated with serum aminotransferase elevations or linked to cases of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548951/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618069.html"
},
{
    "Title": "Streptozocin",
    "Text1": "Streptozocin is a unique antineoplastic agent used to treat metastatic pancreatic islet cell carcinoma. Streptozocin has been associated with a high rate of serum enzyme elevation during therapy and to rare instances of severe, clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548344/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684053.html"
},
{
    "Title": "Sulfadiazine",
    "Text1": "Sulfadiazine is a sulfonamide antibacterial agent used in the therapy of mild-to-moderate infections due to sensitive organisms. Sulfadiazine, like other sulfonamides, is a well known cause of clinically apparent, idiosyncratic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548681/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682598.html"
},
{
    "Title": "Sulfasalazine",
    "Text1": "Sulfasalazine is an antiinflammatory agent used extensively in chronic, long term therapy of inflammatory bowel disease. Sulfasalazine is structurally composed of a sulfonamide (sulfapyridine) and 5-aminosalacyclic acid (5-ASA) joined by an azo bond. Sulfasalazine is a rare, but well known cause of idiosyncratic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548792/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682204.html"
},
{
    "Title": "Sulindac",
    "Text1": "Sulindac is a commonly used nonsteroidal antiinflammatory drug (NSAID) that is available by prescription only and used predominantly to treat chronic arthritis. Sulindac is a rare, but well established cause of idiosyncratic, clinically apparent drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548315/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a681037.html"
},
{
    "Title": "Sunitinib",
    "Text1": "Sunitinib is multi-specific tyrosine kinase receptor inhibitor that is used in the therapy of gastrointestinal stromal tumors and advanced renal cell carcinoma. Sunitinib therapy is associated with transient elevations in serum aminotransferase and bilirubin levels and rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548118/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607052.html"
},
{
    "Title": "Suvorexant",
    "Text1": "Suvorexant is an orexin receptor antagonist used for the treatment of insomnia and sleep disorders. Suvorexant therapy is associated with rare occurrence of transient serum enzyme elevations, but has not been implicated in cases of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547900/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614046.html"
},
{
    "Title": "Tacrolimus",
    "Text1": "Tacrolimus is a calcineurin inhibitor and potent immunosuppressive agent used largely as a means of prophylaxis against cellular rejection after transplantation. Tacrolimus therapy can be associated with mild serum enzyme elevations, and it has been linked to rare instances of clinically apparent cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548545/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601117.html"
},
{
    "Title": "Tafenoquine",
    "Text1": "Tafenoquine is an aminoquinoline that is used in combination with other antimalarials for the prevention of relapse of Plasmodium vivax malaria and by itself as prophylaxis against all species of malaria. Tafenoquine has been linked to low rates of transient and asymptomatic serum enzyme elevations during therapy but has not been associated with instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548428/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618050.html"
},
{
    "Title": "Tagraxofusp",
    "Text1": "Tagraxofusp is a recombinant fusion protein consisting of the binding site of interleukin 3 [IL3] fused with diphtheria toxin and that is given by intravenous infusion and used as an antineoplastic agent for patients with blastic plasmacytoid dendritic cell neoplasm. Treatment with tagraxofusp is associated with a high rate of serum enzyme elevations during therapy, but has not been linked to instances of clinically apparent acute liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548125/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a619022.html"
},
{
    "Title": "Talazoparib",
    "Text1": "Talazoparib is an orally available small molecule inhibitor of the DNA repair enzyme poly ADP-ribose polymerase (PARP) which is used as an antineoplastic agent in the treatment of selected cases of breast cancer. Talazoparib is associated with a moderate rate of serum aminotransferase elevations during therapy and is suspected to cause rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548621/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618070.html"
},
{
    "Title": "Tamoxifen",
    "Text1": "Tamoxifen is a nonsteroidal antiestrogen that is widely used in the treatment and prevention of breast cancer. Long term tamoxifen therapy has been associated with development of fatty liver, steatohepatitis, cirrhosis, and rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548902/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682414.html"
},
{
    "Title": "Tamsulosin",
    "Text1": "Tamsulosin is a selective alpha-1a adrenergic antagonist used in the therapy of benign prostatic hypertrophy. Tamsulosin therapy is associated with a low rate of serum aminotransferase elevations, but clinically apparent acute liver injury due to tamsulosin is very rare.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548017/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a698012.html"
},
{
    "Title": "Tasimelteon",
    "Text1": "Tasimelteon is a melatonin receptor agonist that is used for the treatment of non-24 hour sleep-wake disorder in blind individuals. Tasimelteon therapy is associated with a low rate of serum enzyme elevations, but has not been implicated in cases of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548636/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615004.html"
},
{
    "Title": "Tedizolid",
    "Text1": "Tedizolid is an oxazolidinone antibiotic, similar to linezolid, which has a broad spectrum of activity against gram positive bacteria including methicillin resistant Staphyloccocal aureus (MRSA). Tedizolid has been associated with a low rate of transient serum aminotransferase elevations during therapy, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548697/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614038.html"
},
{
    "Title": "Telaprevir",
    "Text1": "Telaprevir is an oral, direct acting hepatitis C virus (HCV) protease inhibitor that is used in combination with other antiviral agents in the treatment of chronic hepatitis C, genotype 1. Telaprevir has not been linked to instances of acute liver injury during therapy, but has been linked to cases of severe cutaneous reactions such as DRESS and Stevens Johnson syndrome which can be associated with mild hepatic injury. In addition, when combined with peginterferon and ribavirin, telaprevir has been associated with cases of hepatic decompensation in patients with preexisting cirrhosis.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548138/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611038.html"
},
{
    "Title": "Telbivudine",
    "Text1": "Telbivudine is a nucleoside analogue and antiviral inhibitor of hepatitis B virus (HBV) replication which is used alone and in combination with other agents in the therapy of the hepatitis B. Telbivudine does not appear to be a significant cause of drug induced liver injury, but can be associated with flares of the underlying hepatitis B either during therapy or upon withdrawal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548766/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607045.html"
},
{
    "Title": "Telithromycin",
    "Text1": "Telithromycin is a ketolide, a novel form of macrolide antibiotic that is recommended for treatment of community acquired pneumonia. Telithromycin was approved for use in the United States in 2004 and subsequently linked to several cases of severe drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548597/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604026.html"
},
{
    "Title": "Telmisartan",
    "Text1": "Telmisartan is an angiotensin II receptor blocker used in the therapy of hypertension. Telmisartan is associated with a low rate of transient serum aminotransferase elevations, but has yet to be linked to instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548042/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601249.html"
},
{
    "Title": "Telotristat",
    "Text1": "Telotristat is an oral, small molecule inhibitor of tryptophan hydroxylase that is used in the treatment of symptoms of carcinoid syndrome. Telotristat is associated with modest rate of minor serum enzyme elevations during therapy but has not been linked to cases of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547987/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617029.html"
},
{
    "Title": "Temazepam",
    "Text1": "Temazepam is an orally available benzodiazepine used in the therapy of insomnia. As with most benzodiazepines, temazepam therapy has not been associated with serum aminotransferase or alkaline phosphatase elevations, and clinically apparent liver injury from temazepam has not been reported and must be very rare, if it occurs at all.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548556/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684003.html"
},
{
    "Title": "Temozolomide",
    "Text1": "Temozolomide is an orally administered alkylating agent used largely in the therapy of malignant brain tumors including glioblastoma and astrocytoma. Temozolomide has been associated with a low rate of serum enzyme elevations during treatment and with rare instances of clinically apparent cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548816/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601250.html"
},
{
    "Title": "Temsirolimus",
    "Text1": "Temsirolimus is an inhibitor of cell proliferation and anticancer agent that is used as treatment of advanced renal cell cancer. Temsirolimus therapy is frequently associated with mild serum enzyme elevations, but has yet to be linked to instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548811/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607071.html"
},
{
    "Title": "Tenofovir",
    "Text1": "Tenofovir is an acyclic nucleotide analogue of adenosine used in combination with other agents in the therapy of the human immunodeficiency virus (HIV) and as single agent in hepatitis B virus (HBV) infection. Tenofovir does not appear to be a significant cause of drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548917/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616021.html"
},
{
    "Title": "Terazosin",
    "Text1": "Terazosin is a nonselective alpha-1 adrenergic antagonist used in the therapy of hypertension and benign prostatic hypertrophy. Terazosin therapy is associated with a low rate of transient serum aminotransferase elevations and to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548096/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a693046.html"
},
{
    "Title": "Terbinafine",
    "Text1": "Terbinafine is an orally and topically active allylamine fungicidal agent which is used to treat superficial fungal infections of the skin and nails. Terbinafine has been clearly linked to rare instances of acute liver injury that can be severe and sometimes fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548617/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699061.html"
},
{
    "Title": "Teriflunomide",
    "Text1": "Teriflunomide is an orally available immunomodulatory agent used to treat relapsing multiple sclerosis. Teriflunomide is associated with transient serum enzyme elevations during therapy and with rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548525/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613010.html"
},
{
    "Title": "Teriparatide",
    "Text1": "Teriparatide is a recombinant human parathyroid hormone analogue that is used to treat osteoporosis in women or men with a high risk for bone fracture. Teriparatide therapy has not been associated with serum aminotransferase elevations during therapy and has not been implicated in instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548722/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a603018.html"
},
{
    "Title": "Tesamorelin",
    "Text1": "Tesamorelin is a synthetic growth hormone releasing hormone analogue used in the treatment of visceral adiposity in human immunodeficiency virus (HIV) infected patients with lipodystrophy. Tesamorelin is given subcutaneously and has major effects on glucose and lipid metabolism, but has not been linked to serum aminotransferase elevations during therapy or to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548730/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611035.html"
},
{
    "Title": "Tetracycline",
    "Text1": "Tetracycline is an oral, broad-spectrum antibiotic used to treat mild-to-moderate infections due to susceptible microbial organisms. High doses of several forms of tetracycline given intravenously have been associated with acute fatty liver that can be severe and result in liver failure and death. Oral tetracycline use has been rarely and not very convincingly linked to acute hepatic injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547920/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601028.html"
},
{
    "Title": "Thalidomide",
    "Text1": "Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548371/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699032.html"
},
{
    "Title": "Theophylline",
    "Text1": "Theophylline is an orally administered xanthine derivative that induces relaxation of smooth muscle in the bronchial tree causing bronchodilation. Theophylline is widely used in therapy of asthma and is not believed to cause liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548479/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a681006.html"
},
{
    "Title": "Thioguanine",
    "Text1": "Thioguanine (also referred to as 6-thioguanine and as tioguanine) is a purine analogue that is used in the therapy of acute and chronic myelogenous leukemias. Thioguanine therapy is associated with minor, usually transient and asymptomatic elevations in serum aminotransferase levels and has also been linked to rare instances of cholestatic acute liver injury and to chronic liver injury, resulting in portal hypertension due to nodular regenerative hyperplasia.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548502/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682099.html"
},
{
    "Title": "Thioridazine",
    "Text1": "Thioridazine is a phenothiazine and antipsychotic agent that is no longer in common use. Thioridazine has been linked to rare instances of clinically apparent acute cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548347/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682119.html"
},
{
    "Title": "Thiotepa",
    "Text1": "Thiotepa is an intravenously or locally applied alkylating agent which is currently used in the therapy of breast, ovarian and bladder cancer. Thiotepa therapy has been associated with low rates of serum enzyme elevations during therapy and rare instances of acute, clinically apparent injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548174/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682821.html"
},
{
    "Title": "Thyroid Hormone",
    "Text1": "Thyroid hormones used therapeutically include crude thyroid extracts as well as synthetic forms of L-thyroxine (levothyroxine, T4) and L-triiodothyronine (liothyronine, T3). Thyroid hormone plays an essential role in growth and development and regulates multiple metabolic processes that are responsible for functional homeostasis. When given in high doses, thyroid hormone preparations can cause mild serum enzyme elevations. In addition, standard doses of levothyroxine have been linked to rare instances of mild, immunoallergic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548497/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a617013.html"
},
{
    "Title": "Tiagabine",
    "Text1": "Tiagabine is a unique anticonvulsant used largely as an adjunctive agent in therapy of partial seizures in adults or children. Therapy with tiagabine is not associated with serum aminotransferase elevations, and clinically apparent liver injury from tiagabine has not been reported and must be rare if it occurs at all.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548376/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a698014.html"
},
{
    "Title": "Ticagrelor",
    "Text1": "Ticagrelor is an oral antiplatelet drug that is used with low dose aspirin to decrease the risk of myocardial infarction and stroke in patients with acute coronary syndromes. Ticagrelor has been linked to rare instances of hypersensitivity reactions accompanied by mild liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548529/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611050.html"
},
{
    "Title": "Ticlopidine",
    "Text1": "Ticlopidine is an inhibitor of platelet aggregation that is used to decrease the risk of stroke in patients known to have atherosclerosis. Ticlopidine is associated with a low rate of serum enzyme elevations during treatment and has been linked to rare instances of idiosyncratic, clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548038/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a695036.html"
},
{
    "Title": "Tigecycline",
    "Text1": "Tigecycline is a parenteral glycycline antibiotic used for treatment of serious infections due to susceptible organisms. Tigecycline therapy is sometimes accompanied by minor aminotransferase elevations, but has not been definitely associated with clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547888/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614002.html"
},
{
    "Title": "Tildrakizumab",
    "Text1": "Tildrakizumab is humanized monoclonal antibody to interleukin-23 that is used to treat moderate-to-severe plaque psoriasis. Tildrakizumab is associated with a low rate of transient and asymptomatic serum enzyme elevations during therapy, but has not been linked to cases of idiosyncratic, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548296/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a618026.html"
},
{
    "Title": "Timolol",
    "Text1": "Timolol is a nonselective beta-adrenergic receptor blocker that is widely used for the therapy of hypertension, angina pectoris and prevention of vascular headaches. Timolol has yet to be convincingly associated with clinically apparent liver injury and is often used in patients with liver disease and cirrhosis.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548254/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684029.html"
},
{
    "Title": "Tinidazole",
    "Text1": "Tinidazole is an orally available, broad spectrum antimicrobial agent used in the treatment of bacterial, protozoal and parasitic infections. Tinidazole is a nitroimidazole similar to metronidazole and is likely to have a similar spectrum and frequency of side effects, including a low rate of serum enzyme elevations during therapy and rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548538/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604036.html"
},
{
    "Title": "Tiotropium",
    "Text1": "Tiotropium is a synthetic anticholinergic agent that is used as an inhalant for treatment of acute bronchospasm due to chronic bronchitis or emphysema. Tiotropium has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548876/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604018.html"
},
{
    "Title": "Tiotropium",
    "Text1": "Tiotropium is a synthetic anticholinergic agent that is used as an inhalant for treatment of acute bronchospasm due to chronic bronchitis or emphysema. Tiotropium has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548876/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604018.html"
},
{
    "Title": "Tiotropium",
    "Text1": "Tiotropium is a synthetic anticholinergic agent that is used as an inhalant for treatment of acute bronchospasm due to chronic bronchitis or emphysema. Tiotropium has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548876/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604018.html"
},
{
    "Title": "Tipranavir",
    "Text1": "Tipranavir is an antiretroviral protease inhibitor used in the therapy and prevention of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Tipranavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and is a rare cause of clinically apparent, acute liver injury. In coinfected patients, hepatic injury during highly active antiretroviral therapy including tipranavir may be a result of exacerbation of the underlying chronic hepatitis B or C, rather than a direct effect of the medication.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548389/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a606009.html"
},
{
    "Title": "Tizanidine",
    "Text1": "Tizanidine is a commonly used muscle relaxant that has been linked to rare instances of acute liver injury, a few of which have been fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548048/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601121.html"
},
{
    "Title": "Tobramycin",
    "Text1": "Tobramycin is a parenterally administered, broad spectrum aminoglycoside antibiotic that is widely used in the treatment of moderate to severe bacterial infections due to sensitive organisms. Despite its wide use, tobramycin has rarely been linked to instances of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548505/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682660.html"
},
{
    "Title": "Tocilizumab",
    "Text1": "Tocilizumab is a humanized monoclonal antibody to the interleukin-6 (IL-6) receptor which is used in the therapy of rheumatoid arthritis and other autoinflammatory conditions. Tocilizumab commonly causes mild serum aminotransferase elevations that are usually short lived and asymptomatic, but has also been linked to rare instances of clinically apparent liver injury with jaundice and occasional reactivation of hepatitis B.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548243/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611004.html"
},
{
    "Title": "Tofacitinib",
    "Text1": "Tofacitinib is an oral, small molecule inhibitor of Janus kinases that is used to treat moderate-to-severe rheumatoid arthritis, psoriatic arthritis and inflammatory bowel disease. Tofacitinib is associated with transient and usually mild elevations in serum aminotransferase levels during therapy, but has yet to be linked to cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547848/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613025.html"
},
{
    "Title": "Tolcapone",
    "Text1": "Tolcapone is a catechol-O-methyltransferase inhibitor used in the therapy of Parkinson disease as adjunctive therapy in combination with levodopa and carbidopa. Tolcapone has been associated with serum enzyme elevations during treatment and with several instances of clinically apparent acute liver injury, which can be severe and even fatal.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548573/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a698036.html"
},
{
    "Title": "Tolmetin",
    "Text1": "Tolmetin is a nonsteroidal antiinflammatory drug (NSAID) that is available by prescription only and used for therapy of chronic arthritis. Tolmetin is associated with low rates of serum aminotransferase elevations during therapy and has been linked to rare instances of clinically apparent drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548271/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a681033.html"
},
{
    "Title": "Tolterodine",
    "Text1": "Tolterodine is an anticholinergic agent used to treat urinary incontinence and hyperactive bladder syndrome. Tolterodine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548516/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699026.html"
},
{
    "Title": "Tolterodine",
    "Text1": "Tolterodine is an anticholinergic agent used to treat urinary incontinence and hyperactive bladder syndrome. Tolterodine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548516/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699026.html"
},
{
    "Title": "Tolvaptan",
    "Text1": "Tolvaptan is a vasopressin 2 receptor antagonist which is used for short term treatment of severe hyponatremia in patients with heart failure, cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone (SIADH). It has been used experimentally to prevention progression of disease in autosomal dominant polycystic kidney disease (ADPKD). Tolvaptan recently has been implicated in causing serum aminotransferase elevations as well as clinically apparent acute liver injury during long term use.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548503/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a609033.html"
},
{
    "Title": "Topiramate",
    "Text1": "Topiramate is a unique antiseizure medication that is widely used in treatment of partial and generalized seizures as well as for bipolar disorder, migraines and weight loss. Topiramate has been rarely associated with hepatic injury and largely when used in combination with other anticonvulsant medications.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548632/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612037.html"
},
{
    "Title": "Toremifene",
    "Text1": "Toremifene is a nonsteroidal antiestrogen that is used in the treatment of estrogen receptor positive breast cancer. Long term toremifene therapy has been associated with development of fatty liver, steatohepatitis, cirrhosis, and rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548338/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a608003.html"
},
{
    "Title": "Trabectedin",
    "Text1": "Trabectedin is natural product derived from the Caribbean sea squirt which has antineoplastic activity and is used to treat soft tissue sarcoma. Trabectedin therapy is associated with a high rate of transient serum enzyme elevations during treatment and with occasional instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548148/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615059.html"
},
{
    "Title": "Tramadol",
    "Text1": "Tramadol is an opioid analgesic used for the therapy of mild-to-moderate pain. Tramadol overdose can cause acute liver failure. Pharmacologic doses of tramadol has not been associated with cases of clinically apparent drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548235/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a695011.html"
},
{
    "Title": "Trametinib",
    "Text1": "Trametinib is a dual-kinase inhibitor that is used in the treatment of advanced malignant melanoma, usually in combination with darbafenib. Trametinib therapy is associated with transient elevations in serum aminotransferase and alkaline phosphatase levels during therapy, but has yet to be linked cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548731/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a613040.html"
},
{
    "Title": "Trandolapril",
    "Text1": "Trandolapril is an oral angiotensin-converting enzyme (ACE) inhibitor used in the therapy of hypertension and heart failure. Trandolapril is associated with a low rate of transient serum aminotransferase elevations, but has yet to be linked to instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548682/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697010.html"
},
{
    "Title": "Tranylcypromine",
    "Text1": "Tranylcypromine is a nonhydrazine monoamine oxidase inhibitor (MAO inhibitor) used in therapy of severe depression. Tranylcypromine therapy is associated with rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548572/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682088.html"
},
{
    "Title": "Trazodone",
    "Text1": "Trazodone is a serotoninergic modulating antidepressant that is used in therapy of depression, aggressive behavior and panic disorder. Trazodone therapy can be associated with transient, usually asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548557/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a681038.html"
},
{
    "Title": "Triamterene",
    "Text1": "Triamterene is a potassium-sparing diuretic widely used in the therapy of edema. Triamterene has been linked to rare cases of clinically apparent drug induced liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547859/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682337.html"
},
{
    "Title": "Triazolam",
    "Text1": "Triazolam is an orally available benzodiazepine used predominantly for therapy of insomnia. As with most benzodiazepines, triazolam therapy has not been associated with serum aminotransferase or alkaline phosphatase elevations, and clinically apparent liver injury from triazolam has been reported but is very rare.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547843/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684004.html"
},
{
    "Title": "Trifluoperazine",
    "Text1": "Trifluoperazine is a phenothiazine and antipsychotic agent that no longer commonly used in clinical practice. Trifluoperazine is a rare cause of clinically apparent acute cholestatic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548927/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682121.html"
},
{
    "Title": "Trifluridine",
    "Text1": "Trifluridine/tipiracil is the combination of an antineoplastic pyrimidine analogue (trifluridine) with an inhibitor of its metabolism (tipiracil) that is used in the therapy of refractory, metastatic colorectal cancer. Trifluridine/tipiracil is associated with a low rate of transient serum enzyme elevations during therapy, but has not been implicated in cases of clinically apparent acute liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548483/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a615049.html"
},
{
    "Title": "Trihexyphenidyl",
    "Text1": "Trihexyphenidyl is an oral anticholinergic agent used predominantly in the symptomatic therapy of Parkinson disease and movement disorders. Trihexyphenidyl has not been associated with serum enzyme elevations during treatment, but has been implicated in rare cases of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547977/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682160.html"
},
{
    "Title": "Trimethobenzamide",
    "Text1": "Trimethobenzamide is an orally available, antiemetic agent used in the therapy of nausea and vomiting associated with medications and gastrointestinal, viral and other illnesses. Trimethobenzamide has not been linked convincingly to elevations in serum enzymes during therapy and despite widescale use for almost 50 years, it has rarely been linked to instances of clinically apparent liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548057/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682693.html"
},
{
    "Title": "Trimipramine",
    "Text1": "Trimipramine is a tricyclic antidepressant used in the therapy of major (endogenous) as well as reactive (exogenous) depression. In clinical trials, trimipramine therapy was not associated with an increased rate of elevations in serum aminotransferase levels, and it has yet to be linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547855/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a602010.html"
},
{
    "Title": "Triptorelin",
    "Text1": "Triptorelin is a gonadotropin releasing hormone (GnRH) agonist that is a potent inhibitor of the synthesis of testosterone (in men) and estrogen (in women) and is used to treat advanced prostate cancer. Triptorelin is associated with a low rate of transient serum enzyme elevations during therapy, but has not been linked convincingly to cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548756/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611047.html"
},
{
    "Title": "Trisalicylate",
    "Text1": "Choline magnesium trisalicylate is a nonacetylated dimer of salicylic acid that is used in the therapy of chronic arthritis and for general management of pain and fever. Trisalicylate has been linked to rare instances of acute, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547963/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a602021.html"
},
{
    "Title": "Trospium",
    "Text1": "Trospium is an antispasmotic and anticholinergic agent used to treat urinary incontinence and overactive bladder syndrome. Trospium has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548779/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a604037.html"
},
{
    "Title": "Ustekinumab",
    "Text1": "Ustekinumab is a human monoclonal antibody to a polypeptide found on interleukin-12 and -23 that is used to treat autoimmune conditions and is approved for use in severe psoriasis. Ustekinumab is associated with a low rate of serum enzyme elevations during therapy, but has not been linked to cases of idiosyncratic, clinically apparent liver injury. Ustekinumab has immunomodulatory activity and may cause reactivation of hepatitis B in susceptible patients.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548014/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611013.html"
},
{
    "Title": "Valacyclovir",
    "Text1": "Valacyclovir is a nucleoside analogue antiviral agent and prodrug of acyclovir which is used in therapy of herpes simplex and varicella-zoster virus infections. Valacyclovir has been associated with rare instances mild, clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548655/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a695010.html"
},
{
    "Title": "Valsartan",
    "Text1": "Valsartan is an angiotensin II receptor blocker used alone or in combination with other agents to treat hypertension and reduce cardiovascular mortality after myocardial infarction. Valsartan is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547944/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697015.html"
},
{
    "Title": "Vandetanib",
    "Text1": "Vandetanib is a multi-kinase inhibitor that is used in the therapy of advanced or metastatic medullary thyroid cancer. Vandetanib therapy is commonly associated with transient elevations in serum aminotransferase during therapy, but has not been linked to cases of clinically apparent acute liver injury with jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548169/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612007.html"
},
{
    "Title": "Vardenafil",
    "Text1": "Vardenafil is a selective inhibitor of phosphodiesterase type 5 (PDE5) and is used as therapy of erectile dysfunction. Vardenafil has not been associated with serum aminotransferase elevations nor with clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548920/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a603035.html"
},
{
    "Title": "Varenicline",
    "Text1": "Varenicline is a partial agonist of the nicotinic acetylcholine receptor and is used to help in smoking cessation. Varenicline has been associated with a low rate of serum enzyme elevations during therapy and, since approval and its widescale use, with rare instances of clinically apparent mild liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548100/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a606024.html"
},
{
    "Title": "Vedolizumab",
    "Text1": "Vedolizumab is a humanized monoclonal antibody to integrin a4ß7 which is used in the treatment of inflammatory bowel disease. Vedolizumab has been linked to a low rate of serum enzyme elevations during therapy, but has not been linked to cases of idiosyncratic, clinically apparent liver injury with jaundice. Because vedolizumab is a potent inhibitor of lymphocyte function, it may cause reactivation of chronic hepatitis B in susceptible patients.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548741/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614034.html"
},
{
    "Title": "Vemurafenib",
    "Text1": "Vemurafenib is a selective inhibitor of BRAF kinase that is used in the therapy of patients with metastatic and advanced malignant melanoma. Vemurafenib therapy is commonly associated with transient elevations in serum aminotransferase during therapy and has been linked to rare, but occasionally severe cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548656/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612009.html"
},
{
    "Title": "Venetoclax",
    "Text1": "Venetoclax is an oral selective BCL-2 inhibitor and antineoplastic agent used in the therapy of refractory chronic lymphocytic leukemia (CLL). Venetoclax is associated with a low rate of transient serum enzyme elevations during therapy, but has not been implicated in cases of clinically apparent acute liver injury with jaundice. Venetoclax has potent immunosuppressive activity and may be capable of causing reactivation of hepatitis B.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548460/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a616028.html"
},
{
    "Title": "Verapamil",
    "Text1": "Verapamil is a first generation calcium channel blocker used for treatment of hypertension, angina pectoris and superventricular tachyarrhythmias. Verapamil has been linked to a low rate of serum enzyme elevations during therapy and to rare instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548362/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a684030.html"
},
{
    "Title": "Vigabatrin",
    "Text1": "Vigabatrin is a GABA derivative that is used in combination with other agents as therapy of refractory complex partial seizures and as monotherapy for infantile spasms. Vigabatrin is associated with a paradoxical decrease in serum enzyme levels during therapy, explained by its direct inhibition of aminotransferase activity. Vigabatrin has not been convincingly linked to cases of clinically apparent liver injury, but was linked to a fatal case of Reye syndrome in a child with severe developmental delay.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548253/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a610016.html"
},
{
    "Title": "Vilazodone",
    "Text1": "Vilazodone is a selective serotonin reuptake inhibitor (SSRI) and partial serotonin receptor agonist which is used in the therapy of major depressive disorders. In premarketing clinical trials, vilazodone therapy was not associated with an increased rate of elevations in serum aminotransferase levels, and it has yet to be linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548223/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a611020.html"
},
{
    "Title": "Vismodegib",
    "Text1": "Vismodegib is a kinase inhibitor active used in the therapy of unresectable or metastatic basal cell carcinoma. Vismodegib therapy is associated with a low rate or transient elevations in serum aminotransferase during therapy and has been linked to rare cases of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548629/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a612010.html"
},
{
    "Title": "Vitamin A",
    "Text1": "Vitamin A is a fat soluble vitamin necessary for health, deficiency of which can cause disorders of vision, skin, bone and immunity. The recommended daily allowance for vitamin A is 300 to 700 µg for children and approximately 700 to 900 µg for adults, amounts which can be provided by a normal diet. Higher doses of vitamin A can be toxic, leading to a constellation of signs and symptoms as well as liver injury, jaundice, enlargement of the liver and spleen, portal hypertension and cirrhosis.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548165/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a621028.html"
},
{
    "Title": "Vitamin B",
    "Text1": "Vitamin B refers to several water soluble vitamins often found together in foods, all of which are necessary for normal growth and metabolism, but none of which are synthesized in adequate amounts by humans. The common forms of vitamin B include vitamin B1 (thiamine), B2 (riboflavin), B3 (niacin), B6 (pyridoxine) and B12 (cyanocobalamin). Except for niacin (when given in high doses), there is no evidence that the other B vitamins, in physiologic or even super-physiologic high doses cause liver injury or jaundice. The major forms of vitamin B and selected other water soluble vitamins (biotin, pantothenic acid, choline) are discussed briefly in this record.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548710/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682586.html"
},
{
    "Title": "Vitamin C",
    "Text1": "Vitamin C (ascorbic acid) is a water soluble vitamin found in citrus fruits and green vegetables and deficiency of which is the cause of scurvy. There is no evidence that vitamin C, in physiologic or in moderately high doses, causes acute liver injury or jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548448/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682583.html"
},
{
    "Title": "Vitamin D",
    "Text1": "Vitamin D is a fat soluble vitamin important in the regulation of calcium metabolism and bone health and deficiency of which cause rickets, a disease marked by lack of mineralization of bone. Conventional doses of vitamin D are well tolerated without appreciable adverse effects. High doses of vitamin D can be toxic, leading to a constellation of signs and symptoms but not liver injury or jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548094/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a620058.html"
},
{
    "Title": "Vitamin E",
    "Text1": "Vitamin E (alpha tocopherol) is a fat soluble vitamin and potent antioxidant that is believed to be important in protecting cells from oxidative stress, regulating immune function, maintaining endothelial cell integrity and balancing normal coagulation. There is no evidence that vitamin E, in physiologic or even super-physiologic, high doses, causes liver injury or jaundice.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548283/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a621029.html"
},
{
    "Title": "Vorapaxar",
    "Text1": "Vorapaxar is an inhibitor of platelet aggregation that is used to decrease the risk of further cardiovascular thrombotic events in patients with a history of myocardial infarction or peripheral vascular disease. Vorapaxar therapy is associated with a low rate of serum aminotransferase elevations, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548903/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614044.html"
},
{
    "Title": "Voriconazole",
    "Text1": "Voriconazole is a triazole antifungal agent used primarily in the treatment or prevention of aspergillosis and candidal infections. Voriconazole therapy is associated with transient, asymptomatic serum aminotransferase elevations and is a known cause of clinically apparent acute drug induced liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547891/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a605022.html"
},
{
    "Title": "Vorinostat",
    "Text1": "Vorinostat is an oral histone deacetylase inhibitor and antineoplastic agent that is approved for use in refractory or relapsed cutaneous T cell lymphoma. Vorinostat is associated with modest rate of minor serum enzyme elevations during therapy, but has not been linked to cases of clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548004/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a607050.html"
},
{
    "Title": "Vortioxetine",
    "Text1": "Vortioxetine is a serotonergic antidepressant used for major depression disorders. Vortioxetine has been associated with a low rate of minor serum aminotransferase elevations during treatment, but has not been linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548752/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a614003.html"
},
{
    "Title": "Warfarin",
    "Text1": "Warfarin is a commonly used oral anticoagulant with anti-vitamin K activity. Warfarin therapy is associated with rare instances of idiosyncratic, clinically apparent liver injury that are usually mild and rapidly reversible on stopping.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548837/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a682277.html"
},
{
    "Title": "Zafirlukast",
    "Text1": "Zafirlukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma. Zafirlukast has been linked to rare, but occasionally severe cases of acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547915/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697007.html"
},
{
    "Title": "Zaleplon",
    "Text1": "Zaleplon is a benzodiazepine receptor agonist and hypnotic that is used as a sleeping pill. Zaleplon has not been implicated in causing serum enzyme elevations or clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548924/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601251.html"
},
{
    "Title": "Zanamivir",
    "Text1": "Zanamivir is an inhibitor of the influenza neuraminidase enzyme and is given by inhalation as therapy and prophylaxis against influenza A and B. Zanamivir has not been associated with clinically apparent liver injury, at least when given by inhalation.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548527/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699021.html"
},
{
    "Title": "Zanubrutinib",
    "Text1": "Zanubrutinib is an oral inhibitor of Bruton’s tyrosine kinase that is used in the therapy of refractory mantle cell lymphoma. Zanubrutinib has been associated with a low rate of serum enzyme elevations during therapy, but has not been linked to cases of clinically apparent acute liver injury although it may pose a risk for reactivation of hepatitis B in susceptible patients.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK553313/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a620009.html"
},
{
    "Title": "Zidovudine",
    "Text1": "Zidovudine is a nucleoside analogue and reverse transcriptase inhibitor used in combination with other agents in the therapy and prophylaxis of the human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Zidovudine is a rare, but well established cause of clinically apparent acute and chronic liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548210/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a601168.html"
},
{
    "Title": "Zileuton",
    "Text1": "Zileuton is an antiinflammatory leukotriene pathway inhibitor classified as an inhibitor of the enzyme 5-lipoxygenase that is used in the treatment of asthma and allergic rhinitis. Zileuton has been linked to rare cases of drug induced liver disease and is considered to be contraindicated in patients with active liver disease.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548397/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a697013.html"
},
{
    "Title": "Ziprasidone",
    "Text1": "Ziprasidone is an atypical antipsychotic used in the treatment of schizophrenia and bipolar disorder. Use of ziprasidone has not been consistently associated with serum enzyme elevations and has yet to be linked to instances of clinically apparent acute liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548663/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a699062.html"
},
{
    "Title": "Zolpidem",
    "Text1": "Zolpidem is a benzodiazepine receptor agonist that is used for the treatment of insomnia. Zolpidem has rarely been implicated in causing serum enzyme elevations and has not been reported to cause clinically apparent liver injury.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK547962/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a693025.html"
},
{
    "Title": "Zonisamide",
    "Text1": "Zonisamide is a new generation anticonvulsant that is typically used in combination with other antiepileptic medications for partial onset seizures. Zonisamide has not been associated with elevations in serum aminotransferase levels and clinically apparent drug induced liver disease has been reported with its use but is very rare.",
    "Page_URL": "https://www.ncbi.nlm.nih.gov/books/NBK548809/",
    "URL_LINK": "https://medlineplus.gov/druginfo/meds/a603008.html"
}
]
